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GENOME-WIDE ANALYSIS OF yvfI GENE in Bacillus subtilis  
SUMMARY 
Bacillus subtilis is a highly adaptive organism that can change its physiological state 
in response to received environmental signals and different growth conditions. Its 
genome is completely sequenced and its 4,2 Mbp pair long genome is known to 
encode for approximately 4,100 genes. About one third of total genes have specific 
defined functions and this numbers increases with each new study that targets genes 
with unknown functions. Explored patterns on B. subtilis genome uncovered the 
ability of B. subtilis to use highly diverse types of carbon sources and to produce 
secondary metabolites, including antibiotics and industrially important enzymes. 
Moreover, B. subtilis is also known to encode for prophages that signifies a possible 
role for bacteriophage infection in the transfer of genes during bacterial evolution. B. 
subtilis also evolved diverse types of cellular processes which involve two-
component signal transduction systems that sense environmental signals and 
develops an adaptive response, which can in turn act as a transcriptional regulator to 
change gene expression profile. These cellular processes include sporulation, biofilm 
formation, chemotaxis, virulence, antibiotic production and resistance. 
Among the different types of transcriptional regulator proteins, GntR family 
transcriptional repressor consists of about 2000 different proteins that have different 
action sites and also that function in different organisms. These proteins act as 
regulators on many different types of regulons. In Bacillus subtilis, the protein 
encoded from a novel gene, yvfI which was recently found to be essential for 
bacilysin biosynthis, consists of a FadR C-terminal ligand binding (FCD) domain 
which is very common among GntR family of proteins. Furthermore, 44 amino acid 
extended YvfI protein was identified to display an incomplete but considerable 
match to the wHTH domain of GntR family type proteins. Moreover, very recent 
study has shown that the yvfV-yvfW-yvbY (lutABC) operon which is required for 
lactate utilization is under the negative control of YvfI in Bacillus subtilis. The   
present research aimed at identification of genes that are regulated by YvfI 
transcriptional factor and therefore a genome wide comparative transcriptome 
analysis of wild type control strain PY79 that produces YvfI trancriptional factor and 
yvfI disrupted TEK1 mutant, yvfI::T10::spc during logarithmic phase (~OD600 0,7)  
and stationary phase (~ OD600 7) were performed. Subsequently, in order to confirm 
previously evaluated microarray data, quantitative analysis of expression of many 
genes that were identified to be induced or repressed during stationary phase were 
realized by using reverse transcription quantitative-PCR (RT-qPCR). Finally, YvfI 
affected genes were grouped according to their functional properties. As a result,  
this work enabled the identification of many pathways that are regulated by YvfI 
protein during stationary growth phase. These pathways include degradative enzyme 
production, antibiotic production and resistance, carbohydrate utilization and 
transport, nitrogen metabolism, membrane transport, fatty acid and lipid metabolism, 
protein synthesis and translocation, cell-wall synthesis, energy production and 
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membrane bioenergetics, mobile genetic element, phage infection, sporulation,  delay 
of sporulation and cannibalism, biofilm formation. In a harmony with YvfI 
regulation during stationary phase, YvfI was also found to inhibit carbohydrate 
metabolism and participate in regulation of genes involved in lipid metabolism 
during exponential growth phase. Furthermore, YvfI was found to induce resistance 
against bacitracin and repress pyrimidin biosynthesis during that  phase.  
Furthermore, comparative studies were performed in order to define expressional 
differences between IPTG induced (yvfI gene overexpressed) “B. subtilis PY79 
amyE::Pspac::yvfI, yvfI::Tn10” mutant strain and non-induced (yvfI gene not 
overexpressed) “B. subtilis PY79 amyE::Pspac::yvfI, yvfI::Tn10” mutant strain and 
this part of study clarified that YvfI is involved in the regulation of nitrogen 
metabolism, amino acids. catabolism and transport. Moreover, YvfI regulator protein 
probably induces indirectly the conjugal transfer of “ICEBs1” locus while it is also 
involved in the expression of prophage-like elements when overexpression achieved. 
Moreover, identification and localization of promoter region of yvfI gene by 5‟-
RACE-PCR analysis was also achieved. As a result, yvfI transcription was shown to 
be controlled from a 
A
-type promoter. Furthermore, a consensus sequence that 
shows a perfect match to Spo0A binding motif, three putative AbrB binding and one 
CodY binding sites were identified on the sequence that indicate that this gene is 
most probably under the control of global regulatory system operated by Spo0A, 
CodY and AbrB. 
Promising diverse regulatory behavior of YvfI displays a harmony with the fact that 
YvfI belongs to GntR family regulatory proteins that exert regulatory activity by 
applying repressions and inductions on many different types of regulons. Therefore, 
this study introduced YvfI as a critical regulator protein that helps to the adaptation 
of B. subtilis cells to different stimuli. 
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Bacillus subtilis’DE yvfI GENİNİN GENOM ÖLÇEĞİNDE ANALİZİ 
ÖZET 
Bacillus subtilis, çevresinden aldığı sinyallere ve büyüme koşullarına göre fizyolojik 
durumunu değiştirebilen, yüksek adaptasyon yeteneğine sahip bir organizmadır. Bu 
değişimler organizmanın morfolojisi ve fenotipine keskin bir şekilde yansırlar. 
Büyüme hızındaki dalgalanmalar, oksijen direnci, sıcaklık, pH ve besin 
kaynaklarının ulaşılabilirliği, B. subtilis‟in fizyolojik durumunu farklılaştırmaya 
yönelten başlıca sebeplerdir. Örneğin, logaritmik büyüme fazı sonlarına doğru sınırlı 
besin kaynağı sinyalini alan organizmada, hareketlilik ve kemotaksis sistemleri 
uyarılarak, hayatta kalma stratejileri gelişmektedir. Besin kaynağındaki kısıtlılık 
devam ettiğinde ise, organizmanın metabolizmasında antibakteriyel, antifungal ve 
antimetabolik özellikleri olan antibiyotiklerin üretimi, diğer organizmalarla rekabet 
ortamında galip gelebilmek için hızlanmaktadır. Alternatif kaynaklardan besin 
tüketimi için üretilen proteazların yanında, yabancı DNA‟nın hücre içine taşınımını 
sağlayan kompetans ve son olarak sporlanma da değişen çevresel şartlara adaptasyon 
için B. subtilis tarafından verilen cevaplardır. 
B. subtilis genomunun tamamen dizilenmesiyle birlikte, bu organizma patojen 
olmaması, kolay idare edilebilmesi, yüksek büyüme ve bölünme hızına sahip olması, 
kolay transforme edilebilmesi, adaptasyona uygun metabolizması, hidrolitik 
enzimler, polipeptit antibiyotikler ve çeşitli biyokimyasallar üretebilmesi sayesinde 
çok araştırılan bir model organizma olarak kabul edilmiştir. Genom dizilemesi 
sonucu 4,2 Mbp uzunluğundaki genomun yaklaşık olarak 4,100 geni kodladığı ortaya 
çıkmıştır. Gen setlerinin haritalanması ile total genomun üçte birinin kendine özgü 
tanımlanmış fonksiyonu olduğu ortaya çıkarken, bu sayı bilinmeyen fonksiyonlara 
sahip genler üzerindeki yeni araştırmalar sayesinde artmaktadır.  
B. subtilis genomunun yapısının keşfi ile B. subtilis‟in antibiyotik ve sanayi 
açısından önemli enzimler gibi ikincil metabolitleri üretebildiği ve çeşitli karbon 
kaynaklarını yüksek oranda kullanılabildiği ortaya çıkmıştır. Ayrıca, B. subtilis‟ in 
genomunun 10 civarında profaj ve profaj benzerlerini kodladığı ve böylece 
bakteriyel evrim sırasındaki genlerin transferindeki bakteriyofaj enfeksiyonunda rol 
alma ihtimali ortaya çıkmıştır. Bunların yanında, büyük gen ailelerinin varlığı gen 
düplikasyonlarından ortaya çıkmıştır ve en büyük gen ailesi 77 aday ATP-bağlayıcı 
taşıyıcı proteinden oluşmaktadır. 
Proteinlerde tek bileşenli sistemler, sinyal algılayıcı ve fonksiyonel cevap verici 
bölgelere sahiptirler. Prokaryotlarda sinyal iletimi bu sistemler aracılığıyla 
gerçekleşirken, fonksiyonel çıktı bölgesi büyük oranda sarmal-dönüş-sarmal (helix-
turn-helix) bölgesinden oluşmaktadır. Tek bileşenli sistemler ve HTH 
transkripsiyonel düzenleyiciler, DNA bağlanma bölgelerindeki dizilerin 
benzerliklerine göre gruplanmışlardır. Transkripsiyonel düzenleyici proteinlerin 
değişik türleri arasında, farklı aksiyon bölgeleri ve aynı zamanda farklı 
organizmalarda işleyen yaklaşık 2000 farklı proteinden oluşan GntR ailesi 
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bulunmaktadır ve bu aile yaygın olarak kanatlı sarmal-dönüş-sarmal motifi ile 
karakterize edilmişlerdir. GntR ailesin mensup 4 büyük altgrup kategorize edilmiştir. 
Bu gruplardan ilki olan FadR en kalabalık alt grup olarak göze çarpmaktadır. FadR-
benzeri proteinlerin fonksiyonlarındaki çeşitlilik oldukça yoğundur. Bu proteinler, 
aminoasit matabolizmasının regülasyonuyla ve aspartat, pirüvat, glycolat, galaktonat, 
laktat, malonat ya da glukonat gibi metabolik yol izleriyle ilişkilidir.  
Bunların yanı sıra, yeni tanımlanan bir gen olan, B. subtilis yvfI geninin GntR 
ailesinde çok yaygın bulunan FadR C-ucu ligand bağlayıcı (FCD) bölgesini ihtiva 
ettiği gösterilmiştir. Ayrıca bu genin B. subtilis‟de basilisin üretiminde gerekli 
olduğu da gösterilmiştir. Ayrıca YvfI proteinin genişletilmiş 44 amino asit daha 
içeren versiyonunun da GntR ailesi benzeri proteinlerinin kanatlı sarmal-dönüş-
sarmal bölgesiyle tam anlamıyla olmasa da önemli bir derecede benzeştiği 
gösterilmiştir. Ayrıca, çok yeni bir çalışma göstermiştir ki, yvfV-yvfW-yvbY (lutABC) 
operonu, yvfI‟nın baskın kontrolü altındadır.  
Bu sunulan çalışmada, YvfI transkripsiyonel faktörü tarafından etkilenmesi mümkün 
genleri tanımlayabilmek için YvfI kodlayamayan TEK1 mutantı, yvfI::T10::spc, ve  
YvfI transkripsiyonel faktörü üreten kontrol suşu PY79 arasında, logaritmik faz 
sırasında (~OD600 0,7) ve  durağan fazda (~OD600 7) detaylı karşılaştırmalı 
transkriptom analizi gerçekleştirilmiştir. Çalışmanın bu bölümünde daha önce 
değerlendirilen, micoarray yöntemi ile elde edilen verileri doğrulamak için durağan 
faz sırasında baskılanmış ya da indüklenmiş genlerin kantitatif analizleri RT-qPCR 
tekniği kullanılarak gerçekleştirilmiştir. Çalışmanın bu kısmının sonucunda, YvfI 
tarafından düzenlenen genler fonksiyonel özelliklerine göre gruplanmışlardır. Sonuç 
olarak bu çalışma ile büyümenin durağan evresinde YvfI proteini tarafından 
düzenlenmiş bir çok yol tanımlanmasının keşfi sağlanmıştır. Bu yollar; indirgenmiş 
enzim üretimi, antibiyotik üretimi ve direnci, karbonhidrat kullanımı ve iletimi, 
nitrojen metabolizması, zar iletimi, yağ asidi ve lipit metabolizması, protein sentezi 
ve yer değiştirmesi, hücre duvarı sentezi, enerji üretimi ve zar biyoenerjisi, mobil 
genetik elementi, bakteriyofaj enfeksiyonu, sprolanma, sprolanma gecikimi, 
yamyamlık ve biofilm oluşumudur. 
Durağan faz sırasında YvfI düzenlemesi ile uyum içerisinde olarak, eksponensiyel 
fazda YvfI proteinin karbonhidrat metabolizmasını engellediği ve lipit 
meatbolizmasında görevli genleri düzenlemede rol aldığı bu çalışmada gösterilmiştir. 
Bunların yanı sıra, karşılaştırmalı transkriptom çalışmaları IPTG ile indüklenen (yvfI 
olağandan fazla düzeyde ifade edilmiş) B. subtilis PY79 amyE::Pspac::yvfI, yvfI::Tn10 
mutant suşu ve indüklenmeyen (yvfI olağan düzeyde ifade edilmiş) B. subtilis PY79 
amyE::Pspac::yvfI, yvfI::Tn10 mutant suşu arasında yürütülmüştür. Bu çalışma 
YvfI‟nın nitrojen metabolizmasında görev aldığını ve amino asitlerin katabolizması 
ve taşınmalarında düzenleyici etki gösterdiğini ortaya koymuştur. Ayrıca, YvfI 
düzenleyici proteinin olağandan fazla düzeyde ifade edilmiş olmasının  “ICEBs1” 
lokusunun konjugal transferini dolaylı olarak indüklediği ve profaj benzeri 
elementlerin ekspresyonuna sebep olduğu ortaya konmuştur. 
Ayrıca,  bu araştırma 5‟-RACE-PCR analizi ile yvfI geninin promotör bölgesinin 
tanımlanması ve yerinin saptanmasını amaçlamaştır. Sonuç olarak yvfI 
transkripsiyonunun 
A
-tipi promotör tarafından kontrol edildiği gösterilmiştir. Bunun 
dışında, yvfI gen dizisi ve promotör bölgesi üzerinde Spo0A proteini bağlanma 
motifiyle mükemmel bir benzerlik gösteren konsensüs motifi ile üç AbrB bağlanma 
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motifi ve bir CodY motifi gösterilmiştir. Böylece, bu genin quorum-sensing yol izi 
üzerinden, global düzenleyici proteinler tarafından düzenlendiği belirlenmiştir. 
Sonuç olarak, YvfI‟nın umut verici muhtelif düzenleyici davranışları YvfI‟nın, bir 
çok değişik tipte regulona baskı ve indüksiyon uygulayarak düzenleyici aktivite 
gösteren GntR ailesi düzenleyici proteinlerine ait olduğu önerisi ile uyum 
göstermektedir. Bu yüzden bu çalışma B. subtilis‟in farklı uyaranlara uyumlu tepkiler 
vermesine yardımcı olmada, YvfI‟yı kritik bir düzenleyici protein olarak 
konumlandırmaktadır. 
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1. INTRODUCTION 
1.1 Bacillus subtilis 
Members of the Bacillus genus are Gram  positive organisms that are omnipresent in 
the nature; therefore can be found to be facing a diverse variety of environmental 
conditions and habitats. These ubiquitous organisms are well known to be rod-
shaped, aerobic or facultative, endospore-forming bacteria (Sonenshein et al., 1993; 
Harwood et al. 1990). The most extensively studied member of the Bacillus genus is 
Bacillus subtilis which was identified and named after by Ferdinand Cohn in 1872. 
Among the many characteristics that are attributed to Bacillus subtilis, being a 
chemoorganotroph, producing endospores, altering its physiology to develop 
adaptive responses and secreting many types of secondary metabolites are the most 
distinguishing features.  
As being a chemoorganotroph, Bacillus subtilis displays the ability to oxidize a wide 
variety of organic compounds. Due to this characteristic, B.subtilis can grow on a 
simple salt medium which would offer glucose or other sugars as carbon and energy 
source, inorganic nitrogen and adequate supply of oxygen (Trun and Trempy, 2004; 
Harwood et al. 1990). Furthermore, B. subtilis displays a mesophilic characteristic 
which allows it to grow as normal-sized colonies within a day in case it is incubated 
at 37
o
C (Harwood et al., 1990). Additionally, B. subtilis can survive under anaerobic 
conditions in such a case that nitrate is supplemented as the terminal electron 
acceptor to the environment (Earl et al., 2008, Harwood, 1996, Glaser et al., 1995, 
Cruzramos et al., 1995, Stein et al., 2005). During its growth, certain features of its 
metabolism might drive the organism into autolysis, which arises from the 
production of the peptidoglycan degrading enzymes that choose its own cell 
membrane structure as the target and resulting in autolysis caused by the increasing 
osmotic pressure across the cell membrane (Trun and Trempy, 2004). 
Moreover, Bacillus subtilis is highly adaptive organism that smoothly responds to 
changes in the environment and subsequently, different growth conditions create big 
affects on its phenotype and morphology. The ultimate causes of these changes can 
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be listed as fluctuations on the growth rate, oxygen tension, temperature, pH or 
nutrient availability (Sonenshein et al., 1993). For instance, when exposed to limited 
nutrient condition at the end of the exponential phase, B. subtilis develops a motility 
and chemotaxis system that leads to a promotion of its survival strategies. In case this 
limitation does not cease to exist, then its metabolism initiates antibiotic production 
which stands for over than two dozen of ribosomal and non-ribosomal antibiotics 
that have antibacterial, antifungal and antimetabolic features to eliminate competition 
and secretion of enzymes such as proteases to consume nutrients from alternative 
resources. Furthermore, genetic competence development in order to uptake 
exogenous DNA and sporulation are also other responses that might be exerted by 
Bacillus subtilis, when nutritional limitation remains effective (Sonenshein et al., 
1993; Hamoen et al., 2003). 
Thus, especially after the sequencing of its genome is completed B. subtilis became a 
highly investigated model organism thanks to its non-pathogenicity, easy handling, 
high growth rate, easily transformability, adaptive metabolism, ability to produce 
hydrolytic enzymes (e.g. alkaline proteases, amylases), polypeptide antibiotics (e.g. 
bacitracin), biochemicals (e.g. nucleosides) and insecticides (e.g. endotoxins) (Kunst 
et al., 1997, Harwood, 1996; Sonenshein et al.,1993; Hamoen et al., 2003). Hence, it 
is not only a highly rated model organism but it also displays commercially 
important health-beneficial properties; such that its spore form helps to prevent 
gastrointestinal disorders by acting as a probiotic and it is confirmed that it can be 
used as an alternative to many antibiotics thanks to its characteristic of being a novel 
prophylactic, therapeutic and growth promoting agent (Hong et al., 2004, Williams, 
2007, Fujiya et al., 2007).  
1.2 Genetic View of Bacillus subtilis  
Bacillus subtilis stands as one of the most articulately studied member of Bacillus 
species and it is a model organism for low GC Gram positive bacteria (Kobayashi et 
al., 2003). G+C content of the B.subtilis genome is reported to be about %43 while 
A+T regions can be found on specific regions of the chromosome (Kunst et al., 
1997). Studies on its genomic sequence was completed and published in Nature in 
November 1997 by Kunst and his friends. 4,214,810 base pair long genome of 
Bacillus subtilis is now known to consist of ≈4,100 genes (Kunst et al., 1997, 
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Kobayashi and Ogasawara, 2002). Following the first studies, a large set of genes 
were mapped, revealing out that about one third of total genes had specific defined 
functions and proteins encoded from another 1000 were classified as having 
unknown functions. Another prediction was set for about a quarter of the Bacillus 
subtilis genome to encode fueling and biosynthetic proteins (Moszer, 1998; Harwood 
et al., 1990). Additionally, B. subtilis genotype has further supported its being a 
highly adaptive organism, such that, large sets of genes were proposed to be 
responsible for environmental stress adaptations (Harwood et al., 1990). Explored 
patterns on B. subtilis genome further strengthened the capacity of B. subtilis to use 
highly diverse types of carbon sources and its ability to produce secondary 
metabolites, including antibiotics and industrially important enzymes. Furthermore, it 
was reported to encode for about ten prophages or prophage remnants that signifies a 
possible role for bacteriophage infection in the transfer of genes during bacterial 
evolution. Furthermore, the presence of large gene families has rised as the results of 
gene duplications and the largest family contains 77 candidate ATP-binding transport 
proteins (Hoch and Losick, 1997). 
Formerly, when the sequence was first published, only about 58% of the genes had 
assigned functions. However, this number has incresead up to 63% in the current 
databases (Kobayashi and Ogasawara, 2002). In a more recent study, published by 
Kobayashi and his colleagues in 2003, they have performed gene inactivation studies 
in order to estimate the minimal gene set required to maintain survival. In 
comparison to the results obtained in previous studies, which pointed out 192 genes 
to be essential for survival in given optimum conditions, another 79 genes were 
predicted to be essential as a result of this current study. Nearly half of the essential 
genes were categorized to fuction in information processing. Remaining genes were 
proposed to function in cell envelope synthesis, morphology and division 
specification and scarcely in cell energetics. On the other hand, 4% of essential genes 
were revealed out to display unknown functions (Kobayashi et al., 2003). Moreover, 
4215 kb genome further consists of a set of 86 tRNA genes, 30 rRNA genes and 
three small stable RNA genes (Kobayashi and Ogasawara, 2002). Additionally, the 
polarity of B. subtilis genome comes from the residence of 75% of genes in the 
leading strand and clustering of of highly expressed genes near the origin of 
replication (Rocha et al., 2000). 
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1.3 Bacillus subtilis Antibiotics 
Bacillus antibiotics that have been recognized for more than 50 years exhibit a highly 
diverse range of antimicrobial activity: while bacitracin, pumulin, laterosporin, 
gramicidin and tyrocidin exerts their effect towards Gram-positive bacteria; colistin 
and polymyxin are anti-Gram-negative antibiotics; and a broad spectrum antibiotic, 
difficidin is known to be produced as secondary metabolites (Stein et al., 2005; Trun 
and Trempy, 2004). Furthermore, antifungal agents are widely synthesized by B. 
subtilis strains as small antibiotic peptides, which cover less than 2000 Da in 
molecular weight and these peptide agents include iturin, surfactin, fengymycin, 
bacilysin, bacillomycin, mycosubtilin, B29I and mycobacillin (Majumdar and 
Bose, 1960; Sengupta et al., 1971; Tsuge et al., 2001; Stein, 2005; Peypoux et 
al., 1999; Carrillo et al., 2003; Peypoux et al., 1980, Peypoux et al., 1986; Li et al., 
2009).  
Number of antibiotics that are known to be produced by several hundred wild-type B. 
subtilis strains have reached to about two dozen and these antibiotics display a 
variety of structure. Genomic region that has been occupied by the genes that encode 
for these antibiotics is estimated to be about 350 kb which stands for approximately 
4-5% of the genome of B. subtilis (Stein, 2005). The function that is attributed to 
these antibiotics is beyond to be solely anti-microbial agents, but it is now known 
that some types of antibiotics have role in setting the morphology and physiology 
and promote the survival strategies of B. subtilis in diverse niches. Peptide antibiotics 
represent the largest and the most diverse class and they are synthesized either 
through ribosomal machinery followed by post-translational modifications and 
proteolytic processing (recognized as lantibiotics and lantibiotic-like peptides) or 
through non-ribosomal machinery by large megaenzymes, the non-ribosomal peptide 
synthetases (NRPSs). These two different biosynthetic pathways allow the 
incorporation of unusual (non-proteinaceous) constituents to these peptide antibiotics 
that exert a highly rigid, mainly hydrophobic with unusual components like non-
essential and D-amino acids (Katz and Demain, 1977; Stein, 2005; Li et al., 2009; 
Moszer, 1998). 
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1.3.1 Bacilysin 
Bacilysin is a simple and small sized (125kDa) dipeptide antibiotic strain which is 
produced and excreted by B. subtilis Marburg 168 strain against a wide range of 
bacteria and fungi  especially Candida albicans (Steinborn et al., 2005). B. 
amyloliquefaciens, B. licheniformis and B. pumilus  are among the species that are 
known to produce bacilycin which is considered to be a species trait of Bacillus 
subtilis (Loeffler et al., 1986). Bacilysin [L-alanine-(2.3-epoxycyclohexanone-4)-L-
alanine] (Figure 1.1) is composed of L-alanine residue at N-terminus and non 
proteinogenic L-anticapsin residue at C terminus (Walker and Abraham, 1970).  
 
Figure 1.1 : The structure of bacilysin. 
Antibiotic moiety of this dipeptide is displayed by its L- anticapsin residue (Kenig et 
al., 1976). The synthesis of anticapsin is initiated from prephenate of the aromatic 
acid pathway which is the primary precursor of bacilysin (Hilton et al., 1988). Prior 
to get subjected to peptidase, bacilysin is carried by a distinct peptide permease 
system into the cytosol where L-anticapsin residue is released and this free 
intracellular anticapsin residue acts as an inhibitor of glucosamine synthetase which 
in turn determines bacterial peptidoglycan or fungal mannoprotein biosynthesis and 
then ultimately leading to cell protoplasting and lysis (Kenig et al., 1976; Perry and 
Abraham 1979). On the other hand, antibiotic moiety of anticapsin is antagonized by 
glucosamine or N-acetylglucosamine (Walton and Rickes 1962; Kenig and Abraham, 
1976). 
Bacilysin production of B. subtilis 168 was found to be induced in specific 
circumstances including growth in a synthetic medium and to be inhibited by a 
number of growth conditions, such as certain nutrient supplements like glucose or 
casaminoacids and environmental factors such as pH and temperature (Özcengiz et 
al. 1990; Özcengiz and Alaeddinoglu 1991a, b; Basalp et al. 1992). Regulation of 
bacilysin biosynthesis has been widely studied revealing out that its production is 
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regulated on different levels both positively and negatively. Positive regulation is 
known to drived by guanonsine 5‟-diphosphate 3‟-diphosphate (ppGpp) (Inaoka et 
al., 2003) and also by quorum-sensing mechanism via peptide pheromone PhrC 
(Yazgan et al., 2003). ppGpp plays a crucial role in the transcription process of the 
biosynthetic ywfBCDEFG operon and that the transcription of these genes is 
dependent upon the level of intracellular GTP concentration of which is sensed by 
CodY-mediated repression system (Inaoka et al., 2003; Yazgan et al., 2003). 
Furthermore, negative regulation of CodY is more effectively sensed in the presence 
of excessive glucose or casamioacids (Ratnayake-Lecamwasam et al.,2001; Shivers 
and Sonenshein 2004). On the other hand, CodY also displays an important role in 
case of the regulation of spo0A and additionally, it also represses srfA operon. 
Therefore, when there is a codY null mutation, an increase in bacilysin production in 
wild-type cells becomes observable and repression on oppA, srfA and spo0A 
disappears. Moreover, recent studies have suggested that srfA operon deletion in the 
bacilysin producing wild type cells caused the bacilysin-negative phenotype 
(Mascher et. al., 2004 and Yazgan et al., 2003). Transposon mutagenesis studies 
have revealed out that bacilysin biosynthesis is directly linked to and under control of 
quorum sensing global regulation of ComQ/ComX, PhrC (CSF), ComP/ComA in a 
spo0K-dependent manner (Yazgan et al., 2001). Besided, the relationship between 
the sporulation and bacilysin biosynthesis has revealed out that changes in bacilysin 
formation pattern was caused by common effectors of sporulation (Basalp et al., 
1992). 
Biosynthetic core function on bacilysin production depends on a polycistronic 
operon ywfBCDE renamed as bacABCDE and the adjacent ywfGH genes (Figure 
1.2) (Steinborn and Hofemeister 1998/2000; Inaoka et al., 2003).  
 
Figure 1.2:  Organization of the bacilysin gene cluster ywfABCDEFG and ywfH gene 
of Bacillus subtilis 168 (Inoaka et al., 2003). 
 The unusual amino acid anticapsin is generated as a branching off from prephenate 
of the aromatic amino acid pathway through the action of BacA which is an atypical 
prephenate decarboxylase and BacB which is an aminotransferase that catalyzes an 
allylic isomerization (Hilton et al., 1988, Mahlstedt and Walsh 2010). BacA and 
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BacB products are found to be regioisomers of H(2)HPP (dihydro-4-
hydroxyphenylpyruvate) and then BacB is chosen as the substrate by YwfH, a short 
chain reductase that ultimately causes to promotion of cyclohexenol-containing 
tetrahydro-4-hydroxyphenylpyruvate H(4)HPP product. H(4)HPP gets subjected to 
transamination by YwfG which induces therefore formation of tetrahydrotyrosine 
(H(4)Tyr). This four enzyme (BacA, BacB, YwfH, and YwfG) pathway leads to the 
H(4)Tyr production and ultimately to anticapsin formation through a unknown 
reaction (Figure 1.3) (Mahlstedt and Walsh 2010).  
 
Figure 1.3: Four enzyme (BacA, BacB, YwfH, and YwfG) pathway leading to the 
H(4)Tyr production and ultimately to L-anticapsin formation. 
BacD gene is responsible for the ligation of L-alanine and L-anticapsin residues and 
it encodes for a L-amino acid ligase belonging to ATP-dependent carboxylate-
amine/thiol ligase superfamily and this study revealed this ligase as the branching 
point of bacilycin biosynthesis from nonribosomal peptide synthetase (NRPS) system 
(Stein, 2005). Furthermore, studies on the in vitro enzymatic synthesis of bacilysin 
proposed that formation of bacilysin was not carried out by multiple-carrier 
thiotemplate mechanism because adenylation and thiolation were observed only for 
L-alanine, but not for L-anticapsin (Marahiel, 1997; von Döhren  et al., 1999). On the 
contrary, it should be noted that formation of tetrahydrotyrosine (H(4)Tyr) from 
above mentioned four enzyme complex was pointed out to play building role in 
cyanobacterial nonribosomal peptides such as micropeptins and aeruginopeptins 
(Mahlstedt and Walsh 2010). Furthermore, BacE is responsible for self-protection 
from bacilysin by encoding an efflux protein for bacilysin excretion (Steinborn et al., 
2005). 
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1.4 GntR-Type Regulatory Proteins 
When mentioning about proteins, a two-component signal transduction system 
contains input and response domains in two different proteins that communicate via a 
His-Asp phosphotransfer. On the other hand, one component system refers to the 
proteins that have signal sensing domain and a functional response domain (Ulrich et 
al. 2005). In prokaryotes, signal transduction is acquired through these systems 
where sensor input domain is usually small-molecule binding domain and functional 
output domain is predominantly helix-turn-helix domain (Ulrich et al. 2005). It 
should be noted that although helix-turn-helix domain is the most common output 
domain, several other transcriptional regulator groups have been identified that 
consist of zinc-fingers, leucine-zipper, homeodomain, and β-sheet DNA-binding 
domains (Harrison, 1991; Pabo and Sauer, 1992). Still, the most extensively 
characterized and widely experimented group stands as the HTH group (Haydon and 
Guest, 1991; Henikoff et al., 1988; Brennan and Matthews, 1989; Weickert and 
Adhya, 1992; Gallegos et al., 1993; Nguyen and Saier, 1995) in which the the second 
α-helix is often called as the the “recognition” helix and it is addressed to the DNA 
major groove. Generally, HTH proteins bind to their target as dimers, therefore they 
possess the ability to bind 2-fold symmetric DNA sequences. Accordingly, this group 
is now counted useful for estimating general axioms that direct protein-DNA 
interactions (Pabo and Sauer, 1992; Wintjens and Rooman, 1996). 
One component systems and hence HTH transcriptional regulators are subdivided 
into families according to sequence similarities, generally in the DNA binding 
effector domain (Haydon and Guest, 1991; Ulrich et al., 2005; Henikoff et al., 1988; 
Weickert and Adhya, 1992; Gallegos et al., 1993; Nguyen and Saier, 1995; Rosinski 
and Atchey, 1999). These families are usually classified after the best-characterized 
member and these families include LysR (Henikoff et al. 1988), TetR (Ramos et al. 
2005), IclR (Nasser et al. 1994), GntR (Haydon and Guest 1991), and AraC 
(Gallegos et al. 1997) superfamilies. Sequence comparisons and phylogenetic, 
structural, and functional studies have resulted in exploration of a common 
consensus sequence that is recognized by each family and wherefrom it offered a 
way to label new members based on their families (Karmirantzou and Hamodrakas, 
2001). 
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Sequence similarities are not common between DNA binding or oligomerization 
domains therefore these sites are not usually taken into consideration when deciding 
for which member belongs to which family. On the other hand, they display a crucial 
part in the regulating process. Most importantly, it is often these domains that 
provide correct alignment of HTH motif and DNA binding ability of transcriptional 
regulatory protein (Rigali et al., 2002). Therefore a recent study conducted by Rigali 
and friends in 2002, has focused on exploration of the link that exists between 
regions involved in the regulating process by studying the HTH GntR family of 
bacterial regulators.  
Regulators from GntR family transcriptional repressor consist of a conserved N-
terminal DNA binding domain (D-b domain) followed by C-terminal domain 
involved in the effector binding and/or oligomerization (E-b/O domain) and 
additionally they are best characterized by a winged helix-turn-helix motif which acts 
as the DNA recognition domain (Haydon and Guest 1991; Rosinski and Atchley 
1999; van Aalten et al. 2000; Lee et al. 2000; Rigali et al. 2002; Aravind and  
Anantharaman 2003). First description addressing this family was given by Haydon 
and Guest in 1991 and it was named as GntR, based on the repressor of the gluconate 
operon in Bacillus subtilis (Fujita et al., 1986; Reizer et al., 1991). These proteins act 
as regulators by applying regulations on many different types of regulons. GntR 
family of transcriptional regulators consists of about 2000 different proteins that have 
different action sites and also that function in different organisms including archeal 
organisms (Rigali et al., 2002). 
Study by Rigali and friends in 2002 has led to defining family signatures and 
therefore many subfamilies. Initially, a phylogenetic tree was created by using full-
length multiple alignment of GntR-resembling members (Figure 1.4). As a result, it 
became obvious that C-terminal heterogeneity has divided the families into four 
major classes based on effector binding and/or oligomerization (E-b/O domain) 
types. Two-dimensional structural predictions has supported four major types 
prediction (Figure 1.5, a–d) including distinct varying members in each subfamily 
and this subdivision was accepted to be highly efficient considering the fact that only 
7% of tested proteins had escaped from this subdivision. It is also suggested by this 
study that members that belong to a defined subfamily were commonly created by 
duplication events. 
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Figure 1.4. Phylogenetic tree created by using full-length multiple alignment of 
GntR-like members. GntR-resembling transcriptional regulators were 
categorized into four major subfamilies based on the observed C-
terminal structural topologies.  
The first GntR subfamily, FadR, is the most crowded subfamily as it covers 40% of 
GntR-like regulatory proteins. Members of this subfamily consist of a six or seven α-
helices containing C-terminal domain depending on subgroups (Figure 1.5a). VanR-
like regulators differ from FadR protein subgroup based on the loss of the first α-
helix (α4). The crystal structure of the C-terminal domain of FadR has been 
enlightened (van Aalten et al., 2000; van Aalten et al., 2001) and its three-
dimensional structure was decided to be useful to stand for a scaffold to conduct 
studies on the entire subfamily (Rigali et al., 2002). Considering functional 
properties of the FadR-like proteins, it is remarkable that these proteins are 
associated to the regulation of amino acids metabolism or to various metabolic 
pathways such as aspartate (AnsR), pyruvate (PdhR), glycolate (GlcC), galactonate 
(DgoR), lactate (LldR), malonate (MatR), or gluconate (GntR). For instance, 
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in Escherichia coli FadR protein from GntR repressor family acts regulating fatty 
acid biosynthetic and degradation genes (DiRusso et al., 1999). Corynebacterium 
glutamicum protein LldR, which is responsible for the regulation of L-Lactate and 
sugar utilization operon was identified very recently to belong to the FadR subfamily 
of GntR family regulators (Georgi et al., 2008).  
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Figure 1.5. Sequence alignments of the C-terminal domains of proteins belonging to 
the GntR family on the basis of their structure. Symbols for conserved 
amino acid properties were given as follows: !, conserved hydrophobic 
residues (ILVAMFYW); @, aromatic residues (FYW); −, negatively 
charged residues (ED); +, positively charged residues (RKH); ○, small 
residues (GSATPN). ↓ and θ indicate residues implicated in effector 
binding and dimerization of the FadR protein (van Aalten et al., 2000; 
van Aalten et al., 2001). Also in panel a, the underlined residue 
represents the single amino acids mutations on what affect gluconate 
binding ability in GntR (Yoshida et al., 1995). In panel d, the underlined 
residue corresponds to the amino acid lysine that established the covalent 
link with the cofactor in aminotransferases. Spaces in consensus 
sequences refers to insertions within the alignment.  
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Second subfamily, HutC, differs from all-helical FadR C-terminal domains, because 
the C-terminal domain of HutC-like proteins contains both α-helical and β-sheet 
structures (Figure 1.5b). The subfamily represents 31% of GntR-like regulators and 
its 170 amino acid long C-terminal domain resembles highly to FadR subgroup of 
FadR subfamily in length (Rigali et al., 2002; van Aalten et al., 2000). At several 
positions, including β3, α7, and β6, structural elements were observed to be changed in 
the means of conservation and this alteration in E-b/O topology was accorded to the 
structural adaptations as responses to high diversity of biological processes regulated 
by HutC-like members (Rigali et al., 2002). This subfamily was named after the 
HutC regulator from Pseudomonas putida, which was previously suggested to 
display an inhibitory effect on the expression of histidine utilization genes and to be 
repressed by the binding of uroconate (Allison and Phillips 1990). YvoA protein that 
belongs to GntR/HutC family of bacterial transcriptional regulators regulates many 
biological pathways from antibiotic production to profileration and growtn not only 
in Bacillus subtilis but also in other organisms like Streptomyces griseus or 
Streptomyces coelicolor (Rigali et al., 2006; Resch et al., 2010; Seo et al. 2002). 
Furthermore, many other proteins like TraR that functions in oligomerization were 
found to belong to the GntR/HutC subfamily repressor (Kataoka et al., 2008). 
Among other studied members of the HutC family FarR from Escherichia coli was 
reported to regulate citric acid cycle pathway and reacts against long-chain fatty 
acids (Quail et al. 1994). Contrarily, Sampaio and friends suggested that FarR 
regulates genes coding for  2-O-α-mannosyl-D-glycerate transport and metabolism 
system. On the other hand,  FarR-dependent regulation in C. glutamicum has put out 
a support to FarR  function described  by  Quail  et  al.  İn 1994 (Haenssler et al., 
2007).  TreR from Bacillus subtilis regulates trehalose operon and this protein  is  
inhibited  by  trehalose-6-phosphate  (Schock  and Dahl 1996), furthermore proteins 
like KorSA, KorA are  repressors  of  the  genes  involved  in conjugative  plasmid  
transfer  in  Streptomyces  species (Kendall and Cohen 1988; Hagege et al. 1993).   
In case of third subfamily, called MocR, E-b/O domain is extensively distinct from 
the first two types because of average length of C-terminal domain of about 350 
amino acids and because of its homology to the class I of aminotransferase proteins 
(Sung et al., 1991) (Figure 1.5d). These proteins catalyze a transamination reaction 
which is important for amino acid metabolism as well as in linkages to carbohydrate 
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and fatty acid metabolism. During transamination, an amino group of an amino acid 
is transferred to a α-keto acid in a reversible manner by these regulatory proteins 
which are usually found as dimers during action and pyridoxal 5‟-phosphate (PLP) 
works as a cofactor of their regulating activity (Ko et al., 1999). One example of 
these regulatory proteins is PdxR in Streptomyces venezuelae, which is involved in 
the regulation of pyridoxal phosphate synthesis (Magarvey et al., 2001). Another 
example can be given from Rhodobacter capsulatus in which the GntR-Like 
regulator TauR which shows the highest similarity to the MocR subfamily, named 
after S. meliloti MocR, was found to activate expression of taurine utilization genes 
(Wiethaus et al., 2008; Rossbach et al., 1994). In contrast to FadR, HutC, and YtrA 
subfamilies, which exert their regulatory effects on identified pathways by binding to 
inverted repeats that are found on the promoter regions of their target genes, MocR-
like proteins bind to direct repeats on the promoter regions (Rigali et al., 2002). For 
instance, MocR-like protein GabR from B. subtilis acts as both an autorepressor and 
an inducer of genes involved in the utilization of γ-aminobutyrate (GABA) as the 
sole nitrogen source (Belitsky, 2004; Belitsky and Sonenshein, 2002). 
The fourth subfamily, YtrA was shown to be moderately smaller than the other three 
subfamilies based on the fact that it possesses a short C-terminal domain consisting 
of only two α-helices (Figure 1.5c). The subfamily represents 6% of GntR-like 
regulators and most of this limited number of proteins regulates some of the operons 
involved in ATP-binding cassette (ABC) transport systems (Rigali et al., 2002).  
In case the DNA-binding (D-b) domain topology was investigated through structural 
predictions, all of the secondary structure elements in the whole GntR family was 
found to be rather well conserved in similar relative positions. They were found to 
consist of three α-helices and two (sometimes three) β-sheets. Their permutation was 
proposed to be: α1α2α3β1β2 (Figure 1.6). 
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Figure 1.6. Structure-based sequence alignment of the N-terminal DNA-binding 
domain of proteins of the GntR family. Symbols for conserved amino 
acid properties are as follows: !, conserved hydrophobic residues 
(ILVAMFYW); @, aromatic residues (FYW); −, negatively charged 
residues (ED); +, positively charged residues (RKH); ○, small residues 
(GSATPN). ↓ and θ indicate, in FadR, residues refers to DNA binding 
and dimerization (van Aalten et al., 2000; van Aalten et al., 2001). The 
mutation on underlined amino acid residues is known to alter the DNA 
binding ability of AphS (Ortuno-Olea and Duran-Vargas, 2000), FadR 
(Raman et al., 1997), and GntR (Yoshida et al., 1993). Spaces in 
consensus sequences refer to insertions within the alignment. 
When D-b domains of GntR type regulator proteins were compared, similarities 
between amino acid alignments of these domains were found to be constricted to 
25%. Therefore, it was concluded that common DNA-binding domain ancestor of 
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GntR family is represented by structural topology rather than by amino acids 
alignment. On the other hand, one quarter percentage was proven to elevate to 40 and 
60% when subfamilies are analyzed separately. Therefore, although subfamilies were 
categorized by the C-terminal domains, C-terminal similarity was reflected on the 
DNA-binding domain and on the HTH motif itself. Figure 1.6 further displays the 
fact that similarities between MocR and YtrA subfamilies were distinctively higher. 
The fusion between the D-b domain and the E-b/O domain was proposed to realized 
separately for the FadR, HutC, and MocR/YtrA subfamilies hence explaining that 
these subfamilies were definitely not emerged from each other. Still, figure 1.4, 
strengthens the observation of high level similarity between the D-b domains 
belonging to the MocR and YtrA subfamilies because phylogenetic tree also 
displayed higher similarity such that these two subfamily was designated to emerge 
from a common branch and this fact emphasize a conserved amino acids composition 
in their N-terminal domain (Rigali et al., 2002). It should be noted that some unusual 
secondary structure element alignments was observed in the N-terminal structural 
consensus (α1α2α3β1β2). These anomalities include NtaR from Chelatobacter 
heintzii and EmoR from the EDTA-degrading bacterium, BNC1 lacking their first α-
helix (α1), WhiH from Streptomyces aureofaciens or PdxR from S. venezuelae 
containing one extra helix upstream of α1, YtrA regulators displaying an additional β-
sheet upstream of α1 (Rigali et al., 2002). 
In the means of operator sites analysis it was supposed in the same study by Rigali et 
al. that highly conserved DNA-binding motifs may bind similar operator sequences. 
When C-terminal inverted repeat operator site sequences of previously studied GntR-
like proteins were aligned, bound sites has given a palindromic 5′-
(N)yGT(N)xAC(N)y-3′ sequence. (y) stands for divergence on the number of 
nucleotides whereas (N) stands for the nature of nucleotide. Based on the observed 
palindromic sequence, it was concluded that the center of the sequence was highly 
conserved, while the adjacent sequence diverged and this model was also observed 
by Weickert and Adhya in the study that focused on LacI/GalR family. Hence the 
central region of the operator was accepted to be the signal-attracting region, whereas 
the peripheral zones worked as the operator discriminator in these regulatory 
proteins. 
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1.5 YvfI, a GntR-Type Regulatory Protein, Involved in Bacilysin Production 
In addition to global regulatory genes, bacilysin biosynthesis in Bacillus subtilis was 
also reported to be regulated by a novel gene, yvfI (Koroglu et al., 2008). In this 
study, three mutants that display bacilysin negative phenotype were isolated using 
transposon mutagenesis studies (Figure 1.7). 
 
Figure 1.7 : mini-Tn10 insertional mutagenesis derivatives of wild type PY79 strain 
of Bacillus subtilis and three mutants TEK1, TEK2 and TEK3 assayed 
for their antimicrobial activity by paper disc-agar diffusion assay.  
Following the confirmation that antimicrobial activity came directly from lack of 
bacilysin, DNAs  from  TEK1,  TEK2  and TEK3  were  subjected to southern blot 
analysis and by using mini-Tn10 (ori-spc)  probe  three independent mutant  isolates 
were shown to carry the same insertional mutation on the same locus. Tn10 
insertions and their ﬂanking regions were cloned as further step and as a result of 
sequencing analysis, insertion in all three mutants were found to be in the yvfI gene 
which displays the  genomic  organization given in figure 1.8.  
 
Figure 1.8 : Genomic organization of the yvfI gene and peripheral chromosomal 
regions (Kunst et al., 1997). Also shown is the 427 or 460 nucleotide 
long transposon insertion in the yvfI gene (Köroğlu et al., 2008). 
Hence, transposon mutagenesis was applied in order to point out mutations on which 
genes resulted in bacilysin-negative phenotype and as a result, determined mutation 
on yvfI gene has shown that yvfI was essential for dipeptide antibiotic bacilysin 
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biosynthesis in Bacillus subtilis (Köroğlu et al., 2008). Furthermore, A conserved 
Domain Database (CDD) (Marchler-Bauer et al. 2005) search was applied for YvfI 
protein and this study pointed out FadR C-terminal ligand binding (FCD) of YvfI 
protein which is located at the C-terminal of protein and very common among GNTR 
family of proteins. FCD domain-harboring proteins were previously published by 
van Aalten and colleagues (2000). 44 amino acid extended proposed YvfI protein 
(Kunst et al., 1997) was also examined to reveal an incomplete but considerable 
match to the GntR wHTH domain. Therefore, it was demonstrated that YvfI 
sequence shows great homology with its orthologs from different species. Studies on 
YvfI sequence suggested that this protein displays high homology with its orthologs 
from different species including FadR (Marchler-Bauer et al., 2005). FadR-like 
proteins function in the regulation of many pathways involved in amino acids 
metabolism, L-lactate and sugar utilization, fatty acid transport and degradation as 
well as in many metabolic pathways including those for aspartate, pyruvate, 
glycolate, galactonate metabolism (Rigali et al., 2002).   
Moreover, very recent study has shown that the yvfV-yvfW-yvbY (lutABC) operon is 
under the control of yvfI, consequently renamed as lutR and was further accepted to 
be a part of GNTR regulatory proteins that consists of a HTH recognition domain 
(Chai et al., 2009). Furthermore, it was speculated by Chai an coworkers that the 
yvfV-yvfW-yvbY operon speciﬁes a pathway for the utilization of L-lactate and 
therefore this operon was renamed as LutABC. Furthermore, homologous operons 
were demonstrated in different bacterial genomes, suggesting that LutABC operon 
stands for a widely conserved genomic organisation for L-Lactate utilisation (Figure 
1.9b). However, a 15 kb loop was observed that separates lutABC operon from  the  
lutR, which encodes for GntR-type repressor, lutP, which putatively encodes for a 
lactate permease sigL,  and  yvfG  genes  and  the  epsA-to-O operon so that B. 
subtilis differs from  B.  licheniformis on that matter (Figure 1.9a) (Chai et al., 2009; 
Veith et al., 2004). Hence these observations all together have led to the conclusion 
that function of the lutABC operon is related to not all but to one or more members of 
the cluster. Keeping in mind that lutP putatively encodes for a lactate permease, it 
was suggested by Chai and coworkers that  lutABC  operon  is  involved  in  lactate 
metabolism. 
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Figure 1.9 :  Genomic organisation the  lutABC  (formerly  yvfV-yvfW-yvbY)  
operon.  (A)  An  alignment  of  genomic organisation of lutABC and 
epsA-to-O operons of B. subtilis and B. licheniformis. (//)  represents 
15 kb loop between lutR gene and lutABC operon. (B) Homologous 
operons from different bacterial genomes. (*) represents 15 kb loop 
between lutR gene and lutABC operon. (Chai et al., 2009) 
Because lutA-lacZ fusion strain showed an increased activity when strain was 
subjected to lutR deletion, it was hypothesized that lutABC operon was subjected to 
repression by LutR (Chai et al., 2009). In this study, it was demonstrated that lutABC 
operon is not solely under the control of LutR but also SinR (Figure 1.10). Moreover 
it was concluded that LutR and SinR act in cooperation on the repression of LutABC 
operon. SinR is known to repress 18 genes that belong epsA-to-O and yqxM-sipW-
tasA operons and these operons are responsible for  extracellular matrix that hold the 
long chains cells known as biofilm (Branda et al., 2005; O‟Toole and Kaplan, 2000; 
Stoodley et al., 2002; Sutherland, 2001; Ren et al., 2004; Kearns et al., 2005; Chu et 
al., 2006; Branda et al., 2006).  
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Figure 1.10 : Proposed model for LutABC mediated utilization of L-lactate and 
LutR and SinR drived regulation of  the  operon during which the 
LutR and  SinR  repressors  are  hypothesized  to act in cooperation 
on the repression of LutABC operon by binding to DNA. L-lactate is 
proposed to interact with LutR, thereby derepressing the operon, 
which demands both LutR and SinR to be repressed. 
1.6 Aim of the Study 
Prior to the studies reporting the involvement of YvfI on the regulation of lutABC 
operon, YvfI in B. subtilis has first been identified as a novel gene required for the 
biosynthesis of the dipeptide antibiotic bacilysin. Furthermore, extended YvfI protein 
was accepted to display a partial but important match to the wHTH domain which is 
signifant for GntR family regulatory proteins. This protein also found to show high 
homology with its orthologs from different species including FadR and proteins that 
belong to this subfamily function in the regulation of many pathways involved in 
amino acids metabolism, L-lactate and sugar utilization, fatty acid transport and 
degradation as well as in many metabolic pathways including those for aspartate, 
pyruvate, glycolate, galactonate metabolism. The present research aimed at the 
understanding the broader regulatory role of YvfI in B. subtilis. For this purpose, 
DNA microarray technology was applied for the detailed comparative transcriptome 
analysis of wild type control strain PY79 that produces YvfI transcriptional factor 
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and yvfI disrupted TEK1 mutant, yvfI::T10::spc during stationary phase (~OD600; 7) 
where yvfI expression reaches a maximum level in cells grown in PA medium and 
during logarithmic phase of growth (~OD600; 0,7)  Furthermore, quantitative reverse 
transcriptase PCR was also performed for the validation and articulation of data 
obtained from array analysis. For the genes that did not meet Bayesian probability 
criteria, lacZ-fusions were further constructed to observe their expression profile 
changes conducted by YvfI. Furthermore, comparative studies were performed in 
order to define expressional differences between IPTG induced (yvfI gene 
overexpressed) “B. subtilis PY79 amyE::Pspac::yvfI, yvfI::Tn10” mutant strain and 
non-induced (yvfI gene not overexpressed) “B. subtilis PY79 amyE::Pspac::yvfI, 
yvfI::Tn10” mutant strain. 
This research also focused on gaining an insight about the regulation of  yvfI gene 
expression. For this purpose, transcription initiation site of yvfI gene was determined 
by performing 5‟ RACE-PCR analysis in this study. 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Bacterial strains 
Throughout this study, Bacillus subtilis PY79, which is a prototrophic derivative of 
Bacillus subtilis 168 standard strain was used as the wild type strain. Strains and their 
genotypes that are used in this project are listed in Table 2.1. 
Table 0.1 : Bacterial strains and their genotypes used in this project. 
Strain Genotype Source 
Bacillus 
subtilis PY79 
Wild type, BSP cured prototrophic 
derivative of B.subtilis 168 
P.Youngman 
E.coli 
Top10F‟ 
[lacIq Tn10(Tet
r
)], mcrA (mrr-
hsdRMS-mcrBC), f80lacZ M15 
lacX74, deoR, recA1, araD139 (ara-
leu)7697, galU, galK, rpsL (Strr), 
endA1, nupG 
M.A.Marahiel 
MI105 spoIIE::lacZ::kat Grossman 
TEK1 yvfI::Tn10::spc T. E. Köroğlu 
TEK7 yvfI::lacZ::erm T. E. Köroğlu 
OYK1 amyE::Pspac::yvfI in this study 
OYK2 rapI::lacZ::erm in this study 
OYK3 yvfI::Tn10::spc rapI::lacZ::erm in this study 
OYK4 spoIIE::lacZ::kat  in this study 
OYK5 yvfI::Tn10::spc spoIIE::lacZ::kat in this study 
 
  24 
2.1.2 Bacterial culture media 
Culture media compositions and preparation techniques are given in Appendix C. 
2.1.3 Buffers and solutions 
The compositions and preparation of buffers and solutions are given in Appendix D. 
2.1.4 Chemicals and enzymes 
The chemicals and enzymes that were used in this study are given in Appendix E 
along with their suppliers. 
2.1.5 Laboratory equipment 
The laboratory equipment used during the project is listed in Appendix H. 
2.1.6 Maintenance of bacterial strains 
B. subtilis  and E. coli strains were grown in Luria-Bertani (LB) liquid medium and 
kept on Luria-Bertani (LB) agar plates at +4 
○
C. For extended storage, 10 % LB 
glycerol stock was prepared for each strain and stocks were kept at -80°C.  
2.1.7 pGEM®-T easy cloning vector 
pGEM®-T Easy Vector System that is supplied by Promega, is used in this study 
because it is a convenient system for the cloning of PCR products (Figure 2.1). 
Within the α-peptide coding region of the enzyme β-galactosidase, pGEM®-T Easy 
Vectors contains promoter regions for T7 and SP6 RNA polymerase flanking the 
multiple cloning region within which there reside multiple restriction sites. The 
pGEM®-T Easy Vector multiple cloning region is flanked by restriction enzymes 
EcoRI, BstZI and NotI digestion sites. Hence, these three enzyme provide the 
opportunity of three single-enzyme digestions for the release of the cloned insert. 
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Figure 2.1 : pGEM®-T Easy Vector circle map and sequence reference points. 
2.1.8 pDrive cloning vector 
pDrive Cloning Vector is provided by QIAGEN in a linearized form with a U 
overhangs at each 3‟ and 5‟ ends which allows direct ligation with A overhangs of 
PCR products generated by iTaq and other non-proofreading DNA polymerases 
(Figure 2.2). The vector allows kan and amp selection and blue/white screening and 
includes α–peptide portion of LacZ gene. This vector contains several restriction 
endonuclease recognition sites around the cloning site and on either site a T7 and 
SP6 promoter is located. These promoters allows not only in vitro transcription 
procedure but also sequence analysis with standart sequencing primers. By means of 
the multiple cloning sites, restriction analysis of the recombinant plasmid can be 
performed easily. pDrive Cloning Vector also exibits a phage f1 origin which allows 
production of single stranded DNA. A map of the pDrive Cloning Vector is retrieved 
from Qiagen official web site.  
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Figure 2.2 : Genomic map of pDrive Cloning Vector. 
2.1.9 pMUTIN T3 cloning vector 
Insertional mutagenesis is a commonly used method in order to study the 
characterization of open reading frames found on Bacillus subtilis. Therefore, several 
constructed vectors are used for the systematic gene inactivation and to observe the 
changes in the phenotype or life cycle of the bacterium (Vagner et al., 1998). For this 
purpose a special integrational plasmid, called pMUTINT3, that offer many efficient 
properties is commonly chosen (Figure 2.3). These plasmids are unable to replicate 
in B.subtilis and in order to be able to measure the target gene expression they carry a 
reporter lacZ gene. Moreover, pMUTIN T3 plasmid has an inducible promoter, 
Pspac, developed by Yansura and Henner (1984) in order to control the expression 
of the genes found downstream of the target gene. The Pspac inducible promoter 
includes one of the three-lac operators, known as “O1” and RNA polymerase 
recognition sequences of the SPO1 phage. Besides, the plasmid carries amp and erm 
antibiotic resistance genes expressed in E.coli and B. subtilis, respectively. 
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Figure 2.3: Genomic map of pMUTINT3 vector including the functional genes in 
the structure as well as the restriction map (Vagner et al., 1998). 
2.1.10 pDR66 cloning vector 
pDR66 was  constructed by Ireton et al.  from pDH32  (Shimotsu and Henner 1986) 
and  pAG58 (Jaacks et al. 1989) vectors. This multipurpose cloning vector contains 
the selectable marker amp for growth in E.coli and a selectable marker for B. subtilis 
(cat) and an origin of replication for maintenance in E. coli (Figure 2.4). Another 
important trait of pDR66 is its regions of homology to the nonessential amyE locus 
(amyE front and amyE back). pDR66 displays multiple cloning site with HindIII, 
XbaI, SalI, and SphI sites downstream of Pspac. Furthermore, intact lacZ is removed 
from the vector. 
 
Figure 2.4 : Map  of pDR66,  used as a cloning  vector that was constructed to create  
a fusion of the desired gene to the  LacI-repressed/IPTG-inducible  
promoter,  Pspac.  
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2.2 Methods 
2.2.1 DNA techniques and manipulation 
2.2.1.1 Plasmid DNA isolation 
Qiagen Plasmid Purification Mini Kit (Qiagen Inc., Valencia, CA) was preferably 
used for isolation of E. coli plasmid DNA. Bacterial cells that were cultured 
overnight in LB medium at 37
o
C, were harvested at 13.000 rpm for 5 minutes. After 
removing supernatant, the pellet was thoroughly resuspended in 300 μL P1 buffer 
(Appendix B). Then, solution mix was supplemented with 300 μL P2 (Appendix B) 
buffer and mix was then incubated at room temperature for 5 minutes. Following this 
incubation, 300 μL P3 (Appendix B) buffer was added and mixed through inverting 
the tubes until the lysate is no longer viscous. The sample was incubated for 15 
minutes on ice. Following centrifugation at 13.000 rpm for 15 minutes, supernatant 
was transferred to a new clean 1,5 mL eppendorf tube. Plasmid DNA was 
precipitated following the addition of 0,7 volume isopropanol and collected by 
centrifugation at 13.000 rpm for 30 minutes. DNA containing pellet was washed with 
1 mL of 70% ethanol. Ethanol was evaporated at 37
 ◦
C for 15 minutes and finally, the 
pellet was dissolved in 15 μL elution buffer (EB) at 37◦C, and stored at -20◦C. The 
isolated DNA was run on 1 % agarose gel. 
2.2.1.2 Chromosomal DNA isolation 
Chromosomal DNA‟s of B. subtilis strains were isolated and purified by using a 
standart procedure designed for Bacillus species (Cutting and Horn, 1990). 1,5 mL of 
overnight culture of Bacillus subtilis was harvested by centrifugation at 13000 rpm 
for 5 minutes. Supernatant was discarded and obtained pellet was resuspended in 567 
μL of TE buffer (Appendix B). 10 μL of proteinase K (20 mg/mL), 6 μL of RNase 
(10 mg/mL), 24 μL of lysozyme (100 mg/mL) and 30 μL of 10% SDS were added to 
the cell mixture and homogenized mixture was incubated for 1 hour at 37°C in a 
water bath. Then, 100 μL of 5M NaCl solution and 80 μL of CTAB/NaCl  (Appendix 
B) (prewarmed to 65
o
C because of viscosity) solution were added and the sample and 
it was incubated for 10 minutes in 65°C water bath. Freshly prepared 
phenol/chloroform/isoamyl alcohol (25:24:1) was then added to the mixture in equal 
volume and it was centrifuged at 13000 rpm for 10 minutes. After centrifugation, the 
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upper phase was transferred to a new 1,5 mL microfuge tube and 0,7 volume 
isopropanol was supplied. Following gently mixing, the sample was centrifuged at 
13000 rpm for 15 minutes. The supernatant was removed and the pellet was washed 
with 1 mL 70% ethanol and centrifuged at 13000 rpm for 5 minutes. Subsequently, 
ethanol residues were evaporated at 37°C for 1 hour and isolated DNA was dissolved 
in 10 μL of TE buffer. Obtained chromosomal DNA was stored at 4°C. 
2.2.1.3 RNA isolation 
Bacillus subtilis cells grown in PA medium were collected and total RNA was 
immediately isolated using “Qiagen RNeasy Midi Kit”. Cells were pelleted by 
centrifugation at 10000xg for 5 minutes and biomass was stored at -80°C before 
isolation. Procedure was applied at room temperature and in order to prevent RNA 
degradation, RNAse free environment was provided. Lysis buffer RLC containing 
guanidine hydrochloride, was supplemented with 10 µl β-Mercaptoethanol (β-ME), 
just before use. On column DNase I digestion with RNase free DNase set (Qiagen) 
was applied in order to avoid any DNA contamination. Isolated RNA was divided 
into aliquots and stored at -80°C. 
2.2.1.4 Polymerase chain reaction (PCR) 
The sequences of primers used in PCR reactions are given in Table B.1. PCR 
components and amounts used are given in Table 2.2. 
PCR was performed using i-Taq polymerase supplied by iNtRON Biotechnology, 
Inc. Reaction steps were as follows: 
Initial denaturation,  94 
oC for 3‟ 
Denaturation,   94 
oC for 1‟ 
Annealing,   55
 oC for 1‟                  for 5 cycles 
Extension   72
 oC for 1‟   
Denaturation,   94 
oC for 1‟ 
Annealing,    60
 oC for 1‟                  for 25 cycles 
Extension,  72 
oC for 1‟ 
Final extension,  72 
oC for 15‟ 
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Table 2.2 : PCR components and amounts used. 
Component Amount (20 μL in 
total) 
10X Buffer (+MgCl2) 2 μL 
dNTP  2 μL 
Template 1 μL 
Reverse primer  0,5 μL 
Forward primer 0,5 μL 
i-Taq polymerase 0,3 μL 
dH2O 13,7 μL 
The concentration of chromosomal DNA was 0,01 to 0,001 ng/µl. The 
oligonucleotide primers were used at 1 - 10 pM (equimolar) and deoxyribonucleoside 
5‟triphosphates (dNTPs) were used at 2 mM final concentration. 
2.2.1.5 Polymerase chain reaction (PCR) for sequencing 
PCR components for sequencing and amounts used are given in Table 2.3. The 
sequence of M13 reverse primer used for Sequence PCR was as follows: 5‟- AGC 
GGA TAA CAA TTT CAC ACA GGA -3‟ 
Table 2.3 : Components and amounts used for Sequence PCR. 
Component     Amount (10 μL 
in total) 
5X Sequencing Buffer 2 μL 
Big Dye Terminator v3.1 2 μL 
Template  1 μL 
Primer (10pmol) 1 μL  
dH2O 4 μL 
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Following PCR for sequence analysis, 25 μL ethanol and 1 μL of sodium acetate 
solution was mixed with 10 μL of PCR product and the mixture was incubated on ice 
for 15 minutes. The mixture was then centrifuged at 14000 rpm for 15 minutes. 
Supernatant is discarded and 250 μL of ethanol was used in order to wash the pellet. 
The mixture was centrifuged at 14000 rpm for 15 minutes. Supernatant is discarded 
once again and the pellet was dried off from ethanol residues completely by 
incubating at 95
o
C for 3 minutes. 20 μL formamide eas finally added onto the DNA 
pellet and incubated at 95
o
C for 3 minutes and then vortexed. After denaturation with 
formamide, the sample was incubated at -20
o
C for 2-3 minutes. 
In order to perform sequence analysis, Avant 3130 Genetic Analyzer (POP7 polymer 
with a capillary array length of 50 cm) together with the particular components 
provided by Applied Biosystems (ABI) were used.  
2.2.1.6 Agarose gel electrophoresis  
Electrophoresis was carried out on a horizontal submarine electrophoresis apparatus 
and in a gel system composed of  ~1%  agarose gel (%0,8 for chromosomal DNA 
visualization, 1% for plasmid DNA and PCR product visualizations) containing 
1xTAE buffer (Appendix B) and ethidium bromide of a 0.2 μg/mL final 
concentration. 6X Loading dye was diluted to 1X in the samples. Electrophoresis 
was performed at 90-120 Volts for 20-30 minutes. DNA bands were visualized on a 
shortwave UV transilluminator (UVP) and photographed by using Gel Imaging 
System. EcoRI+HindIII digested DNA marker and HinfI digested DNA Marker 
(Appendix D) were used to determine the molecular weights of DNA bands for 
desired purposes.  
2.2.1.7 Gel extraction 
Desired DNA fragments were extracted and purified from agarose gel by using 
“QIAquick  Gel  Extraction  Kit”  (Qiagen Inc., Valencia, CA) according  to  the  
manufacturer‟s protocol.  The  DNA fragment was excised from the gel and protocol 
was applied to the gel pieces containing DNA fragments. After obtaining DNA, an 
aliquot was run on 1 % agarose gel to monitor the final DNA concentration and 
stored at -20°C.   
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2.2.1.8 Ligation of PCR products into pGEM®-T easy vector 
Ligation of PCR products to pGEM®-T Easy Vector was performed as follows: 5 μL 
2X Rapid Ligation Buffer, T4 DNA Ligase, 1 μL (50 ng/μL) pGEM®-T Easy 
Vector, 2 μL insert DNA (PCR product) and 2 μL dH2O were mixed in a microfuge 
tube. Reaction mixture was incubated overnight at 4
◦
C. After ligation was completed, 
the mixture was used to transform electrocompetent E. coli Top10F‟ cells. 
2.2.1.9 Ligation of PCR products into pDrive vector 
Ligation of PCR products to pDrive Vector was performed as follows: 5 μL ligation 
master mix buffer, 1 μL (50 ng/μL) pDrive vector, 3 μL insert DNA (PCR product) 
and 1 μL dH2O were mixed in a microfuge tube. Reaction mixture was incubated at 
16
o
C for 1,5 hours and then enzyme denaturation was achieved at 70
o
C for 10 
minutes. After ligation was completed, the mixture was used for transformation of 
E.coli Top10F‟.  
2.2.1.10 Ligation of pMutinT3 vector 
Ligation procedure for cloning into the pMutinT3 vector was carried out as follows: 
9,5 μL of PCR products as insert DNA and 0,5 μL of pMutinT3 vector were mixed in 
a microfuge tube. Reaction mixture was incubated for 5 min at 65°C. Then, the tube 
was cooled on ice. Then, 2μL of ligation 10x buffer, 2 μL of Polyethylene glycol 
(50% PEG 8000), 2 μL of T4 DNA ligase, 4 μL of dH2O were added into the 
reaction mixture. Finally, the mixture was incubated at 16°C for 16 h and the mixture 
was use to transform electrocompetent E. coli Top10F‟ cells. 
2.2.1.11 Restriction enzyme digestion 
Digestion reactions were carried out in a way that the amount of 10X digestion 
buffer was 1/10 of the total reaction mix. The reaction mix was incubated for 1-4 
hours at 37°C, then enzyme denaturation at 65°C for 10 minutes. The sample was 
stored at -20
o
C. 
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2.2.2 Transformation 
2.2.2.1 Preparation of E.coli electrocompetent cells and transformation of 
electrocompetent E.coli Top10F’ cells 
The overnight culture of E.coli Top10F‟ was diluted 1:100 fold into 400 mL 2xYT 
medium, containing 20 μg/mL Tetracyclin. Then incubated at 37
 o
C by shaking until 
the optical density of the culture at 600 nm has reached 0,6. After incubating the cells 
on ice for 30 minutes, cells were harvested by centrifugation at 5000 rpm for 5 
minutes. Following the removal of supernatant, pellet was resuspended in 40 mL ice 
cold distilled water and centrifuged at 5000 rpm for 15 minutes. Supernatant was 
discarded and pellet was resuspended once again in 20 mL ice cold distilled water 
and centrifuged at 5000 rpm for 15 minutes again. After this step, supernatant was 
discarded for the last time and pellet was resuspended in 1 mL of cold sterile 10% 
glycerol. Finally, 40 μL aliquots were prepared from the competent cells and these 
aliquots were frozen immediately in liquid nitrogen and stored at -80
 o
C. 
For transformation, competent E. coli cells were melted on ice shortly. 10 μL of 
ligation products was placed gently into the competent cell aliquot and was mixed 
gently. Then, mix was transferred into pre-cooled electroporation tube. The sample 
was placed onto electroporator and the pulse at 1800V was applied to the cells. After 
addition of 1mL LB broth into the mixture, it was transferred into a 2 mL eppendorf 
tube. Incubation was made at 37
o
C for 60 minutes by shaking at 200 rpm. After 
incubation, the cells were pelleted at 5000 rpm for 10 min and supernatant was 
discarded. Obtained pellet was resuspended in 100 μL 0,85% saline solution 
(Apendix B). Transformed cells were further plated on selective medium containing  
appropriate antibiotic (100μg/mL ampicillin). For the blue-white colony screening, 
cells were plated on LB agar media containing 40 mg/mL X-gal, 1 mM IPTG and 
100μg/mL ampicillin. 
2.2.2.2 Preparation of B. subtilis competent cells and transformation 
Preparation of B. subtilis competent cells and their transformation process were 
performed as described by Klein et al. (1992). HS and LS (Appendix B) mediums 
were used for the preparation of B. subtilis competent cells. Adequate amount of B. 
subtilis cells were inoculated into 3 mL of HS medium and cultured overnight at 
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37°C by shaking at 250 rpm. 0,5 mL of this overnight culture was transformed into 
20 mL of freshly prepared LS medium and incubated at 30°C by shaking at 200 rpm 
until the optical density of the culture at 600 nm has reached 0,55. Then, 1 mL of 
competent cells was transferred into 1 μL of chromosomal or plasmid DNA 
containing eppendorf tubes. The cells were then incubated at 37°C for 2 hours by 
shaking at 200 rpm and incubated cells were harvested by centrifugation at 5000 rpm 
for 10 minutes. Finally, the pellet was resuspended in 100 μL of sterile saline 
solution and was spread out on LB agar plates containing selective antibiotics and 
incubated at 37°C for 16 h. 
2.2.2.3 Selection of transformants by MLS resistance method 
Competent B. subtilis cells were transformed by the same conditions given in the 
Section 2.2.2.2 except directly spreading out on LB agar plates containing selective 
antibiotics. In the MLS resistance method, firstly, 2 μL of 2 mg/mL erythromycin 
(erm) antibiotic was added into 2,5 mL 0,7 % LB agar which was melted and kept at 
50°C. Then, immediately, mixture was mixed and quickly poured on a antibiotic-free 
LB agar plate containing solidified 25 mL of 1,5% LB agar. Following incubation at 
37°C for 2 hours, a second overlay was carried out by overlaying this second layer 
that contained 2,5 mL of melted 0,7 % LB agar, 20 μL (2 mg/mL) erythromycin 
antibiotic solution and 20 μL (50 mg/mL) lincomycin antibiotic solution. The agar 
plate was incubated at 37°C for 1-2 days.  
2.2.3 Microarray analysis 
Total RNA was isolated from  B. subtilis strains by using the RNeasy Midi RNA 
isolation kit (Qiagen). Detailed transcriptome analysis was performed at the 
University of Groningen with the help of their technical support. Superscript cDNA 
Post Labelling Kit was used to label cDNAs. Fort this purpose, isolated total RNAs 
were firstly reverse transcribed into cDNAs. 10-20 ug  total RNA was annealed using 
2 µl random  nonamers 1,6 g/l and total end volume was completed to 18 µl. 
Reaction mix was gently mixed, held at  70°C for 5 minutes and cooled down on 
room temperature for 10 minutes. Following this step, reverse transcription mix was 
prepared as 6 µl of 5x Superscript III buffer,  3 µl of  0.1 M DTT, 1.2 µl of  25x AA-
dUTP / nucleotide mix and 1.8 µl of Superscript III reverse transcriptase. This mix 
was added to the 18 µl annealing mix and held at  42°C for 16 hours in order to be 
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sure that reverse transcription takes place. Later on, the nontranscribed mRNA was 
degraded using  3 µl of NaOH and holding at 37°C for 15 minutes. Finally 15 µl of 
12M HEPES free acid was added to the cDNA solution. Purification of amino allyl-
modified cDNA was performed using NucleoSpin® Extract II  columns (Biokè, 
Leiden, the Netherlands) and the exact protocol of the kit. Measurement of cDNA 
concentration was done using Nanodrop  and labeling protocol was made continued  
if the  cDNA concentration is arround 200 ng/ul in total volume of 60 ul. In order to 
label amino allyl-modified cDNA with CyDye(GE Healthcare, Amersham, The 
Netherlands), 5 µl of CyDye NHS esters were added to amino allyl modified cDNA  
and incubated at room temperature, in the dark for 60 to 90 minutes. 15 µl  of 4 M  
Hydroxylamine were added to each Cy5 and Cy3 coupling reaction and incubated at 
30°C , in the dark, for 15 minutes. Purification of CyDye labelled cDNA was made 
using NucleoSpin ExtraxtII columns and the exact protocol of the kit. Measurement 
of incorporation of Cy dyes in the cDNA was done using Nanodrop and  
concentration of Cy3 and Cy5 were expected to be at least 0.5 pmol/ul in a total 
volume of 50 ul. Labelled cDNA‟s were mixed in equal quantities cDNA of 
Cy3/Cy5 for hybridization. Samples were dried using the speedvac high temperature. 
Dried   Cy3/Cy5 samples pellet were dissolved in 7 µl of  H2O and incubated at 94°C 
for 2 minutes. Then, 35 µl of  preheated Hybridisation buffer, Ambion Slidehyb #1 
buffer (Ambion Europe Ltd) (68°C) was gently mixed and spinned at maximum 
speed for 1 minute to get rid of precipitates. Then, microarray slides were placed 
with Lifter Slip on a heat-block at 50°C shown  in figure 2.5. The arrays were 
constructed as described elsewehere (van Hijum et al., 2003a). Furthermore, slide 
spotting, slide treatment after spotting and also slide quality control were done as 
before (van Hijum et al., 2005). 
 
Figure 2.5 : Placement of Lifterslip on microarray slide. 
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35 µl of the prepared sample was targeted to the end of the slide and the sample was 
let go between the glass surfaces by capillary force. Then, the microarray slides were 
placed in the prewarmed Hybridization cassette and they were held in the 
hybridization oven at 48 °C for more than 16 hours. Following hybridization, slides 
were washed for the removal of hybridization buffer and unbound cDNAs. Fresh 
wash buffers I (2 x SSC / 0,5 % SDS), II (1 x SSC / 0,25 % SDS), III (1 x SSC / 0,1 
% SDS) were preheted before use and lifterslips were taken out gently in a falcon 
tube filled with 50 mL wash buffer I until the glass rests on the conical bottom of the 
tube. Then the washings were continued  immediately. Slides were washed in buffer 
I for 5 minutes, then twice  in buffer 2 for 5 minutes and finnally in buffer III for 5 
minutes. Finally slides were dried for 2 minutes in a centrifuge at 2000 rpm and 
scanning of the slides was done using GenePix 4200AL Microarray Scanner (Axon 
Instruments, CA, USA). Fluorescent signals were quantified using ArrayPro 4.5 
(Media Cybernetics Inc., Silver Spring, MD). Following the acquisition of 
expression data, expression levels were processed and normalized with Micro-Prep 
in order to handle microarray data and transforming raw data into processeable Excel 
data through avoidance of inconsistencies (van Hijum et al., 2003b). Then the 
expressional difference ratios were further processed using Cyber-T tool that works 
on t-test variant combined with a Bayesian statistical framework (Baldi and Long, 
2001). Parameters used in Cyber-T tool are: 2 as „minimum non-zero replicates‟, 
„sliding window‟ of 101 and confidence value of 10. Accepted Cyber-T (Bayes) p 
value was set to 0,01. Gene lists obtained through the analysis are in supplementary 
materials. Microarray data has been deposited in Gene Expression Omnibus database 
(GSE34414). 
2.2.4 Quantitative PCR analysis  
Total RNA was isolated by using the RNeasy Mini RNA Isolation Kit (Qiagen). 
Equal amounts (2 µg) of total RNAs were reversely transcribed by using a 
“Transcriptor cDNA Synthesis Kit” (Roche) with random hexamer primers (60µM) 
supplied with the kit. The obtained cDNA was used as template for the reverse 
transcriptase quantitative PCR. Ampliﬁcation and detection of PCR products were 
performed with the “SYBR Green Master Mix Kit” (Roche) and Light Cycler 480 
(Roche) instrument. As recomended by the constructors, 2 µls of the cDNA synthesis 
reaction mixture was directly used as template in a 20 µl of reverse transcriptase 
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PCR mixture with 10 pmols of gene specific primers. Reverse transcriptase PCRs 
were run at 52
o
C annealing temperature, as all the primers used in this study were 
designed to work at this temperature to obtain the comparable data. Melting curve 
analysis was used to monitor the speciﬁcity of the reaction. The 2-ΔΔCt method was 
used to calculate relative gene expressions (Pfaffl, 2004). The expression levels of 
the investigated genes were determined relative to the wild type Bacillus subtilis 
PY79 sample. The ratios (2
-ΔΔCt
) were calculated and log2 transformed. Experiments 
were performed as replicates and minimum three independent experiments were run. 
The sigA, veg and qcrA genes were used as  internal controls, since the expression of 
those genes were constant under both control and mutant conditions in both 
microarray and real-time PCR experiments. 
2.2.5 5’-Rapid amplification of cDNA ends (5’-RACE)  
Total RNA was isolated from  B. subtilis cells grown in PA medium to 
midexponential growth phase and to early stationary growth phase by using the 
RNeasy Midi RNA isolation kit (Qiagen). SMART
TM
 RACE cDNA Amplification 
kit (Clontech) was used through which total RNA was reverse transcribed into the 5‟-
RACE cDNA (Figure 2.6).  
 
Figure 2.6 : Mechanism  of  SMART™  cDNA  synthesis. (SMART RACE cDNA 
synthesis kit manual).  
In  this  procedure,  PowerScript™  Reverse  Transcriptase  (RT),  a variant of 
MMLV RT and SMART II™ A Oligonucleotide were used. During the reaction, 
PowerScript reverse transcriptase enzyme applies terminal transferase activity and 
reaches the end of the RNA template and adds 3 to 5 generally dC residues to  the  3'  
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end  of  the  ﬁrst-strand  cDNA.  SMART  II  A oligonucleotide, containing a 
terminal strain of guanine nucleotides, anneals to the dC-rich cDNA tail and 
therefore, reverse transcriptase utilizes this annealed oligo an extended template. 
Those converted cDNAs were served as templates for 5‟-RACE PCR amplification 
reactions by using Advantage
TM  
2 PCR Kit (Clontech) in the presence of UPM and 
the gene-specific primer (Table B.1). PCR program was initiated at 94 °C for 3 min, 
followed by  35 cycles of  94°C for 1 min, 52  ºC  for  1  min,  72  ºC  for  2.5  min  
and  a  final  extension  at  72  ºC  for  10  min. One additional nested PCR reaction 
was performed in order to gain more distinct results by using Nested Universal 
Primer A (NUP) supplied with kit and a second nested gene-specific primer. 
Resulting PCR product were cloned in pDrive Cloning Vector (Qiagen) and 
sequenced. 
2.2.6 Beta-galactosidase activity assay 
As the initial step, Bacillus subtilis cells grown overnight at 37°C in PA medium 
(Appendix A). Then, 100 mL of PA medium were inoculated to an initial optical 
density of about 0,1 at 595 nm (OD595). Cultures were incubated at 37°C shaking at 
250 rpm for 30 h and sampling was done at each hour. 
1 mL of culture samples were centrifuged at 13000 rpm for 5 minutes and the 
supernatant was discarded. Then, the pellet was washed with 500 μL of ice-cold 25 
mM Tris-Cl (pH 7,4) by centrifugation. After the removal of washing buffer, the 
pellet was resuspended in 640 μL Z-buffer and 160 μL of lysozyme was added in 
order to provide cell lysis. Following the incubation at 37°C for 5 min, the samples 
were taken on ice and 8 μL of 10% Triton-X100 was added. Prior to incubation on 
ice, mixtures were vortexed for 2 seconds. Following the incubation, β-galactosidase 
assay was initiated by prewarming the extracts to 30°C. Subsequently, 200 μL of 
ONPG solution was added and the solution was watched for the progression of the 
yellow color. At the exact time that yellow color stabilized, the reaction was stopped 
by the addition of 100 μL 1 M Na2CO3 and reaction time was recorded. Finally, the 
samples were centrifuged at 13000 rpm for 5 min. and their supernatant subjected to 
the measurement of OD at A420 and A550. Calculations for β-galactosidase specific 
activity were carried out according to the formulation given by Miller in 1972 which 
was Miller Units=((A420 – (1.75 x A550 ))/( Reaction time (min) x A595)) x 1000. 
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Furthermore a graph that represents both the β-galactosidase activity and log A595 
were drawn. 
2.2.7 Spore count assay 
B. subtilis cells were grown in LB medium at 37
 o
C overnight and DSM medium was 
inoculated with the overnight culture to 0,1 OD at 600 nm. Following the incubation 
at 37
o
C, a sample was removed from the cultures, diluted serially 10-fold in 0,85% 
saline solution and 0,1 mL aliquots of dilutions were plated on LB agar plates for 
total viable cell count. Afterwards these dilutions were heated at 80
o
C for 30 min and 
plated once again for total spore forming units count. All the plates were incubated 
overnight at 37
o
C and colony forming units were counted and sporulation percentage 
of the cells were calculated. 
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3. RESULTS AND DISCUSSION 
3.1 Strain Constructions 
3.1.1 Construction of amyE::Pspac::yvfI recombinant strain 
In order to construct the ectopic integration vector for yvfI, yvfI gene fragment which 
stands between 94378 and 95051 bp was amplified by PCR using chromosomal 
DNA of B. subtilis PY79 wild type strain as template (Figure 3.1). On the 
oligonucleotide yvfI F1 and yvf R1 primers given below, underlined sequences 
represent restriction sites for HindIII and PaeI enzymes on forward and reverse 
primers respectively.  
yvfI F1 : 5' – C C G A A G C T T C G G A G G C C C T A T T A G A T A T G A -3' 
yvfI R1 : 5' – C G G G C A T G C T T A T T G C A C A T T T T C C T C G A A - 3' 
 
Figure 3.1 : Amplification of 674 base pair long yvfI gene fragment. Marker 10 :  
PhiX174 DNA/BsuRI (lane 1). Amplified yvfI gene fragment (lane 2). 
Following 674 base pair long yvfI internal gene fragment amplification by PCR, 
direct cloning of yvfI to pGEMT was performed and the recombinant vector was used 
  42 
to transform E.coli Top10F‟ cells. Obtained plasmids were isolated and were 
digested with HindIII and Pael restriction enzymes in order to visualize cloning of 
the correct fragment.  
Digestion of the plasmid DNAs with HindIII and PaeI has resulted in 692 bp long 
fragment (containing extra residues from the restriction sites on the primers) and 3,15 
kbp PGEMT vector. Hence it was concluded that some of the transformants included 
692 bp long yvfI gene fragment.  The selected clone is shown in figure 3.2. 
Furtehrmore, transformed plasmid was further subjected to sequence PCR and yvfI 
fragment was confirmed. 
                                                1               2 
 
Figure 3.2 : PaeI and HindIII double digestion of plasmid DNA from selected 
tranformant. Marker 3: Lambda DNA / EcoRI + HindIII (lane 1), 
digested plasmid (lane 2). 
Cloned fragment in pGEMT was used for the ligation into the pDR66 vector. In this 
purpose, pDR66 vector DNA and previously constructed, yvfI carrying recombinant 
vector were digested with HindIII and PaeI in order to create sticky ends that could 
be hybridized to each other. As a result of this double digestion of the selected 
transformant, two bands were obtained, one of them was a 692 bp DNA fragment 
which equal to cloned yvfI gene and the other one a 3.15 kbp fragment which 
represents the lineer form of the pGEMT. As a consequence of the double digestion 
of pDR66 plasmid, only a 9.2 kbp band which equals to linear form of the pDR66 
vector was observed. (figure 3.2).  
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Fiure 3.3 : Double digestion of selected transformant DNA (lane 2) and pDR66 
vectors (lane 3) with HindIII and PaeI. Marker 10 : PhiX174 DNA / 
BsuRI (lane 4), Marker 3: Lambda DNA / EcoRI + HindIII (lane 1).  
Following extraction of both gene fragment and linearized pDR66, yvfI gene 
fragment was inserted into pDR66 by using T4 DNA ligase protocol. Following, 
transformation of pDR66 vector carrying yvfI gene into the E.coli competent cells, 
confirmation of the insertion of yvfI gene fragment into pDR66 was performed 
through double digestion of the obtained plasmids with HindIII and PaeI. As a 
consequence of restriction analysis, it was proven that yvfI gene had been inserted 
into pDR66 as shown in figure 3.4.  
 
 
Figure 3.4 : The double digestion of plasmids isolated from E.coli Amp
R
 
transformants. Marker 3: Lambda DNA / EcoRI + HindIII (lane 1) 
Marker 10 : PhiX174 DNA / BsuRI (lane 12) and yvfI gene fragment 
cleaved from the rest of the pDR66 vector as a consequence of a 
double digestion with HindIII and PaeI. (lane 2-11). 
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In order to transform B.subtilis wild type PY79 cells with recombinant pDR66 
vector, plasmid DNA of selected clone 7 was used to transform competent cells of B. 
subtilis yvfI::Tn10::spc strains to chloramphenicol resistance. Obtained strains were 
tested for their ability to metabolize starch on starch media in order to check the 
disruption of amyE locus (Figure 3.5). Consequently, recombinant strain of 
amyE::Pspac::yvfI was selected for detailed transcriptome analysis. 
 
Figure 3.5 :  Starch test performed on B.subtilis amyE::Pspac::yvfI Cm
R
 Spc
R
 
transformants. 
3.1.2 Construction of rapI::lacZ insertional plasmid 
In order to determine the expression profile of rapI gene in the absence and presence 
of yvfI gene, mutant B. subtilis strains containing yvfI::lacZ fusion at yvfI locus were 
constructed using wild type PY79 and TEK1 strains of B. subtilis. In order to 
construct the lacZ fusion vector, 390-bp-long rapI gene fragment was amplified by 
PCR using chromosomal DNA of B. subtilis PY79 wild type strain as template  
(Figure 3.6). On the oligonucleotide rapI F and rapI R primers given below, 
underlined sequences represent restriction sites for HindIII and BamHI enzymes on 
forward and reverse primers respectively.  
rapI F : 5' – G C C A A G C T T T T G C G G G G T G T T T T C T T A - 3' 
rapIR : 5' – C G G G G A T C C T T C A G C T A T T C G A T A A G C - 3' 
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Figure 3.6: Amplification of 390 base pair long rapI gene fragment. MassRuler™ 
DNA Ladder, Low Range (lane 1). Amplified rapI gene fragment 
(lane 2). 
Following 390 base pair long rapI internal gene fragment amplification by PCR, 
fragment was extracted from the gel and ligated into pDrive cloning vector using the 
standard ligation procedure. Then, pDrive vector carrying the rapI gene fragment 
was used to transform E.coli Top10F‟ cells. X-gal/IPTG-ampicillin containing agar 
plates were used as selectice medium in order to perform blue-white screening. 
White colonies were selected to be the transformants and those colonies were further 
processed through plasmid isolation to confirm the presence of recombinant pDrive 
vector. Furthermore, transformed plasmid was further subjected to sequence PCR 
and yvfI fragment was confirmed.      
Digestion of the plasmid DNAs with BamHI and HindIII has resulted in 390 bp long 
fragment and 3,85 kbp pDrive vector. Hence, it was concluded that transformants 
included 390 bp long rapI gene fragment.  The selected clone is shown in figure 3.7. 
Furthermore, transformed plasmid was further subjected to sequence PCR and yvfI 
fragment was confirmed. Moreover pMutinT3 plasmid was also subjected to double 
digestion with BamHI and HindIII enzymes and linearized plasmid appeared as a 
single band on agarose gel (Figure 3.8). 
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Figure 3.7 : Double digestion of selected transformant DNA (lane 2) 3851 bp pDrive 
cloning vector with 390 bp rapI insert. Marker 3: Lambda DNA / 
EcoRI+HindIII (lane 1). 
 
 
 
Figure 3.8 : Linearized 8834 bp pMUTIN integrative plasmid. 
Cloned fragment in pDrive was used for the ligation into the pMutinT3 vector. 
Following this purpose, pMutinT3 vector DNA and previously constructed, rapI 
carrying recombinant vector were digested with HindIII and BamHI restriction 
endonucleases. Double digestion of the selected transformants has resulted in the 
visualization of a 390 bp DNA fragment, representing cloned rapI gene fragment and 
a 3.85 kbp fragment which standing for the lineer form of the pDrive. As a 
consequence of the double digestion of pMutinT3 vector, 8,83 linearized vector was 
obtained.  Following extraction of both gene fragment and linearized pMutinT3, rapI 
gene fragment was inserted into linearized vector through ligation using T4 DNA 
ligase. Ensueing transformation of pMutinT3 vector containing rapI gene into the 
E.coli Top 10F‟competent cells, rapI gene fragment inside pMutinT3 was further 
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confirmed through double digestion of the obtained plasmids with HindIII and 
BamHI. As a result of restriction analysis, it was proven that rapI gene was inserted 
into mentioned vector as shown in figure 3.9.  
 
Figure 3.9 : 8,83 kbp pMUTIN plasmid containing 390 bp rapI gene fragment 
digested with BamHI and HindIII restriction endonucleases (lane 2-4) 
Marker 3: Lambda DNA / EcoRI+HindIII (lane 1). 
As a further step, integrative plasmid pMUTIN containing rapI gene fragment was 
used to transform B. subtilis PY79 cells and TEK1 yvfI::Tn10::spc cells via single 
cross-over event known as Campbell-like integration method in order to construct 
rapI::lacZ::erm genotype in the chromosome of PY79 and TEK1 cells. 
Transformants were selected against erythromycin resistance gene (Erm
R
) that is 
found on pMUTIN plasmid. The mutant strain constructed was named as Bacillus 
subtilis OYK2 (rapI::lacZ::erm) and OYK3 (yvfI::Tn10::spc rapI::lacZ::erm) 
strains. Chromosomal DNA isolation was performed using these transformant 
colonies and isolated chromosomal DNA‟s were subjected to PCR for validation 
purposes. Therefore two sets of primers were used for the verification process; 
primers that amplify erm cassette and rapI gene specific primers. In conclusion, PCR 
analysis confirmed the construction of recombinant pMutinT3 plasmids carrying rapI 
inserts (Figure 3.10).  
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Figure 3.10 : PCR for the confirmation of the constructed recombinant pMutinT3 
plasmids carrying rapI inserts. PCR products of 703 bp erm cassette 
and 390 bp rapI fragment. Lanes 1-2 indicate PCR products resulting 
from erm cassette amplification, OYK2 strain used as template. Lane 
3 indicates PCR products resulting from erm cassette amplification, 
OYK3 strain used as template. Lanes 4-5 indicate PCR products 
resulting from rapI gene fragment amplification, OYK2 strain used as 
template. Lane 6 indicates PCR products resulting from rapI gene 
fragment amplification, OYK3 strain used as template. Marker: 
MassRuler™ DNA Ladder, Low Range (lane 1) 
3.1.3 Construction of spoIIE::lacZ::cat mutant strains 
In order to detect spoIIE directed-lacZ expression in wild type and yvfI mutant cells, 
spoIIE::lacZ bearing strain ML105 (spoIIE::lacZ::cat) supplied by A. D. Grossman 
was subjected to chromosomal DNA isolation and isolated chromosomal DNA was 
used to transform both natural competent cells of wild type PY79 and of the TEK1 
(yvfI::Tn10::spc) strain. Transformants were selected for their ability to metabolize 
X-gal and obtained mutant strains were further used to measure gene expression 
activities. 
3.2 Determination of the yvfI transcription start sites by 5’RACE-PCR 
As mentioned in introduction part 1.6, a Conserved Domain Database (CDD) 
(Marchler-Bauer et al. 2005) search for YvfI protein has pointed out FadR C-
terminal ligand binding (FCD) of YvfI protein which is located at the C-terminal of 
protein. Furthermore, YvfI protein with a 44 amino acid extended sequence 
(O07007; EMBL accession number CAB08003) was proposed (Kunst et al., 1997) 
and it revealed an incomplete but considerable match to the GntR wHTH domain at 
the N-terminus (Figure 3.12). CLUSTAL W algorithm analysis was applied to GntR 
and YvfI proteins and this incomplete match is given in Figure 3.11. 
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YvfI         -----------------------------MIKNGELKPGDKLDSVQALAESFQVSRSAVR 31 
GntR         MLDSKDLLYPAKWLSKASTGVRVAYELRMRIVSGLIESG-TILSENTIAAEFSVSRSPVR 59 
                                           * .* ::.* .: * :::* .*.****.** 
 
YvfI        EALSALKAMGLVEMKQG--------EGTYLKEFELNQISQPLSAALLMKKEDVKQLLEVR 83 
GntR        EALKILASEKIIRLERMGAVVIGLTEKKIAEIYDVRLLLETFVFERLVKIDIEPLVKDLS 
119 
            ***. * :  ::.:::         * .  : :::. : :.:    *:* :    : ::  
 
YvfI        KLLEIGVASLAAEKRTEADLER----------------------IQDALKEMGSIEADGE 121 
GntR        KILEMMKVSIKYEDADEFSFQDVLFHETIIRAIDHSYIQMIWNNLKPVMESFILLSMRVR 179 
            *:**:  .*:  *.  * .::                       :: .::.:  :.   . 
 
YvfI        LGEKAD-----FAFHLALADASQNELLKHLMNHVSSLLLETMRETRKIWLFSKKTSVQRL 176 
GntR        LKEKYEDFTRILDNHELYIQAIKTKDRALMIQSLHQNFDDVQDKVEDLWLSQQMLAKGAE 239 
            * ** :     :  *    :* :.:    ::: : . : :.  :...:** .:  :     
 
YvfI        YEEH 180 
GntR        YNND 243 
            *::. 
Figure 3.11 : Alignment of amino acid sequences of YvfI and GntR regulatory 
proteins using CLUSTAL W algorithm Sequences that are underlined 
represent α-helices while sequences that are encircled represent β-
sheet configurations of protein N-terminus regions. * (asterisk) 
indicates positions with fully conserved residues, : (colon) indicates 
conservation between groups of strongly similar properties, . (period) 
indicates conservation between weakly similar groups.  
Moreover, helix-turn-helix motif and GntR-type resembling domains are given in 
figure 3.12. Hence, 44 amino acid extended sequence was further accepted for YvfI 
protein which consists of 219 amino acids encoded by 657 bp nucleotide sequence 
(Kunst et al., 1997). 
        10         20         30         40         50         60  
MIKNGELKPG DKLDSVQALA ESFQVSRSAV REALSALKAM GLVEMKQGEG TYLKEFELNQ  
 
        70         80         90        100        110        120  
ISQPLSAALL MKKEDVKQLL EVRKLLEIGV ASLAAEKRTE ADLERIQDAL KEMGSIEADG  
 
       130        140        150        160        170        180  
ELGEKADFAF HLALADASQN ELLKHLMNHV SSLLLETMRE TRKIWLFSKK TSVQRLYEEH  
 
       190        200        210  
ERIYNAVAAG NGAQAEAAML AHLTNVEDVL SGYFEENVQ 
Figure 3.12 : H-T-H helix-turn-helix motif and GntR-type resembling configuration 
of YvfI protein. Amino acid sequence that is underlined defines GntR-
type resembling configuration which involves first 56 amino acids. 
Encircled amino acid sequence defines H-T-H motif which involves 
amino acids starting from 16
th
 ending at 35
th
. 
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Furthermore, using Kyoto Encyclopedia of Genes and Genomes, SSDB motif search 
(Sato et al., 2001) was applied to YvfI protein and the outcomes has supported that 
YvfI protein gives high similarity with GntR family regulatory proteins on 1
th
 to 52
th
 
amino acids, while 15th to 50th amino acids gives high similarity with HTH motifs 
found in database, 78th to 204th amino acids gives the highest homology with other 
represented motifs because the highest e value was calculated for this motif (Table 
3.1). It should be noted that E-value is the expectation value. E-values approaching 1 
represents what should be expected by chance. Thus, the lower an E-value, the more 
specific the search for domains are and threshold level for CDD Pfam queries is set 
to 10
-6 
(Marchler-Bauer et al. 2005).  
Table 3.1 : SSDB motif search result for YvfI protein. 
Motif id From To Definition E value* 
pf:GntR 1 52 Bacterial regulatory proteins, gntR family 8.1e-17 
pf:Rrf2 9 52 Transcriptional regulator 0.0002 
pf:DUF4423 12 55   0.0015 
pf:MarR_2 13 48 MarR family 0.00023 
pf:DUF2250 14 49 
Uncharacterized protein conserved in archaea 
(DUF2250) 
0.027 
pf:HTH_28 14 44   0.11 
pf:HTH_11 15 50 HTH domain 1.4e-05 
pf:HTH_27 15 49   0.014 
pf:Fe_dep_repress 15 48 
Iron dependent repressor, N-terminal DNA 
binding domain 
0.0039 
pf:HTH_IclR 15 44 IclR helix-turn-helix domain 0.0092 
pf:Phage_rep_org_N 15 63 
N-terminal phage replisome organiser 
(Phage_rep_org_N) 
0.02 
pf:HTH_24 15 44   0.045 
pf:HTH_DeoR 15 44 DeoR-like helix-turn-helix domain 0.12 
pf:HTH_20 15 45 Helix-turn-helix domain 0.89 
pf:PaaX 15 48 PaaX-like protein 0.19 
pf:TrmB  16 51 Sugar-specific transcriptional regulator TrmB 0.0003 
pf:HTH_5 16 44 Bacterial regulatory protein, arsR family 0.00054 
pf:HTH_Crp_2 16 48   0.017 
pf:HrcA_DNA-bdg 18 48 
Winged helix-turn-helix transcription 
repressor, HrcA DNA-binding 
0.031 
pf:Mo25 69 174 Mo25-like 0.069 
pf:FCD 78 204 FCD domain 7.8e-26 
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On the basis of known YvfI sequence, yvfI transcription start site was enlightened by 
5‟ RACE PCR technology. For this purpose, total RNA was isolated from B. subtilis 
TEK7 cells (yvfI::yvfI-lacZ) grown in PA medium to midexponential growth phase 
and to early stationary growth phase by using the RNeasy Midi RNA isolation kit 
(Qiagen). SMART
TM
 RACE cDNA Amplification kit (Clontech) was used through 
which an aliquot of 20–40 ng of total RNA was reverse transcribed into the 5‟-RACE 
cDNA using 12 pmol of a genespecific primer (5‟-. AAT ATC CCG AAA GCA 
CAT -3‟) complementray to nucleotides (nt) 623 to 640 downstream of the 
translational start point of  yvfI and Universal Primer A mix (UPM) supplied with kit. 
Those converted cDNAs were served as templates for 5‟-RACE PCR amplification 
reactions by using Advantage
TM  
2 PCR Kit (Clontech) in the presence of UPM and 
the gene-specific primer mentioned above. One additional nested PCR reaction was 
performed in order to gain more distinct results by using Nested Universal Primer A 
(NUP) supplied with kit and a second gene-specific primer (5‟-CAG AAG GGC 
GGC TGA GAG CGG CTG-3‟) complementray to nt 187 to 200 downstream of the 
translational start point of  yvfI. Resulting PCR product were cloned in pDrive 
Cloning Vector (Qiagen) and sequenced.  
5‟-RACE-PCR analysis of yvfI transcription site revealed that transcription of yvfI 
was controlled from a 
A
-type promoter. This promoter described as PyvfI lies at 
position -136 to -115 with respect to yvfI translational start codon that seems to be a 
very strong promoter with a well confirmed consensus -10 (TATAAT) and 
consensus -35 (TTGGCG) sequences separated with 15 bp long space. Furthermore, 
at +12 downstream position, a sequence that shows a perfect match to the consensus 
Spo0A binding motif (5‟-TGNCGAA) was identified (Fig 3.13). Additionally, three 
putative AbrB binding and one CodY binding sites were indicated on the sequence. 
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A 
 
atgactgggtaataagaccagttacctagcattatattttgaaaaaaatcaaagtacaagactttttg 
        AbrB                      AbrB 
 
acaaaatagtcaaaatcttttggcggcccacaaaacagagtataatagatcgtAaacagccagaccta 
         AbrB      -35 σA              -10 σA 
 
caagttacggggtgaattgcattgaaatataaacagattaaaacaaaaaaatatatgaagaagtagcg 
                     CodY                                
            
                                Spo0A   
gatgccctattagat atg atc aaa aat ggc gaa ttg aag ccg ggg gat aaa ctg  
                 M   I   K   N   G   E   L   K   P   G   D   K   L    
 
gac tct gtt cag gcg ctt gct gag agc ttt caa gtc agc cgt tca gcg gtt  
 D   S   V   Q   A   L   A   E   S   F   Q   V   S   R   S   A   V    
                                    
cgc gaa gca ctt tct gcg cta aaa gcg atg ggg ctt gtc gaa atg aaa cag 
 R   E   A   L   S   A   L   K   A   M   G   L   V   E   M   K   Q   
 
Figure 3.13 : (A) Mapping of transcription start sites by 5′-RACE-PCR using TEK7 
(yvfI::yvfI-lacZ erm). The transcription start point of the yvfI 
promoters indicated by a bold uppercase letter. The −10 and −35 
boxes of the two σA-type promoters controlling the yvfI transcription 
and binding sites of the transcriptional regulators, spo0A, abrB, codY 
are in bold characters and underlined. (B) Consensus sequence logo 
obtained from the compilation of 328 previously identified σA-
binding sites (Makita et al., 2004). (C)Binding motif of spo0A bi-
functional regulator obtained from 29 identified binding sequences 
(Makita et al., 2004). (D) Sequence logo of abrB binding site obtained 
from 36 previously determined sequences (Makita et al., 2004). (E) 
codY binding motif obtained from 16 identified sequences (Makita et 
al., 2004). 
B 
C 
D E 
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Hence, these  results  pointed out that yvfI gene is likely under the direct control  of 
global regulatory system operated by Spo0A, CodY and AbrB.  
3.3 Transcriptome studies 
3.3.1 Identification of the genes regulated by YvfI during stationary phase  
In order to identify the genes regulated by the transcriptional factor YvfI, gene 
expression levels were first analyzed on a genome-wide scale comparing the yvfI 
disrupted mutant TEK1 (lutR::T10::spc) samples to a sample of the yvfI
+
 parent 
strain B. subtilis PY79 taken at the onset of stationary phase (OD6007). Since  
transcriptional yvfI-lacZ analysis indicated that a relatively constant level of yvfI-lacZ 
expression during exponential growth phase increases rapidly to a maximal level 
upon entry into stationary phase but decreases rapidly to its basal level following 
within 2-4 hr (Fig. 3.14).  
 
Figure 3.14 : Expression of transcriptional yvfI::lacZ fusion in PA medium. B. 
subtilis TEK7 (yvfI::lacZ::erm) was grown in PA medium and 
samples were taken for assay of β-galactosidase as described in 
Materials and methods. Specific activity  was plotted as a function of 
time relative to the entry into stationary phase. Similar trends were 
obtained when the experiment was repeated in further occasions. 
(▲) growth profile of the strain TEK7;  (●) β-galactosidase activity 
of TEK7 grown in PA medium 
  54 
Microarrays used in this study contained probes for 4107 open reading frames of B. 
subtilis. For microarray analysis, RNA samples from TEK1 and wild type PY79 cells 
during stationary growth were reverse transcribed to cDNA‟s and labeled with Cy5 
and Cy3 fluorescent dyes separately in order to be able to compare expression ratios 
of each individual gene. Fluorescent signals received from Cy3 and Cy5 dyes were 
quantified using ArrayPro 4.5 (Media Cybernetics Inc., Silver Spring, MD) and 
transriptional data was processed and normalized using Micro-Prep in order to 
transform obtained raw data into processeable Excel data (van Hijum et al., 2003b). 
Following the acquisition of processable data, expression ratios were further 
processed using Cyber-T tool that works on t-test variant combined with a Bayesian 
statistical framework (Baldi and Long, 2001). Accepted Cyber-T (Bayes) p value 
was 0,01. DNA microarrays used in this study contained probes for 4107 open 
reading frames of B. subtilis.  
It should be noted that evaluated data of microarray results usually demands 
verification through the usage of a complementary gene expression quantification 
methodology. For this purpose, Real-time PCR employment is the most commonly 
used method. Microarray technology has its own drawbacks and pitfalls such that 
data obtained using this methodology was previously proven to vary depending on 
the quality of RNA which is usually not constant, or the presence of contaminating 
factors including salts and alcohol that create a defect on the activity of reverse 
transcriptase, moreover, nonspecific or cross contamination of probes with non-
targeted genes and many other variables (Freeman et al. 1999; Chuaqui et al. 2005; 
Yang et al. 2002). On the other hand, qPCR methodology has also many drawbacks 
including primer dimer formation or non-targeted annealing, amplification of 
misplacements, change in the efficiency of pPCR data when reaction proceeds, 
presence of contaminating factors for reverse transcriptase (Bustin, 2002; Freeman et 
al. 1999; Chuaqui et al. 2005). All the drawbacks aside, these two methodologies 
mainly differ in their data normalization procedures. Such that, gene expression 
studies using microarray requires a global normalization while RT-qPCR technology 
can only use reference genes so that all the evaluated genes can be normalized 
against expression ratios of these reference genes (Morey et al., 2006). Beside the 
facts that there is no absolute validation method, qPCR usually is employed for the 
verification of microarray data. In case of qPCR, once the mRNA has been reverse 
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transcribed into cDNA, several different methods are commonly used to quantify the 
cDNA, termed absolute and relative quantification. Absolute quantification employs 
an internal or external calibration curve to derive the input template copy number. 
Absolute quantification is important in case that the exact transcript copy number 
needs to be determined, however, relative quantification is sufficient for most 
physiological and pathological studies. Relative quantification relies on the 
comparison between expression of a target gene versus a reference gene and the 
expression of same gene in target sample versus reference samples. In other words, 
relative quantification determines the changes in steady-state mRNA levels of a gene 
across multiple samples and expresses it relative to the levels of an internal control 
RNA (Pfaffl, 2004). This reference gene is often a housekeeping gene and  in this  
study, sigA, veg and ponA genes were chosen to be reference genes thanks to their 
constitutive expression. As reference values, geometric mean of the Cp values of 
three given genes were used.  
Relative quantification does not require standards with known concentrations and the 
reference can be any transcript, as long as its sequence is known. Relative 
quantification is based on the expression levels of a target gene versus a reference 
gene and in many experiments is adequate for investigating physiological changes in 
gene expression levels. To calculate the expression of a target gene in relation to an 
adequate reference gene various mathematical models are established. Calculations 
are based on the comparison of the distinct cycle determined by various methods, 
e.g., crossing points (CP) and threshold values (Ct) at a constant level of 
fluorescence; or CP acquisition according to established mathematic algorithm. In 
the LightCycler software the “Second Derivative Maximum Method” is performed 
where Cp is automatically identified and measured at the maximum acceleration of 
fluorescence. To date, several mathematical models that determine the relative 
expression ratio have been developed. Two types of relative quantification models 
are available and published: (1) without efficiency correction and (2) with kinetic 
PCR efficiency correction. In our study, we focused on the calculations without 
efficiency correction, because all the reaction efficiencies were kept between 1.8 and 
2, where 1 is the minimum level and 2 is the 100% efficiency (Pfaffl, 2004).  In this 
study, a calculation method was used which gives results for each sample that were 
expressed in N-fold changes in mutant strain target gene copies, normalized to 
  56 
reference genes  relative to the copy number of the target gene: 2
- ΔΔCP, (2- [ ΔCp sample 
- ΔCp control]). 
Wild type Bacillus subtilis PY79 and yvfI distrupted mutant strain TEK1 
(yvfI::tn10::spc) cells were grown in bacilysin biosynthetic medium (PA medium) to 
early-stationary phases. Sampling times was set in corcordance with microarray 
experiment. 1 x 10
9
 were collected and total RNA‟s from these cells were isolated by 
using “the RNeasy Midi RNA Isolation Kit” (Qiagen). Reverse transcribed cDNA‟s 
were used as template for the reverse transcriptase quantitative PCR. “SYBR Green 
Master Mix Kit” (Roche) and Light Cycler 480 (Roche) instrument were used for the 
reverse transcriptase PCR analysis. All the primers used in this study were 
selectively chosen so that their Tm match in order to be able to work at the same 
temperature to obtain comparable data.  
Hence, following the methodologies given above, genes showing at least 1,44 fold 
difference with reproducible characteristics in three independent experiments 
[displaying an acceptable Bayes P value (p < 0,01)] were subjected to RT-qPCR 
analysis. RT-qPCR was applied based on transcription units, meaning that first or 
several genes of operons that were identified to be affected were chosen to be 
validated by RT-qPCR. As a consequence, genes that are validated by these two 
methodologies were accepted as YvfI affected genes and the list of the total regulon 
was given listed in Table A.1. It should be noted that there were some exceptions that 
did not fit within the listed accepted conditions. For instance, five genes (yjcM, yqgA, 
yqxIJ, ybyB and yotH) identified in the microarray experiment were not further 
validated using RT-qPCR but still listed in Table A.1 in order not to underestimate 
possible YvfI-regulated genes. In this table, some genes with Bayesian P values that 
exceeded 0,01, were also placed under the respect that their significant differential 
expressions in the TEK1 strain were confirmed by RT-qPCR. These five genes are 
pyrP, trkA, yokD, yvcA and abh (Bayes P value >0,01).  However, another gene with 
not acceptable Bayes P value was further confirmed through constructing rapI-lacZ 
fusion in order to measure gene expression level by beta-galactosidase assay. 
Furthermore, several genes (czcD, citB, epsN, fabR, pbpE, sigW, spoIIE, yneN, yqxM,  
ytsC, ytsD, yvcA, ywfH and the ywfBCDEFG operon) did not show at least 1,44 fold 
difference with reproducible characteristics in three independent experiments in the 
microarray analysis and thus their expression level were represented as ND in table 
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A.1 which stands for “no differential expression observed”. Once again, although 
these genes did not meet the chosen criteria, differential expreesions as a result of 
yvfI mutation for these cited genes (czcD, citB, epsN, fabR, pbpE, sigW, spoIIE, 
yneN, ytsC, ytsD and  yvcA) were demonstrated by RT-qPCR analysis and for the 
expression of spoIIE gene, the path that was selected was to construct spoIIE-lacZ 
fusion in this study to monitor changes in gene expression via beta galactosidase 
assay. Additonally, RT-qPCR was applied based on transcription untis, therefore 
some of the genes of an operon that did not meet the criteria were also studied in 
order to obtain comparable data. To give an overall look, in total, 61 transcriptional 
units were identified to display altered expression in yvfI mutant compared to yvfI
+
 
wild type cells. Among these 61 transcriptional units, 19 of them were mono-
cistronic genes while the remaining 42 consisted of operons that include 141 genes.  
When these transcriptional units were grouped according to their known or putative 
functions, YvfI-affected genes were found to be involved in varied biological 
processes including cell-wall synthesis, membrane bioenergetics (ATP synthesis), 
nitrogen metabolism, protein synthesis and translocation, fatty acids and lipid 
metabolism, carbohydrate utilization and transport, sporulation delay and 
cannibalism, extracellular matrix production, antibiotic production and resistance, 
degradative enzyme production, transfer of mobile genetic element and phage 
infections. 
3.3.1.1 Fatty acid and lipid metabolism  
The first GntR subfamily, FadR, is the most crowded subfamily and it consists of a 
six or seven α-helices containing C-terminal domain depending on subgroups (Figure 
1.5a). FadR-like proteins are associated to the regulation of amino acids metabolism 
or to various metabolic pathways such as aspartate (AnsR), pyruvate (PdhR), 
glycolate (GlcC), galactonate (DgoR), lactate (LldR), malonate (MatR), or gluconate 
(GntR). The FadR protein, the E. coli ortholog of YvfI (Figure 3.15), acting both as a 
repressor and an activator, and  hence acts on regulating fatty acid biosynthetic and 
degradation genes (DiRusso et al., 1999). 
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FadR         MVIKAQSPAGFAEEYIIESIWNNRFPPGTILPAERELSELIGVTRTTLREVLQRLARDGW 60 
YvfI         ------------------MIKNGELKPGDKLDSVQALAESFQVSRSAVREALSALKAMGL 42 
                                * *..: **  * : : *:* : *:*:::**.*. *   *  
 
FadR        LTIQHGKPTKVNNFWETSGLNILETLARLDHESVPQLIDNLLSVRTNISTIFIRTAFRQH 120 
YvfI        VEMKQGEGTYLKEFELNQISQPLSAALLMKKEDVKQLLEVRKLLEIGVASLAAEKRTEAD 102 
            : :::*: * :::*  ..  : *.:   :.:*.* **::    :. .::::  ..  . . 
 
FadR        PDKAQEVLATANEVADHADAFAELDYNIFRGLAFASGNPIYGLILNGMKGLYTRIGRHYF 180 
YvfI        LERIQDALKEMGSIEADGELGEKADFAFHLALADASQNELLKHLMNHVSSLLLETMR--- 159 
             :: *:.*   ..:  ..:   : *: :. .** ** * :   ::* :..*  .  *    
 
FadR        ANPEARSLALGFYHKLSALCSEGAHDQVYETVRRYG---HESGEIWHR--MQKNLPGDLA 235 
YvfI        ---ETRKIWL-FSKKTSVQRLYEEHERIYNAVAAGNGAQAEAAMLAHLTNVEDVLSGYFE 215 
               *:*.: * * :* *.      *:::*::*   .    *:. : *   ::. *.* :  
 
FadR        IQGR 239 
YvfI        ENVQ 219 
                 : : 
Figure 3.15 : Alignment of YvfI (from Bacillus subtilis) and FadR (from 
Escherechia coli) amino acid sequence using CLUSTAL W 
algorithm. Sequences that are underlined represent α-helices of 
protein N-terminus regions. * (asterisk) indicates positions with 
fully conserved residues, : (colon) indicates conservation between 
groups of strongly similar properties, . (period) indicates 
conservation between weakly similar groups.  
The FadR protein functions as the repressor of fatty acid degradative (fad) genes 
(DiRusso et al., 1992). Furthermore, FadR directly induces lipid metabolism through 
the activation of fab genes (Black and DiRusso, 1994). As being an ortholog of FadR 
protein, YvfI as expectedly exerts a positive effect on the genes related to fatty acids 
and lipid metabolisms in B. subtilis. Expression levels of fatty acid and lipid 
metabolism related transcriptional units, fabHB, fabRplsXfabDG, acpA, fabHAF and 
plsC were found to be decreased in yvfI mutant strain (Table 3.2). 
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Table 3.2 : YvfI regulation on genes related to fatty acid and lipid metabolisms in B. 
subtilis. 
Gene 
 
Fold 
difference 
a 
qPCR b Function Transcriptional Organisation c 
     
bioW 1,99 1,46(±0,06) 6-carboxyhexanoate--CoA ligase  
 
ǂ     
 ǂ   
 
bioA 1,38  adenosylmethionine--8-amino-7-
oxononanoate transaminase 
bioF 1,45  8-amino-7-oxononanoate synthase 
bioD 2,06  dithiobiotin synthetase   
bioB ND  biotin synthase  
lip(estA) 2,38 2,65(±0,09) secreted alkaliphilic lipase ǂ    ǂ  ǂ  ǂ  
fabHA 1,87 1,00(±0,12) 3-oxoacyl-(acyl carrier protein) 
synthase III 
 
   ǂ   
 fabF 1,89  3-oxoacyl-(acyl carrier protein) 
synthase II 
ylpC(fabR) 1,36 1,16(±0,09) fatty acid biosynthesis transcriptional 
factor 
 
 
 
      ǂ 
 ǂ  ǂ  
 
plsX 1,66  putative glycerol-3-phosphate 
acyltransferase PlsX 
fabD 2,42  malonyl CoA-acyl carrier protein 
transacylase 
fabG 2,28  beta-ketoacyl-acyl carrier protein 
reductase 
acpA 2,29  acyl carrier protein 
citB -1,38 -2,21(±0,21) aconitate hydratase ǂ     ǂ  
citA -1,50 -2,20(±0,30) citrate synthase 1 ǂ   ǂ ǂ  ǂ 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
ND no differential expression observed 
As seen in Table 3.2, YvfI stimulates the transcription of fabHAF and 
fabRplsXfabHDacpA. In B. subtilis, FabR is a transcriptional repressor known for 
fatty acid and phospholipid biosynthesis regulatory properties on transcription units 
including fabRplsXfabHDacpA and fabHAF. The FabR protein is controlled by the 
cellular levels of malonyl-CoA and intracellular concentration of this particular 
component was suggested to regulate FapR-mediated repression of target genes and 
operons (Schujman et al., 2003; Schujman et al., 2006). Hence, our study speculates 
that YvfI also affects indirectly the genes in the mentioned fab regulon via acting on 
FapR-mediated repression, probably through increasing the intracellular level of 
malonyl-CoA. Relieving FapR mediated repression can also be suggested to occur in 
a more indirect way since the pool of malonyl-CoA is regulated through feedback 
inhibition by the acyl-ACP end products (Davis and Cronan, 2001). 
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In this study, not only fatty acids biosynthetic genes, but also lip gene, that encodes 
for an extracellular lipase, and biotin biosynthesis operon (bioWAFDB) (Bower et al., 
1996) were found to be upregulated. On the other hand, the expression of the citB 
(encoding aconitase) and the citA gene (encoding citrate synthase I) (Jin and 
Sonenshein, 1994), were found to be downregulated by YvfI. During the Krebs citric 
acid cycle, Acetyl-CoA is first converted to citrate by citrate synthetase and citrate to 
aconitate by aconitase (Hederstedt, 1993). Furthermore, in the presence of biotin, 
excess acetyl-CoA in the cell is shifted from Krebs citric acid cycle and converted to 
malonyl-CoA (an essential molecule for fatty acid biosynthesis) by acetyl-CoA 
carboxylase in a biotin-dependent enzyme. Therefore, as citB and citA are 
downregulated by YvfI, it should be expected that acetyl-CoA wouldn‟t be converted 
to aconitate and intracellular acetyl-CoA would be accumulated inside the cell. 
Hence, excessive amount of acetyl-CoA in the cell would lead to the promotion of 
malonyl-CoA synthesis. In toto, YvfI might be speculated to promote malonyl-CoA 
synthesis not only by inducing bioWAFDB operon, resulting in high amount of 
biotin synthesis, but also by repressing the first two enzymes of the Krebs citric acid 
cycle. Besides, YvfI induced lip gene expression might be expected to cause 
degradation of extracellular lipids which would eventually lead to acetyl-CoA 
accumulation and in turn to an increase in the intracellular level of malonyl-CoA, 
relieving FapR mediated repression on the fab genes. 
B. subtilis genome encodes for seven extracytoplasmic σ factors σM, σW, σX, σY, σZ, 
σV, and σYlaC (Huang and Helmann, 1998) that work in a harmony to display a 
control mechanism on many different functions (Helmann, 2002). Among these 
seven factors, the σM, σW, and σX regulons are widely studied and well-characterized. 
These three σ factors collectively control overlapping sets of genes related to 
resistance mechanism against cell envelope-active compounds and antibiotics 
(Helmann, 2002; Luo et al., 2010). When most of the cases are considered, genes that 
provide resistance are generally controlled by a single ECF sigma factor. To give 
examples, σW is responsible for controlling genes that provide resistance not only 
against fosfomycin which is a peptidoglycan synthesis inhibitor, but also against the 
toxic peptide SdpC, and the lantibiotic sublancin (Butcher and Helmann, 2006; Cao 
et al., 2001).  
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One of the operons that depend on σW is fabHAfabF operon and in case the 
membrane fluidity increases in a signal dependent manner, this sigma factor function 
in adapting membrane phospholipid composition (Kingston et al., 2011). fabHA 
becomes downregulated while fabF gets upregulated which in turn results in 
accumulation of straight chain fatty acids and in extension of the length of membrane 
phospholipids. Therefore, these adaptations lead to a increase in membrane viscosity 
and thus to an resistance to detergents and antibiotics produced by other strains 
(Kingston et al. 2011). Therefore, YvfI, through the upregulation of fabHAfabF 
operon, possibly could have led to a accumulation of branched chain fatty acids 
biosynthesis (Kingston et al. 2011). Hereafter, YvfI might have a crucial role in 
adjusting membrane phospholipid composition which is important in adaptation 
processes, during stationary phase, against stress signals and during cell 
differentiation.  
3.3.1.2 Nitrogen metabolism 
Nitrogen metabolism in bacteria is modulated by the intracellular levels of glutamine 
and glutamate, the two central intermediates in nitrogen metabolism that serve as the 
main nitrogen source in the cell (Fisher and Sonenshein, 1991). Glutamine is formed 
from glutamate and ammonium by glutamine synthetase (GS) and required directly 
for the biosynthesis of all of the major macromolecules of the cell: proteins (via the 
amino acids tryptophan, histidine, arginine, and glutamine itself), nucleic acids (via 
purines and pyrimidines), and cell-surface polymers (via glucosamine). An important 
characteristic for B. subtilis in ammonium assimilation is that it does not encode for 
an assimilatory glutamate dehydrogenase. Therefore, glutamate synthetase (GS) 
pathway is the sole pathway for ammonium assimilation through glutamate synthesis 
using Krebs cycle intermediate, α-ketoglutarate, and glutamine as substrates 
(Schreier, 1993) (Figure 3.16).  
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Figure 3.16 : Glutamate biosynthesis in B. subtilis. 
Transcription level of genes for glutamate synthase, gltA (encoding glutamate 
synthase large subunit) and gltB (encoding glutamate synthase (NADPH) small 
chain) were found to be significantly increased in the yvfI mutant (Table 3.3). YvfI 
was also observed to act on glnRA operon (encoding nitrogen responsive regulator 
and glutamine synthetase, respectively) not as much as significantly as observed for 
gltA and gltB genes. However, it should be noted that expression levels of glnRA and 
gltAB operons are co-regulated by TnrA and GlnR under various nutritional 
conditions (Bohannon and Sonenshein, 1989; Fisher, 1999; Wray et al, 2001). 
Furthermore, in case of nitrogen limitation, the expression of glnR, glnA and gltAB 
are repressed by TnrA. Hence, the main role for TnrA was suggested to sense the 
level of glutamate and to control the production of sufficient levels of glutamate in 
the cell (Wray et al, 2001). In consistent with the regulatory role of TnrA, YvfI was 
found to act as another direct negative regulator of both gltAB and glnRA operons. It 
can be supposed that YvfI might directly adapt to changing carbon and/or nitrogen 
state of the cell through regulating transcriptions of gltAB and glnRA operons. 
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Table 3.3 : YvfI regulation on genes related to nitrogen metabolism in B. subtilis. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
pyrR 2,52 2,79(±0,32) bifunctional pyrimidine regulatory 
protein PyrR uracil 
phosphoribosyltransferase 
 
 
 
 
 
 
 
ǂ   ǂ   ǂ   
     
 ǂ  
 
pyrP* NR 3,48(±0,18) uracil permease 
pyrB  1,37 4,34(±0,01) aspartate carbamoyltransferase 
catalytic subunit 
pyrC  1,89  Dihydroorotase 
pyrAA  2,31 5,85(±0,20) carbamoyl-phosphate synthetase 
(glutaminase subunit) 
pyrAB 2,00  carbamoyl-phosphate synthetase 
(catalytic subunit) 
pyrK ND  dihdrooratate dehydrogenase 
pyrD 1,32  dihdrooratate dehydrogenase  
(catalytic subunit) 
pyrF 1,21  orotidine 5'-phosphate 
decarboxylase 
pyrE 1,08  orotate phosphoribosyl transferase 
argC -1,63 -1,98(±0,22) N-acetyl-gamma-glutamyl-
phosphate reductase 
 
 
 
  ǂ     
   ǂ  
 
argJ -1,89  bifunctional ornithine 
acetyltransferase/N-
acetylglutamate synthase protein 
argB -2,08  acetylglutamate kinase 
argD -2,13  acetylornithine aminotransferase 
carA  -2,22  carbamoyl phosphate synthase 
small subunit 
carB  -2,15  carbamoyl phosphate synthase 
large subunit 
argF  -2,16  ornithine carbamoyltransferase 
glnR -1,31 -0,73(±0,10) transcriptional regulator (nitrogen 
metabolism) 
 ǂ     ǂ 
glnA -1,19  glutamine synthase 
gltA -1,31 -2,04(±0) glutamate synthase (large subunit)  
ǂ   ǂ    ǂ 
  
gltB -1,45  Glutamate synthase small chain 
trpE -1,9 -1,26(±0,05) anthranilat synthase component I  
 
ǂ            
     
 
trpD -2,1  anthranilate 
phosphoribosyltransferase 
trpC -2,62  indole-3-glycerol-phosphate 
synthase 
trpF -2,22  N-(5'-phosphoribosyl) anthranilate 
isomerase 
trpB -2,00  tryptophan synthase subunit beta 
trpA -1,04  tryptophan synthase subunit  α 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
ND no differential expression observed 
NR no reproducible data obtained 
*    Bayes P value higher than acceptable value (>0.01) 
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In harmony with the glutamate biosynthesis related genes, the transcription of all the 
genes related to arginine biosynthesis (argCJBDcarABargF and argGH) and 
tryptophane biosynthesis (trpEDCGBA) were found to be significantly down-
regulated by YvfI (Table 3.3). Contrariwise, pyrimidine nucleotide biosynthetic (pyr) 
operon (pyrB-pyrC-pyrAA-pyrAB-pyrK-pyrD-pyrF-pyrE) was observed to be 
induced by YvfI (Table 3.3). In B. subtilis, pyr operon is controlled through 
transcription attenuation mechanism (Lu and Switzer, 1996). Besides to transcription 
attenuation, it is proposed in this study that pyr operon might also be subjected to 
positive control directed by YvfI. In conclusion, it might be speculated strongly that 
YvfI exerts important regulatory roles (both negatively and positively) on nitrogen 
metabolism. 
3.3.1.3 Carbohydrate metabolism 
In this study, YvfI was also demonstrated to repress the acoABCL operon, encoding 
acetoin dehydrogenase complex required for acetoin utilization (Huang et al., 1999) 
(Table 3.4). Acetoin is used as a carbon storage material that is synthesized and 
exported during exponential phase of growth; besides B. subtilis further consumes 
acetoin also during stationary phase of growth, so that it would act as a carbon and 
energy source during sporulation (Lopez and Thoms, 1976).  Expression from this 
operon is subjected to catabolite repression by glucose through CcpA, a global 
regulator of carbon catabolite repression (Ali et al., 2001). This present study assigns 
another regulatory role to YvfI as being a negative regulator of acoABCL operon. In 
addition, msmRE operon encoding a putative regulatory protein belonging to LacI 
family (msmR) that consist of a HTH domain on its N terminal and encoding a 
putative binding proteins for the transport of multiple sugars (msmE) was directly 
downregulated by YvfI. These findings proposed that YvfI functions not only during 
carbohydrate utilization in the early stationary phase cell but also on the regulation of 
carbohydrate transport systems. 
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Table 3.4 : YvfI regulation on genes related to carbohydrate metabolism in B. 
subtilis. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     acoA -1,57 -3,07(±0,22) acetoin dehydrogenase E1 
component (TPP-dependent 
alpha subunit) 
 
 
ǂ   ǂ     
ǂ   ǂ 
 
acoB -1,54   acetoin dehydrogenase E1 
component (TPP-dependent 
beta subunit) 
acoC -1,56   branched-chain alpha-keto acid 
dehydrogenase subunit E2 
acoL -1,36  dihydrolipoamide 
dehydrogenase 
msmR -1,48 -1,43(±0,27) transcriptional regulator (LacI 
family) 
 ǂ      
  ǂ  
msmE -1,51  multiple sugar-binding 
lipoprotein 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
Microarray analysis revealed out that YvfI downregulates the transcription pattern of 
6 genes which are known to be regulated by a stationary phase transition regulator, 
AbrB. It should be noted that AbrB is a stationary phase transition regulator, which is 
assigned during the stationary phase in B. subtilis.  Furthermore, negative regulation 
pattern of AbrB regulatory protein on different genes, such as pbpE, and sigW that 
are transcribed through the extracytoplasmic sigma factor SigmaW dependent 
promoter was previously described (Strauch et al., 2007; Cao et al., 2002) This 
finding further supported the possibility that YvfI acts similarly with AbrB protein 
on effecting σw regulon by decreasing sigW gene transcription. Similar regulation 
pattern between AbrB and YvfI was further detected on aprE and liaI genes while 
varied regulation was observed for sdpA, argC and citB genes (Table 3.5). 
Additionally, the mRNA level of citB was significantly elevated in YvfI mutant. 
Expression of citB is under the complex regulation of CcpC, a citrate inhibited 
repressor and CodY, GTP-dependent repressor of stationary-phase cell, and AbrB, its 
transcription rapidly increases as a response to excessive citrate levels and decreases 
when intracellular pools of GTP and branched-chain amino acids boost up (Kim et 
al., 2003). Data given in this study revealed out that YvfI also participates to this 
complex regulation on citB through acting as a repressor. 
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Table 3.5 : Genes that are found in AbrB regulon and that become induced or 
repressed by YvfI during the stationary phase. 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
In B. subtilis, citB encodes for an aconitase enzyme that catalyzes the reversible 
conversion of citrate and iso-citrate to aconitate during tricarboxylic acid branch of 
Krebs citric acid cycle and product of this gene is also known to be required for 
sporulation (Kim et al., 2003). Aconitase displays an additional role in sporulation 
which is independent from of its enzymatic activity required for the activation of 
Spo0A (Serio et al., 2006). This auxiliary activity provides the protein with a 
regulatory role for setting the proper timing of spore coat assembly and sporulation 
initiation (Craig et al, 1997; Serio et al., 2006). In consequence, YvfI regulatory 
behavior on citB has given more insights on the contribution of YvfI to sporulation 
process which would be explained in details in following sections.  
Furthermore, it should be noted that, AbrB acts as a defined repressor on the biofilm 
formation in Bacillus subtilis during the transition from exponential growth to 
stationary phase (Chu et al., 2008). On the other hand, Abrb is not the sole regulator 
of the system, SinR repressor protein is also known to repress many genes involved 
in biofilm formation, including exopolysaccharide synthesis genes and yqxM-sipW-
tasA genes that are also responsible for late spore processes (Branda et al., 2006; Chu 
et al., 2006). Another operon that was subjected to a regulation by SinR, was found 
to be responsible for lactate utilization during biofilm development and renamed as 
lutABC. Moreover, this operon was characterized to be under the cooperative dual 
control of two repressors SinR and GntR-type repressor, YvfI, renamed as LutR 
(Chai et al., 2009). Therefore, this data further strengthen the possibility for YvfI to 
act very similarly to AbrB, in case of both cooperating with SinR to act on 
architectural complexity of biofilms in the presence of L-lactate (Chai et al., 2009) 
and on effecting σw regulon. 
Gene 
 
Expression 
ratio a 
qPCR b AbrB 
reg 
Function 
yvaW(sdpA)  0,7 1,08(±0,22) - Sporulation delay protein-export of killing factor 
aprE -3,78 -3,07(±0,91) - extracellular alkaline serine protease (subtilisin E) 
argC -1,39 -1,98(±0,22) + N-acetyl-gamma-glutamyl-phosphate reductase 
citB -0,89 -2,21(±0,21) + Aconitate hydratase 
pbpE -0,18 -3,44(±1,13) - penicillin-binding protein 4* (spore cortex) 
sigW -0,35 -4,31(±0,01) - RNA polymerase sigma factor sigW 
yvqI (liaI)  -1,44 -1(±0,05) - permease 
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3.3.1.4 Degradative enzyme production 
In Bacillus subtilis nutrient limitations during the transition stage, enhance the 
production of a wide variety of degradative enzymes such as levansucrase, alkaline 
proteases and metalloproteases, α-amylase, β-glucanase, and xylanase in order to 
scavenge alternative nutrient sources (Stülke et al., 1993). Microarray studies 
conducted in this study, showed that the lipase encoding lip gene (Eggert et al 2000), 
and the yhfEF operon, encoding a putative endogluconase (Kunst et al., 1997), were 
upregulated by YvfI. YvfI was also shown to positively regulate the intracellular 
serine protease encoding gene aprX while repressing aprE, and ispA (Table 3.6). 
YvfI is not the first reported regulatory protein for these particular genes. The 
transcription of ispA and aprE were previously reported to be directly activated by 
DegS-DegU, a two component regulatory systems in B. subtilis (Msadek et al., 
1991), and the transcription of aprX was known to be regulated by SinR as being the 
sole regulator (repressor) described for aprX (Valbuzzi et al., 1999). Herein, YvfI 
might be speculated to be the first positive regulator of aprX. The expression of the 
aprE gene that encodes for a extracellular alkaline serine protease, was tightly 
regulated by a combination of regulatory systems involving activation by DegU and 
repression by AbrB, ScoC and SinR (Msadek et al., 1991, Ogura et al., 2003, Ogura 
et al., 2004, Abe et al., 2009). This present study points out that YvfI is a novel 
transcription factor that regulates aprE along with the previously described 
regulators. 
Table 3.6 : YvfI regulation on genes related to degradative enzyme production in B. 
subtilis. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
aprX 1,57 2,98(±0,17)  serine protease  
ǂ    ǂ  
yhfE 1,63 3,65(±0,04) putative endoglucanase  
ǂ     ǂ yhfF 1,40  2,18(±0,09) hypothetical protein 
aprE -2,35 -3,07(±0,91) extracellular alkaline serine 
protease (subtilisin E) 
ǂ  ǂ    ǂ  
ispA -2,01 -1,68(±0,22) intracellular serine protease  
ǂ ǂ   ǂ   
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
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In B. subtilis, differing in auxiliary function from these degradative enzymes, IspA 
plays a critical role for the onset of efficient sporulation. IspA does not only function 
in creating proteolytic activity in sporulating cells, but it was also proposed to 
employ a regulatory pattern for sporulation, such that mutation of ispA resulted in 
delay of sporulation in B. thuringiensis (Chen et al., 2003). This data further 
strengthens the role of YvfI during sporulation process of Bacillus subtilis. 
3.3.1.5 Antibiotic production and resistance 
In this study YvfI has risen as an important regulatory protein that employs 
regulation on the expression of a number of varied types of antibiotics. For instance, 
YvfI positively controls the non-ribosomally synthesized lipopeptide antibiotic 
fengycin (pliapstatin) and polyketide antibiotic encoded from pks operon that is 
responsible for polyketide antibiotic biosynthesis and lipopeptide antibiotic fengycin-
plipastatin production from ppsABCDE operon responsible for lipopeptide antibiotic 
fengycin-plipastatin production (Table 3.7). Lipopeptide antibiotics and polyketides 
are all related with lipid metabolism since lipopeptide antibiotics partly consist of β-
hydroxyfattyacids and polyketides are usually biosynthesized via condensation of 
malonyl-CoA. In concordance with this data, during early stationary phase YvfI was 
suggested in the previous sections to be related with the expression of genes 
responsible for fatty acid and lipid biosynthesis like fabHB,ylpC,plsX,fabHD,acpA, 
fahHAfabF and plsC, biotin biosynthesis (bioWAFDB) and extracellular lipase 
encoding gene, lip, together with polyketide and plipastatin biosynthetic operons. 
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Table 3.7 : YvfI regulation on genes related to antibiotic production and resistance 
in B. subtilis. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
pksD 1,9 1,44(±0,06) enzyme involved in polyketide 
synthesis 
 
 
 
 ǂ      
 ǂ     
 
    ǂ  
   
 
pksE 1,59  enzyme involved in polyketide 
synthesis 
acpK 1,77  acyl-carrier protein 
pksG 2,10 1,42(±0,18) acetyl-S-AcpK beta-
ketothioester polyketide 
intermediate transferase 
pksH ND  enzyme involved in polyketide 
synthesis 
pksI* ND   enzyme involved in polyketide 
synthesis 
pksJ 2,73 4,14(±0,01) polyketide synthase of type I 
pksL 3,95 6,19(±0,06) polyketide synthase of type I 
pksM 2,17  polyketide synthase 
pksN 2,96  polyketide synthase of type I 
pksR 2,46  polyketide synthase 
ppsA* NR   plipastatin synthetase  
ǂ      ǂ 
  
ppsB 1,1  1,09(±0,18) plipastatin synthetase 
ppsC*  NR  plipastatin synthetase 
ppsD 1,24   plipastatin synthetase 
ppsE 2,42  plipastatin synthetase 
yokD NR 2,65(±0,25) aminoglycosideN3'-
acetyltransferase 
 
ǂ   ǂ    
ywfB(bacA)† ND  bacilysin biosynthesis protein, 
dehidratase 
 
 
 
ǂ ywfA ǂ     
  ǂ   ǂ   
ywfC(bacB)  ND  isomerase component of 
bacilysin synthetase 
ywfD(bacC)*   NR  bacilysin biosynthesis 
oxidoreductase 
ywfE(bacD) ND  alanine-anticapsin ligase 
ywfF(bacE)* NR  efflux protein for bacilysin 
excretion, self-protection against 
bacilysin 
ywfG* NR  transaminase 
ywfH† ND  carrier protein reductase of 
bacilysin biosynthesis 
yybN 1,76 2,05(±0,24) hypothetical protein  
 
 ǂ      
 ǂ  
yybM ND  integral inner membrane protein 
yybL 1,52 1,23(±0,12) integral inner membrane protein 
yybK 1,73  integral inner membrane protein 
yybJ 1,52  ATP-binding cassette protein 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
ND no differential expression observed 
NR no reproducible data obtained 
*    Bayes P value higher than acceptable value (>0.01) 
† Expression profiles were previously elucidated by lacZ-fusion analysis 
It was previously reported that disruption of YvfI has resulted in the loss of dipeptide 
antibiotic bacilysin biosynthesis phenotype (Köroğlu et al., 2008). However, 
  70 
microarray studies have failed to support this data since any significant differences in 
the expression of bacilysin biosynthetic cluster: bacABCDEFywfG operon and ywfH 
was not detected probably due to drawbacks of microarray studies. However, 
expressions of bacABCDEywfG operon (Köroglu et al., 2011) and ywfH gene 
(studied by our group, data not published) were previously studied using lacZ fusion 
assays. Results of these mentioned studies have revealed out that YvfI activity was 
crucial for the maximum level expression of bac operon (Köroglu et al., 2011) and 
ywfH (studied by our group, data not published). It should be noted that the unusual 
amino acid anticapsin from dipeptide bacilycin antibiotic is generated as a branching 
off from prephenate of the aromatic amino acid pathway through the action of BacA 
and BacB (Hilton et al., 1988, Mahlstedt and Walsh 2010). Then BacB is chosen as 
the substrate by YwfH, a short chain reductase that ultimately causes to promotion of 
tetrahydrotyrosine (H(4)Tyr) formation and ultimately to anticapsin synthesis 
through a unknown reaction (Figure 1.3) (Mahlstedt and Walsh 2010). An yvfI 
mutation was shown to decrease ywfB-lacZ expression to about 57% relative to wild 
type level during the stationary phase (Köroglu et al., 2011) while this mutation had 
effected ywfH expression more drastically.   
This study also reports stimulation of yybN-yybM-yybL-yybK operon by YvfI during 
early stationary phase (Table 3.7). As described by Albano et al (2005), yybN-yybM-
yybL-yybK cluster encodes for a protein with N-terminal transport signal sequence 
and three permease-like membrane proteins is involved in transport, respectively. In 
addition, another gene yybJ, located at the downstream of yybK, was also 
significantly affected by yvfI mutation and our transcriptional profiling data revealed 
out that yybJ is might br the last gene in this operon as being a putative ATP binding 
protein, considering similar induction profiles of the rest of the operon. 
Under the light of these findings, it can be accepted as a fact that YvfI is involved in 
the regulation of antimicrobial product biosynthesis. However, YvfI also seems to 
function in providing resistance to bacterium against aminoglycoside antibiotics 
because it clearly induced yokD gene (encoding a putative aminoglycoside 
acetyltransferase as indicated by Hoffman et al., 2005) transcription significantly 
during late stage of growth (Table 3.7). This data is noticeable considering the fact 
that stationary phase cells and biofilm cells, because of their reduced permeability, 
are more tolerant to antibiotics and YvfI strikingly stimulates an aminoglycoside 
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resistance gene during stationary phase of growth which could be related to the 
regulatory behavior of YvfI on biofilm process that would be mentioned in section 
3.3.1.9. 
 3.3.1.6 Regulation of B. subtilis mobile genetic element 
Mobile genetic elements in bacteria contain a variety of genes with different 
functions from antibiotic resistance, symbiosis, to virulence; their high diversity and 
dissemination also stimulate bacterial evolution by conferring new genes and 
phenotypes to their recipients (Burrus and Waldor, 2004; Frost et al., 2005). Phages, 
plasmids, and integrative and conjugative elements (ICEs), also known as 
conjugative transposons are classified as the most frequently seen mobile genetic 
elements (Grohmann et al., 2003; Burrus et al., 2002). A class of ICE elements in B. 
subtilis, 20 kb ICEBs1 (Figure 3.17) gets excised from the chromosome when 
induced, and gains mobility to be transferred to recipient cells. When cells encounter 
unfavorable conditions like high cell density and overcrowded environment with 
cells lacking ICEBs1 and PhrI, a SOS signal is transmitted and ICEBs1 gene 
expression and excision get initiated (Auchtung et al., 2005).  
 
Figure 3.17 : Operonal organization of ICEBs1. ICEBs1 is a 20-kb long element 
which contains app. 24 different ORFs (Auchtung et al., 2005). 
Additionally, sensing population density, its excision and transfer are known to be 
induced by Rap protein, RapI and repressed by the pentapeptide PhrI both of which 
are encoded by ICEBs1 itself (Auchtung et al., 2005). It should drain some attention 
that rapI gene was processed to give an unreproducible expressional profile as a 
result of the microarray analysis, however the constructed rapI-lacZ trancriptional 
fusion implied that rapI, the major inducer of ICEBs1, is significantly down 
regulated by YvfI during transition state (Figure 3.18), suggesting that YvfI represses 
rapI transcription directly. 
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Figure 3.18 : Effect of yvfI mutation on the expression of rapI gene. Growth and -
galactosidase activity of rapI::lacZ fusion (white bars and white 
squares) and its congenic derivative yvfI mutant (rapI::lacZ, 
yvfI::Tn10::spc) (black bars and black circles). Error bars indicate the 
standard deviation of the mean of three independent experiments 
(n=3). 
In Toto, these findings clearly contributed to the suggestion that YvfI contributes to 
the growth-phase dependent regulation of ICEBs1 in B. subtilis as a direct negative 
regulator for rapI.  
3.3.1.7 SPP1 phage infection in B. subtilis 
 More than half of known phages are grouped by the presence of a long non-
contractile tail, as is the case of SPP1 that consists of a 160-nm long tail. 
Bacteriophage SPP1, as a generalized transducing particle, is a virulent Bacillus 
subtilis phage that packages its genome in a 60-nm wide isometric capsid (Plisson et 
al., 2007; Tavares et al., 1992; Yasbin et al., 1974). Host infection of SPP1 is 
initiated by the binding of this 160-nm long tail to YueB, a membrane protein (Sao-
Jose et al., 2004; Sao-Jose et al., 2006). This irreversible binding initiates a series of 
events resulting in release of phage genome into the B. subtilis cytoplasm. This 
membrane bound YueB protein of ∼120 kDa shows great homology with other 
proteins from different species and one of these homologs is the protein Pip, which 
functions as a phage receptor in Lactococcus lactis (Sao-Jose et al., 2004). 
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Table 3.8: YvfI regulation on genes related to SPP1 phage infection in B. subtilis. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
yukE 1,46 1,29(±0,06) hypothetical protein  
 
 
ǂ       
   ǂ 
 
yukD ND  bacteriocin 
yukC 1,75  membrane-associated enzyme 
involved in bacteriocin 
production 
yukB ND  putative cell division protein 
yukA 1,48  hypothetical protein 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
ND no differential expression observed 
Recently, yueB was reported to be a part of an operon including yukE, yukD, yukC, 
and yukBA transcription units (Sao-Jose et al., 2004). Another important observation 
in this study was that yukE, yukC and yukAB genes were significantly stimulated by 
YvfI (Table 3.8). Our overall data implied that YvfI is directly involved in the SPP1 
infection in B. subtilis. 
3.3.1.8 Protein translocation and folding 
Most proteins that are secreted contain a signal peptide in order to direct these 
extracellularly functioning proteins to their final destination (Tjalsma et al., 2000). 
Chaperones and targeting factors generate machinery for protein transport the biggest 
of which is the Sec translocase that deals with preproteins in their unfolded state 
(Driessen et al., 2001). As it is reported, these secretory proteins are directed to Sec 
translocase by the signal recognition particle (SRP) (Hirose et al., 2000). This SRP 
complex is generated by Ffh (Fifty-four homolog) protein (Honda et al., 1993), a 
small cytoplasmic RNA (scRNA) (Nakamura et al., 1994; Nakamura et al., 1992), 
and a histone-like protein (HBsu) (Nakamura et al., 1999). SRP receptor-like protein 
FtsY and Ffh are among the widely conserved family of SRP-GTPases (Eichler and 
Moll, 2001). In B. subtilis RNase III encoded by rnc is responsible for the processing 
of small cytoplasmic RNA (scRNA) precursor. The upregulation of rnc and ffh 
transcription by YvfI (Table 3.9) reveals the possible effect of YvfI on the synthesis 
of SRP as an important component of the protein-secretion machinery of B. subtilis. 
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Table 3.9 : YvfI regulation on genes related to protein translocation and folding in B. 
subtilis. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
ffh 1,51 2,91(±0,04) signal recognition particle-like 
(SRP) GTPase 
 
rnc 2,41 
 
 
1,64(±0,03) ribonuclease III, cleaves both 5'- 
and 3'-sites of the small 
cytoplasmic RNA precursor 
 
 ǂ  ǂ  ǂ   ǂ ylqB 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
3.3.1.9 Sporulation, cannibalism and sporulation delay   
B. subtilis initiates differentiation of specialized cell types when exposed to 
unfavorable environmental conditions in order to allow the bacteria survive in the 
increasingly hostile environment (Grossman, 1995; Phillips and Strauch, 2002; 
Errington, 2003; Piggot and Hilbert, 2004).). Production of antibiotics and 
macromolecular hydrolases, development of motility, chemotaxis and competance 
are among these responses (Kunst et al., 1997). Another response that makes Bacillus 
subtilis to form specialized cells is sporulation, Bacillus subtilis undergoes 
asymmetric cell division, followed by engulfment of the smaller forespore by the 
larger sibling, the mother cell (Errington, 2003; Levin and Grossman; 1998).  
The process of sporulation, which represents a series of morphological and 
physiological events, that occurs through the sequential activation and silencing or 
blocking of genes (Errington, 2003). Spore development is a high energy requiring 
event and the pathway is usually completed before bacterium exit from this state. 
Thus, this bacterium has developed mechanisms to delay entry into sporulation and 
this event is called as cannibalism (Gonzalez-Pastor et al., 2003). 
One of the most important finding of this project revealed out that the transcription 
of sdpABC (yvaWXY) operon, also called “sporulation delay operon” is controlled by 
Yvfl in a positive manner. In B. subtilis, nutritional limitation stimulates the spore 
production and the process of the sporulation is initiated by the transcriptional factor 
Spo0A which is activated through phosphorylation (Losick and Stragier, 1992). At 
the beginning of the sporulation it is discovered that Spo0A strongly induces two 
different operon groups; skf (sporulation killing factor) and sdp (sporulation delay) 
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(Fawcett et al., 2000). The other two member of the Skf operon, SkfE and SkfF 
provide the pumping out of the produced killing factor in order to protect the 
producer cell from the killing factor. Sdp operon, controlled by Spo0A, is responsible 
for the production of extracellular cell signal factor SdpC (weights 5 kD) which 
serves the purpose of signaling between bacteria. SdpC strongly controls yvbA and 
yvaZ genes which are under the sdp operon. In Spo0A-active cells, it is thought that 
transcriptional factor SdpR (YvbA), a member of ArsR family of regulators, strongly 
induces yusLKJ operon which is responsible for the lipid catabolism, and atp operon 
which is responsible for the production of ATP, for the purpose of delaying the onset 
of sporulation by increasing the energy level in the cell. In Spo0A-inactive cells, it is 
considered that through suppression of sigW gene, SdpR contributes to dissolving by 
Skf killing factor. It is thought that the cell is protected from the Skf killing factor 
effect by sigW, which is responsible for the development of detoxification and 
antimicrobial strength. Therefore, in Spo0A-inactive cells, it is accepted that SdpR 
and Skf killing factors move together to dissolve the cell so that Spo0A-active cells 
could use the released nutritions and consequently sporulation can be delayed and 
active growth can be maintained (Gonzalez-Pastor et al., 2003). From the aspect of 
YvfI, it is clearly seen that YvfI behaves parallel with SdpR and acts on regulating 
sdp operon causing induction in SdpC signal production and directly increasing the 
amount of SdpR in the cell and also by promoting atp operon and increasing the 
energy level in the cell at the same time, it appears that YvfI creates a possibility for 
a delayed pass into spore formation process. Furthermore, as an inducer of a putative 
endogluconase encoding gene, yhfE and an intracellular serine protease encoding 
gene, acpX, as described above, YvfI might also be speculated to delay the onset of 
sporulation by stimulating YhfE and AcpX and many other metabolic processes 
including protein biosynthesis through stimulating rplJ (50S ribosomal protein L1), 
tsf (Ts elongation factor), frr (ribosome recyclic factor) and tig trigger factor (prolyl 
isomerase), pyrimidine nucleotide biosynthesis (pyrRPBCAAABKDFE), lipid and 
fatty acid biosynthesis (fabHB; ylpC-plsX-fabDG-acpA; fabHA-fabF; plsC) are 
observed to be induced by YvfI. Hence, in the transition to the stationary phase, YvfI 
regulatory factor also accelerates ATP synthesis and promotes many cellular 
activities necessary for active growth, including protein and nucleotide synthesis, cell 
wall synthesis, cell division, lipid and fatty acid biosynthesis and biotin biosynthesis. 
Therefore, all those mentioned limitations strengthen the possibility that “YvfI could 
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take a role in holding back the cell from sporulation and deccelerating initiation of 
the sporulation and support the cell growth at a certain time by promoting the 
metabolic activities in Spo0A-active cells during stationary phase”. 
Table 3.10 : YvfI regulation on genes related to cannibalism and sporulation delay in 
B. subtilis. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
atpI 1,19  0,56(±0,03) ATP synthase subunit I  
atpB  1,93  ATP synthase subunit A   
 
ǂ  
ǂ 
 
atpE  2,02 1,53(±0,15) ATP synthase subunit C 
atpF  1,99  ATP synthase subunit B 
atpH  1,93  ATP synthase subunit delta 
atpA  2,01 1,13(±0,10) ATP synthase subunit alpha 
atpG  1,91  ATP synthase subunit gamma 
ftsE 1,11 1,94(±0,13) cell-division ABC transporter 
(ATP-binding protein) 
 
  ǂ  ǂ 
 ftsX 1,68  cell-division ABC transporter 
rplJ  1,69 3,42(±0,30) 50S ribosomal protein L10  
   ǂ   ǂ 
 
rplL 1,66  50S ribosomal protein L7/L12  
spoIIE† ND  serine phosphatease  
ǂ      
tig 1,68 1,11(±0,01) trigger factor (prolyl isomerase), 
catalyze in vitro protein folding; 
essential for growth under 
starvation conditions 
 
ǂ  ǂ     ǂ  
tsf 1,69 
 
1,31(±0,53) Ts elongation factor  
 
 
   ǂ    ǂ  
pyrH 1,52 1,74(±0,15) 
 
uridylate kinase 
frr 1,55 1,11(±0,08) ribosome recycling factor 
 
yvaW(sdpA) 1,26  1,08(±0,22) sporulation delay protein-export 
of killing factor 
 
 
    ǂ 
 
yvaX (sdpB) 2,2 1,68(±0,08) Sporulation delay protein-
exporter of killing factor SpbC 
yvaY(sdpC) ND  killing factor SdpC 
yvcE(cwlO) 2,24 1,70(±0,05) secreted cell wall DL-
endopeptidase 
 
   ǂ   ǂ 
Abh* NR -4,57(±0,28) transcriptional regulator of 
transition state genes (AbrB-like) 
 
ǂ    ǂ   
pbpE ND -3,44(±1,13) penicillin-binding protein 4* 
(spore cortex) 
 
ǂ    ǂ   ǂ   
ytsC(bceA) ND -2,68(±0,32) bacitracin ABC efflux 
transporter ATP-binding protein 
 
ǂ   ǂ    
 ǂ  ytsD(bceB) ND -3,77(±0,06) Bacitracin export permease 
protein BceB  
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
ND no differential expression observed 
NR no reproducible data obtained 
*    Bayes P value higher than acceptable value (>0.01) 
† Expression profiles were previously elucidated by lacZ-fusion analysis 
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Beside its above mentioned functions, SdpR also induces cell death in Spo0A-
inactive cells through repressing sigW (Gonzalez-Pastor et al., 2003), thus 
contributes to the loss of resistance against antibiotics and also stimulates the 
expression of sdp and skf  operons indirectly since  reducing 
w
 dependent-
transcription of abh, which encodes for an antimicrobial regulator, would induce the 
expression of the skp and sdp operons (Strauch et al., 2007; Chumsakul et al., 2011). 
This study has revealed that in addition to sigW gene itself, YvfI down regulates 
many genes regulated by 
w
, including  abh, bceAB transcription unit that contributes 
to bacitracin resistance (Bernard et al., 2007), and also pbpE (encoding a penicillin 
binding protein, PBP4 endopeptidase) whose repression leads to reduced resistance 
against vancomycin, penicillin and bacitracin (Palomino et al., 2009). Therefore, it 
can be concluded that YvfI could also work similarly to SdpR by inducing 
cannibalism through Spo0A-inactive cells and this effect is more likely to be exerted 
by decreasing resistance of the cells against antimicrobial agents secreted by 
surrounding organisms and also against killing factor (SkF) produced by their own 
Spo0A-active, sporulating derivatives (Gonzalez-Pastor et al., 2003). 
YvfI strikingly up regulated ftsEX operon in this study and therefore it can be 
speculated that in addition to its role in sporulation delay mechanism, YvfI should 
also have a role in setting the initial steps of sporulation. As Garti-Levi and co-
workers (2008) suggested, FtsE and FtsX proteins encoded from this operon have 
crucial parts at the top of the sporulation phosphorelay cascade that leads to an 
efficient sporulation. A significant finding of this study was that ftsEX mutation on a 
wild type sporulating strain resulted in a expressional delay for a early sporulation, 
spoIIE (Garti-Levi et al., 2008). Under the light of this finding, since YvfI up 
regulated ftsEX operon, this study aimed to reveal whether yvfI mutation would alter 
spoIIE-lacZ expression or not. As a result, it was observed that spoIIE directed-lacZ 
expression was initiated in a 1 hour delayed manner when cells were grown in 
sporulation medium (DSM) (Figure 3.19), therefore this study further supported the 
proposition that YvfI acts on ftsEX and has a role on the regulation of sporulation 
initiation when it started. Spore count assay employed on B. subtilis TEK1 and wild 
type cells grown in DSM medium has revealed out that there were no difference on 
the sporulation percentages of both strains, suggesting that once sporulation initiated, 
no major defects are encountered when sporulation proceeds. 
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Figure 3.19 : Effect of yvfI mutation on the expression of spoIIE. Cells were grown 
in DSM medium at 37
o
C and spollE-directed β-galactosidase synthesis 
was determined at the indicated times. Time zero represents initiation 
of sporulation in DSM. β-galactosidase activity of spoIIE::lacz fusion 
(squares) and its congenic derivative yvfI mutant (spoIIE::lacz::cat, 
yvfI::Tn10::spc) (triangle). Error bars indicate the standard deviation 
of the mean of three independent experiments (n=3). 
3.3.1.10 Biofilm formation 
B. subtilis is also known as a biofilm forming organism and through developing a 
biofilm, this bacterium gains the ability to behave as a multicellular community in 
which cells are held together tightly with the help of an extracellular matrix (Branda 
et al., 2005; Aguilar et al., 2007). Normally, in its natural habitat, B. subtilis stands as 
a flagellated, motile organism, however in case of biofilm formation; this motility is 
converted into a nonmotile state (Branda et al. 2001). This switch in motility is 
represented in figure 3.20 and the key components of biofilm development are 
visualized.  
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Figure 3.20 : Genetic circuitry governing the switch from motile cell to nonmotile 
cell in B. subtilis (Lemon et al., 2008). 
The transcriptional repressor SinR was revealed to be the master repressor protein 
(Kearns et al. 2005) and in flagelleted cells, SinR represses the transcription of genes 
repress many genes involved in matrix formation, including exopolysaccharide 
synthesis genes and tapA(yqxM)-sipW-tasA genes that are also responsible for late 
spore processes (Branda et al., 2006; Chu, 2006). SinR is constitutively produced, 
and when conditions become favorable for biofilm formation, SinR activity is 
antagonized. SinI and two newly identified proteins, YlbF and YmcA, all serve to 
directly and/or indirectly antagonize SinR activity. Repressed SinR activity by SinI, 
YlbF and YmcA results in turn in the decrese of motility, cell chain formation, and 
matrix production (Branda et al. 2006). Furthermore, in nonmotile B. subtilis, 
regulation of cell surface proteins and extracellular matrix synthesis lead to the 
initiation of biofilm development (Gotz, 2002; Latasa et al. 2005). This matrix is 
composed of primarily exopolysaccharides and a protein, TasA which are encoded 
through epsA-O and tapA-sipW-tasA operons, respectively (Branda et al. 2006). 
EpsD, E, F, H, J, L, and M are all proposed to be glycosyl transferases, while EpsK 
is thought to be responsible for the export of saccharide (Branda et al. 
2001). tasA and tapA (yqxM) mutants were also identified to produce cell chains that 
are incompetent to hold together and are defective for matrix production and sipW 
functions as a dedicated signal peptidase (Stover and Driks 1999a, 1999b).   
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In the microarray analysis of this sudy, it was demonstrated that epsD,  epsE, epsK 
and tapA-sipW-tasA operon were induced by YvfI protein (Table 3.11), suggesting 
that YvfI might also have a role in regulation of biofilm formation next to 
cannibalism. Another supportive finding from this sudy was that a putative 
membrane-bound lipoprotein (yvcA) and a small cell wall associated protein (yuaB), 
that are further required for complex colony architecture development (Verhamme et 
al., 2007; Kovacs and Kupiers, 2011), were also significantly induced by YvfI.  
Table 3.11 : YvfI regulation on genes related to biofilm formation in B. subtilis. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
tapA (yqxM) 0,96  2,65(±0,06) lipoprotein for biofilm formation  
  ǂǂ     
 
 
sipW 2,12 1,42(±0,14) type I signal peptidase 
tasA 1,50 2,65(±0,17) major biofilm matrix component 
yuaB  3,33 2,70(±0,25) hypothetical protein  ǂ  ǂ   ǂ 
yvcA* NR 1,56(±0,01)  Lipoprotein  ǂ    ǂ  
yveN(epsD) 2,21 2,63(±0,05) extracellular matrix biosynthesis 
enzyme 
 
ǂ       
      
      
 
 
yveO(epsE) 2,08 1,34(±0,31) Glycosyltransferase 
yvfA(epsK) 1,49 1,10(±0,21) extracellular matrix component 
exporter 
yvfE(epsN) 0,79 1,02(±0,01) aminotransferase 
yvfF(epsO) 1,79 0,94(±0,05) pyruvyl transferase 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Numbers indicate the log 2 transformed expression ratio‟s. (The mean of minimum three 
independent replicate experiments is given and standart deviation of the mean is shown in 
paranthesis), 
c. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
*    Bayes P value higher than acceptable value (>0.01) 
It should be remarked that sporulation, cannibalism and biofilm production are 
tightly interlinked in B. subtilis, such that development of all three physiological 
states are initiated in a Spo0A dependent manner (Hamon and Lazazzera, 2001; 
Branda et al., 2004; Lopez et al., 2009). Cannibalism and biofilm development are 
observed to be initiated on the same colonies where Skf and Sdp toxins and the 
extracellular matrix of the biofilm were also produced (Lopez et al., 2009). Thus, 
above-mentioned roles of YvfI in cannibalism and biofilm formation are further 
strengthened as well as its ability to promote the growth of matrix-producing cells 
while delaying the sporulation. This growth inducing tendency finds more support 
considering that many genes regulated by YvfI are also involved in metabolism 
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directing pathways including degradative enzyme production, ATP production, lipid 
and fatty acid biosynthesis, carbon and nitrogen metabolism, nucleotide metabolism, 
cell wall synthesis, membrane transport, antibiotic production and resistance. 
3.3.2 Identification of the genes regulated by YvfI during exponential phase  
Previously mentioned study indicated that a maximum level of expression was 
observed following the entry into stationary phase (Figure 3.15). Hence, while 
aiming for the identification of all genes included in the regulon of YvfI 
transcriptional regulator, comparative transcriptome analysis of wild type control 
strain PY79 and yvfI disrupted TEK1 mutant, yvfI::T10::spc during exponential 
phase (~ OD 0,7) was studied using microarray analysis. B. subtilis PY79 and TEK1 
strains were grown in PA medium until they reached OD 0,7 at A600. In order to 
identify genes that are differentially expressed in PA medium during chosen growth 
phase, B. subtilis genomic DNA microarrays that harbors 4,107 open reading frames 
were preferred as described before.  
It should be noted that exponential phase data was not expected to be in a great 
harmony with stationary phase expression data since YvfI expression level was 
significantly different for each phase. As discussed in previous sections the 
glutamate biosynthesis related genes, the transcription of all the genes related to 
arginine biosynthesis (argCJBDcarABargF and argGH) and tryptophane 
biosynthesis (trpEDCGBA) were significantly down-regulated by YvfI (Table 3.3). 
On the other hand, pyrimidine nucleotide biosynthetic (pyr) operon (pyrB-pyrC-
pyrAA-pyrAB-pyrK-pyrD-pyrF-pyrE) was observed to be induced by YvfI during 
stationary phase of growth (Table 3.3). Contrariwise regulation of pyr operon by 
YvfI during log phase reveals the temporal regulatory effect of this Gntr-type protein 
(Table 3.12). In B. subtilis, pyr operon is controlled through transcription attenuation 
mechanism (Lu and Switzer, 1996). Besides to transcription attenuation, it is 
proposed in this study that pyr operon might also be subjected to dual control 
directed by YvfI in a growth phase-dependent manner. In conclusion, under the light 
of these findings, it might be speculated now even more strongly that YvfI exerts 
important regulatory roles (both negatively and positively) on nitrogen metabolism. 
Interestingly, in our study, not only the expression of the gene for σW but also many 
genes known in “ w” regulon including bceAB (formerly ytsCD) locus responsible 
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from the bacitracin resistance (Bernard et al., 2007) were found to be down-regulated 
by YvfI during stationary phase; however our logarithmic phase study has shown the 
contrary effect of YvfI mutation on bceB gene, hence increasing bacitracin resistance 
(Table 3.13). Therefore, dual role of YvfI regulatory protein on different pathways 
become more striking, considering both pyr operon and bceB gene regulations by 
YvfI.  
In a harmony with YvfI regulation during stationary phase, YvfI also exerts its 
inhibitory effect on carbohydrate metabolism during exponential phase. acoABCL 
operon, encoding acetoin dehydrogenase complex required for acetoin utilization 
(Huang et al., 1999), msmRE operon encoding a putative regulatory protein and a 
putative binding proteins for the transport of multiple sugars (msmE) was found to be 
downregulated by YvfI. Along with this data, three genes from ydhMNOPQRST 
operon that was assigned as Glucomannan utilization operon of Bacillus subtilis 
(Sadaie et al., 2007) and ywkA that encodes for a malic enzyme (Doan et al., 2003) 
were found to be repressed by YvfI protein (Table 3.12). It should be noted that 
ydhM, ydhN, and ydhO ORFs belonging to ydhMNOPQRST cluster encode for 
proteins homologous to the enzymes IIB, IIA, IIC of lactose-class 
phosphotransferase systems (PTSs) (Sadai et al., 2007). Strikingly, the fifth ORF 
(ydhQ) from this operon encodes for a DNA-binding protein that belongs to GntR 
family of transcriptional regulators (Aravind and Anantharaman, 2003). 
Nevertheless, this operon is negatively regulated by this GntR type repressor YdhQ 
and CcpA which is a global regulator of carbon catabolite repression (Ali et al., 
2001). This study further propose YvfI as another regulatory protein that exerts 
repression on this operon that functions in sugar utilization. Putative sugar utilization 
gene cluster yfnH, yfnG, yfnF, yfnE, yfnD were found to induced by YvfI protein 
(Table 3.13), thus this data further strengten YvfI functioning during carbohydrate 
utilization in the exponential phase cell.  
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Table 3.12 : Transcription units that are down-regulated by YvfI during exponential 
phase of growth. 
Gene 
 
Expression 
ratio a 
Function Transcriptional Organisationb 
    
pyrC  -1,75 dihydroorotase  
 
 
ǂ  ǂ  ǂ   
    ǂ 
pyrB  -1,74 aspartate carbamoyltransferase 
pyrAA  -1,67  carbamoyl-phosphate synthetase 
(glutaminase subunit) 
pyrAB -1,58 carbamoyl-phosphate synthetase 
(catalytic subunit) 
pyrD -1,44 dihydroorotate dehydrogenase (catalytic 
subunit) 
pyrK -0,93 dihydroorotate dehydrogenase (electron 
transfer subunit) 
pyrF -0,89  orotidine 5'-phosphate decarboxylase 
pyrE -0,81  orotate phosphoribosyltransferase 
ydhM -2,34 Oligo-beta-mannoside-specific 
phosphotransferase enzyme IIB 
component 
 
 
ǂ     
ydhN -1,25 Oligo-beta-mannoside-specific 
phosphotransferase enzyme IIA 
component 
ydhO -0,51 Oligo-beta-mannoside permease IIC 
component 
ywkA -2,08 unknown; similar to malate 
dehydrogenase 
 ǂ  ǂ 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
YvfI was found to significantly induce pyrimidin biosynthesis, ATP synthesis,  
glucose and lipid metabolisms as well. In accordance with this data, during 
exponential phase, transcription of butyrate-acetoasetate CoA transferase (yodR) and 
3-oxoadipade
 
CoA transferase (yodS) genes which participate in lipid metabolism 
was found to be increased in the presence of YvfI (Table 3.13). Therefore it should 
be noted that lipid metabolism genes were further induced by YvfI during late stages 
of growth. YvfI was found to repress the intracellular serine protease encoding gene 
aprX (Table 3.6) and the transcription of aprX was already known to be regulated by 
SinR and SinR was speculated as the only known regulator described for aprX 
(Valbuzzi et al., 1999). Hereafter, exponential phase data further supports and 
strengthens the roots of the suggestion that YvfI might be adressed as the first 
positive regulator of aprX. 
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Table 3.13 : Transcription units that are up-regulated by YvfI during exponential 
phase of growth. 
Gene 
 
Expression 
ratio a 
Function Transcriptional Organisation b 
    
yodS             1,61                 Probable coenzyme A transferase subunit 
alpha 
 
ǂ      
 ǂ yodR             1,3                 Probable coenzyme A transferase subunit 
beta 
yodP             1,74               Uncharacterized N-acetyltransferase 
aprX             1,72    intracellular alkaline serine protease        ǂ    ǂ  
yfnH 1,35            Probable glucose-1-phosphate 
cytidylyltransferase 
 
 
ǂ     ǂ 
 
yfnG 1,71         Putative sugar dehydratase/epimerase 
yfnF 1,57            Uncharacterized protein 
yfnE 1,6          Uncharacterized glycosyltransferase 
yfnD 1,68              Uncharacterized protein 
yoqL                  2,47                         SPBc2 prophage-derived putative 
   
ytsD 2,44 Bacitracin export permease protein ǂ     ǂ  
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
3.3.3 Transcriptome data evaluation of amyE::Pspac::yvfI strain 
In order to identify the genes that are directly effected by YvfI transcriptional factor, 
comparative transcriptome analysis of IPTG inducible YvfI producer B. subtilis 
PY79 amyE::Pspac::yvfI, yvfI::Tn10”  mutant strain between IPTG induced (yvfI gene 
expressed) and noninduced (yvfI gene not overexpressed) states was performed. B. 
subtilis amyE::Pspac::yvfI were grown in LB medium until they reached OD of 0,5 at 
600 nm. 1 mM IPTG was used to induce cells and sampling was done at 30th and 
60th minutes. Comparative studies were performed in order to define expressional 
differences between IPTG induced (yvfI gene overexpressed) “B. subtilis PY79 
amyE::Pspac::yvfI, yvfI::Tn10” mutant strain and non-induced “B. subtilis PY79 
amyE::Pspac::yvfI, yvfI::Tn10” mutant strain.  
Initially, yvfI gene expression was examined from the microarray data in order to see 
if the overexpression was achieved or not. As can be seen in Table 3.14 and 3.15 yvfI 
expression ratio was observed to gradually increase while growth further continued. 
No striking or significant upregulation was found from 30th minute transcriptional 
profile analysis. On the other hand trpC, ytmN and ykwD genes were found to be 
repressed by YvfI protein.  In harmony with the identified genes that are regulated by 
YvfI during stationary phase of growth (Table 3.3), tryptophan biosynthetic gene 
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trpC was also found to be repressed by YvfI protein which further support the role of 
YvfI on nitrogen metabolism (Table 3.14). Besides, data from 60 min IPTG 
induction experimental set pointed out another gene product HisC to be severely 
repressed by YvfI, when overexpression of YvfI is achieved (Table 3.15). 
Additionally, ykwD gene was suggested to encode a protein with an N-terminal 
signal peptide that provide the protein with a probable extracellular activity. YkwD 
was further propsed to function as calcium chelating serine protease  (Keijse et al., 
2007) while YtmN functions as L-cystine import ATP-binding protein (Auger et al., 
2002). Hence, It can be concluded that YvfI is not only involved in nitrogen 
metabolism but also this protein is involved in transport and catabolism of amino 
acids.  
Table 3.14. Regulated genes that are revealed out by comparative microarray 
analysis between 30
th
 minute sampling of IPTG induced B.  subtilis 
PY79 amyE::Pspac::yvfI  yvfI::Tn10 strain and 30
th
  minute sampling of 
non-induced B.  subtilis PY79 amyE::Pspac::yvfI yvfI::Tn10 strain.          
Gene 
 
Expression 
ratio a 
Function Transcriptional Organisation b 
    
yvfI  1,25 ATP synthase subunit C ǂ   ǂ    ǂ  
trpC -1,34 Indole-3-glycerol phosphate synthase       
ytmN -1,43 L-cystine import ATP-binding protein   
ykwD -1,56 proposed to be a Ca2+-chelating serine 
protease 
ǂ  ǂ       
 
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
Findings of 60 min IPTG induction experimental set reveals out that effected gene 
profile has changed considerably. Different genes are effected and also direction of 
the effect has changed dependent on YvfI concentration. As mentioned in Section 
3.3.1.6, phages, plasmids, and integrative and conjugative elements (ICEs), are the 
most frequently seen mobile genetic elements (Grohmann et al., 2003; Burrus et al., 
2002). A class of ICE elements in B. subtilis, 20 kb ICEBs1 (Figure 3.19) contains 
phrI gene among 24 different ORFs that are transferred to recipient cells. Moreover, 
population density sensing by ICEBs1, and its conjugal transfer are repressed by the 
pentapeptide PhrI (antagonist of RapI) and induced by RapI (Auchtung et al., 2005). 
Expression analysis using the constructed rapI-lacZ trancriptional fusion has 
revealed out that, the major inducer of ICEBs1, is significantly down regulated by 
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YvfI during transition state such that its expression was completely increased as a 
result of a mutation on yvfI gene (Figure 3.20), suggesting that YvfI represses rapI 
transcription directly. Hence during the exponential phase of growth, as being the 
antagonist of RapI, expression from phrI gene was found to severely repressed by 
YvfI protein (Table 3.15), pointing out that YvfI regulator protein induces indirectly 
the conjugal transfer of “ICEBs1” locus during logarithmic phase of growth. 
Table 3.15. Regulated genes that are revealed out by comparative microarray 
analysis between 60
th 
minute sampling of IPTG induced B.  subtilis 
PY79 amyE::Pspac::yvfI yvfI::Tn10 strain and 60
th
 minute sampling of 
non-induced B.  subtilis PY79 amyE::Pspac::yvfI yvfI::Tn10 strain. 
Gene 
 
Expression 
ratio a 
Function Transcriptional Organisation b 
    
yvfI  2,26 HTH-type transcriptional regulator ǂ   ǂ    ǂ  
yqaF 2,56 yqaF-yqaN operon of the skin element 
Uncharacterized HTH-type 
transcriptional regulator 
ǂ     ǂ   
yomD*  1,75 SPBc2 prophage-derived 
uncharacterized protein 
 ǂ     
yoke* 1,71 SPBc2 prophage-derived 
uncharacterized protein 
ǂ     ǂ  
yoqS 1,68 SPBc2 prophage-derived 
uncharacterized protein yoqS 
 
     
 
yorW* 
 
1,49 
SPBc2 prophage-derived 
uncharacterized protein yorW 
 
         
phrI* -1,46 potassium/proton-divalent cation 
antiporter 
  ǂ  ǂ 
hisH -2,87 Imidazole glycerol phosphate synthase 
subunit HisH 
ǂ       
yorV -1,54 SPBc2 prophage-derived 
uncharacterized protein yorV 
 
          
yopT* -3,01 SPBc2 prophage-derived 
uncharacterized protein 
     ǂ   
a. Numbers indicate the log 2 transformed expression ratio‟s. 
b. Transcriptional organization retrieved from http://genolist.pasteur.fr/SubtiList/, “ǂ” indicates 
the termination sites 
c. * p value < 0,05 
In section 3.3.1.7, it was mentioned that YvfI is directly involved in the SPP1 
infection in B. subtilis through inducing an operon including yukE, yukD, yukC, 
and yukBA transcription units which also contains yueB genes which initiates a series 
of events resulting in release of phage genome into the B. subtilis cytoplasm (Sao-
Jose et al., 2004). This membrane bound YueB protein of ∼120 kDa shows great 
homology with other proteins from different species and one of these homologs is the 
protein Pip, which functions as a phage receptor in Lactococcus lactis (Sao-Jose et 
al., 2004). 
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Recently,  yueB was reported to be a part of an operon including yukE, yukD, yukC, 
and yukBA transcription units (Sao-Jose et al., 2004). Another important observation 
in this study was that yukE, yukC and yukAB genes were significantly stimulated by 
YvfI (Table 3.8). Our overal data implied that YvfI is directly involved in the SPP1 
infection in B. subtilis. Furthermore, Bacillus subtilis contains a number of prophage-
like elements including PBSX, skin, and SP-β (Kunst et al., 1997). Several DNA 
repetitions are found within these regions that are called as prophages and these 
prophages are suggested to diverge from a common ancestor (Meadigue et al., 1995; 
Krogh et al., 1996). Our studies have revealed out that, along with SPP1 infection, 
YvfI can be speculated strongly to involve in SPβc2 prophage infections, considering 
repressed profiles observed from yorV and yopT genes and induced profiles of yomD, 
yokE,  yoqS,  yorW genes (Table 3.15). Moreover, one of the prophage-like elements, 
skin element, was found to be encoded through yqaF-yqaN operon (Kimura et al., 
2010) and this present study further implies the involvement of YvfI on expression of 
prophage-like elements under the light of the fact that yqaF gene is among the 
severely induced genes by YvfI protein (Table 3.15). 
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4. CONCLUSION 
The main purpose of this research was to achieve insight about the regulatory roles 
of YvfI protein and revealing the promoter region, putative regulatory protein 
binding sites and 5‟-end of yvfI cDNA. Therefore a genome-wide comparative 
transcriptome analyses of wild type PY79 strain that produces YvfI transcriptional 
factor and yvfI disrupted TEK1 mutant, yvfI::T10::spc  during  exponential (OD600 
0.7) and stationary growth phase (~ OD6007) was performed. Moreover, comparative 
studies were performed in order to define expressional differences between IPTG 
induced (yvfI gene overexpressed) “B. subtilis PY79 amyE::Pspac::yvfI, yvfI::Tn10”   
mutant strain and non-induced (yvfI gene not overexpressed) “B. subtilis PY79 
amyE::Pspac::yvfI, yvfI::Tn10” mutant strain. Data obtained from  microarray analysis 
were further validated by RT-qPCR and lacZ fusion analysis where necessary.  
Comparative transcriptome analysis data  indicated that YvfI could be involved in 
the regulation of a wide variety of cellular processes. Processable data from 
microarray analysis was further studied and genes showing at least 1,44 fold 
difference with reproducible characteristics, which means displaying an acceptable 
Bayes P value (p < 0,01) were subjected to RT-qPCR analysis. First or several genes 
of operons that were identified to be affected were chosen to be validated by RT-
qPCR. Finally, genes that are formalized by applying these two methodologies were 
further accepted as YvfI affected genes and these genes were grouped according to 
their functional properties. As a result, degradative enzyme production, antibiotic 
production and resistance, carbohydrate utilization and transport, nitrogen 
metabolism, membrane transport, fatty acid and lipid metabolism, protein synthesis 
and translocation, cell-wall synthesis, energy production and membrane 
bioenergetics, mobile genetic element, phage infection, sporulation, delay of 
sporulation and cannibalism, biofilm formation were found to be subjected to 
regulation, either in a negative or in a positive manner, by YvfI protein during 
stationary phase. 
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In a harmony with YvfI regulation during stationary phase, YvfI was also found to 
inhibit carbohydrate metabolism and pyrimidin biosynthesis, induce resistance 
against bacitracin and participate in regulation of genes involved in lipid metabolism 
during exponential phase.  
Comparative studies performed in order to define expressional differences between 
IPTG induced (yvfI gene overexpressed) mutant strain and non-induced (yvfI gene 
not overexpressed) mutant strain have revealed out that YvfI is not only involved in 
nitrogen metabolism but also this protein is involved in transport and catabolism of 
amino acids and when over expression is achieved, YvfI regulator protein probably 
induces indirectly the conjugal transfer of “ICEBs1” locus while it is involved in the 
expression of prophage-like elements. 
In conclusion, YvfI regulatory protein was found to regulate complex interconnected 
regulatory circuits as a novel global regulator. This finding is in harmony with the 
fact that YvfI belongs to GntR family regulatory proteins and regulators from this 
family are consisted of a conserved N-terminal DNA binding domain (D-b domain) 
followed by C-terminal domain involved in the effector binding and/or 
oligomerization (E-b/O domain) and additionally they contain a winged helix-turn-
helix motif which acts as the DNA recognition domain. Most importantly, these 
proteins exert their regulatory activiy by applying repressions and inductions on 
many different types of regulons. GntR family of transcriptional regulators consists 
of about 2000 different proteins, one of which is considered to be YvfI. Therefore, 
YvfI could be a critical regulator protein that responds to different stimuli, recieved 
as a result of changing environmental conditions. As a further study, the effects of 
this protein on mentioned pathways should be investigated in more details in order to 
understand if the effects can be followed phenotypically or not. 
In this research, yvfI transcription site was also determined by 5‟-RACE-PCR 
analysis and found that its transcription was controled from a 
A
-type promoter. This 
promoter region described as PyvfI was identified to lie at position -136 to -115 with 
respect to yvfI translational start codon with a well confirmed consensus -10 
(TATAAT) and consensus -35 (TTGGCG) sequences separated with 15 bp long gap. 
Furthermore, at +12 downstream position, a sequence that shows a perfect match to 
Spo0A binding motif (5‟-TGNCGAA), three putative AbrB binding and one CodY 
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binding sites were identified on the sequence. Hence, these data have shed more light 
to the regulation pattern of yvfI gene indicating that this gene is most probably 
directly regulated by global regulatory genes:Spo0A, AbrB and CodY in B. subtilis. 
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APPENDIX A 
Table A.1 : Genes that are up (A)-  and down (B)- regulated by YvfI during early-
stationary phase (OD6007) 
A. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
aprX 1,57 2,98(±0,17)  serine protease  
ǂ    ǂ  
atpI 1,19  0,56(±0,03) ATP synthase subunit I  
atpB  1,93  ATP synthase subunit A   
 
ǂ  
ǂ 
 
atpE  2,02 1,53(±0,15) ATP synthase subunit C 
atpF  1,99  ATP synthase subunit B 
atpH  1,93  ATP synthase subunit delta 
atpA  2,01 1,13(±0,10) ATP synthase subunit alpha 
atpG  1,91  ATP synthase subunit gamma 
bioW 1,99 1,46(±0,06) 6-carboxyhexanoate--CoA ligase  
 
ǂ     
 ǂ   
 
bioA 1,38   adenosylmethionine--8-amino-7-
oxononanoate transaminase 
bioF 1,45  8-amino-7-oxononanoate synthase 
bioD 2,06  dithiobiotin synthetase   
bioB 0,36   biotin synthase  
czcD* NR 2,25(±0,22) potassium/proton-divalent cation 
antiporter 
 
 ǂ   ǂ ǂ 
trkA(czcO)* 1,76 1,02(±0,06) potassium uptake oxidoreductase 
lip(estA) 2,38 2,65(±0,09) secreted alkaliphilic lipase ǂ    ǂ  ǂ  ǂ  
fabHA 1,87 1,00(±0,12) 3-oxoacyl-(acyl carrier protein) 
synthase III 
 
   ǂ   
 
fabF 1,89  3-oxoacyl-(acyl carrier protein) 
synthase II 
fabHB 3,00 1,98(±0,05) 3-oxoacyl-(acyl carrier protein) 
synthase III 
ǂ    
ylxM 1,32   hypothetical protein, DNA-binding 
protein 
ǂ  ǂ  ǂ 
Ffh 1,51 2,91(±0,04) signal recognition particle-like (SRP) 
GTPase 
ftsE 1,11 1,94(±0,13) cell-division ABC transporter (ATP-
binding protein) 
 
  ǂ  ǂ 
 
ftsX 1,68  cell-division ABC transporter 
hepS  1,35  0,91(±0,18) Heptaprenyl diphosphate synthase 
component I 
 
ǂ      
 ǂ  ǂ ǂ 
 
hepT   1,52  Heptaprenyl diphosphate synthase 
component II 
Ndk 1,37  1,01(±0,24) nucleoside diphosphate kinase 
(purine nucleotide biosynthesis) 
mraY 1,45 1,20(±0,06) phospho-N-acetylmuramoyl-
pentapeptide-transferase 
ǂ     ǂ 
 
 
murD 1,53  UDP-N-acetylmuramoyl-L-alanyl-
D-glutamate synthetase 
pksD 1,9 1,44(±0,06) enzyme involved in polyketide 
synthesis 
 
 
 
 ǂ     
  ǂ     
 
    ǂ  
pksE 1,59  enzyme involved in polyketide 
synthesis 
acpK 1,77  acyl-carrier protein 
pksG 2,10 1,42(±0,18) acetyl-S-AcpK beta-ketothioester 
polyketide intermediate transferase 
pksH 0,42   enzyme involved in polyketide 
synthesis 
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pksI* 0,36   enzyme involved in polyketide 
synthesis 
   
 
pksJ 2,73 4,14(±0,01) polyketide synthase of type I 
pksL 3,95 6,19(±0,06) polyketide synthase of type I 
pksM 2,17  polyketide synthase 
pksN 2,96  polyketide synthase of type I 
pksR 2,46  polyketide synthase 
ppsA* NR   plipastatin synthetase  
ǂ      ǂ 
  
ppsB 1,1  1,09(±0,18) plipastatin synthetase 
ppsC*  NR  plipastatin synthetase 
ppsD 1,24   plipastatin synthetase 
ppsE 2,42  plipastatin synthetase 
pyrR 2,52 2,79(±0,32) bifunctional pyrimidine regulatory 
protein PyrR uracil 
phosphoribosyltransferase 
 
 
 
 
 
 
 
ǂ   ǂ   ǂ   
     
 ǂ  
 
pyrP* NR 3,48(±0,18) uracil permease 
pyrB  1,37 4,34(±0,01) aspartate carbamoyltransferase 
catalytic subunit 
pyrC  1,89  Dihydroorotase 
pyrAA  2,31 5,85(±0,20) carbamoyl-phosphate synthetase 
(glutaminase subunit) 
pyrAB 2,00  carbamoyl-phosphate synthetase 
(catalytic subunit) 
pyrK 0,85   dihdrooratate dehydrogenase 
pyrD 1,32   dihdrooratate dehydrogenase  
(catalytic subunit) 
pyrF 1,21   orotidine 5'-phosphate decarboxylase 
pyrE 1,08   orotate phosphoribosyl transferase 
Rnc 2,41 
 
 
1,64(±0,03) ribonuclease III, cleaves both 5'- and 
3'-sites of the small cytoplasmic 
RNA precursor 
 
 
 
 ǂ  ǂ  ǂ   ǂ ylqB smc 
 
1,42   chromosome condensation and 
segregation SMC ATPase 
ftsY 1,08  signal recognition particle 
rplJ  1,69 3,42(±0,30) 50S ribosomal protein L10  
   ǂ   ǂ 
 
rplL 1,66  50S ribosomal protein L7/L12  
spoIIE
†
 ND  serine phosphatease  
ǂ      
Tig 1,68 1,11(±0,01) trigger factor (prolyl isomerase), 
catalyze in vitro protein folding; 
essential for growth under starvation 
conditions 
 
ǂ  ǂ     ǂ  
Tsf 1,69 
 
1,31(±0,53) Ts elongation factor  
 
 
   ǂ    ǂ  
pyrH 1,52 1,74(±0,15) 
 
uridylate kinase 
frr 1,55 1,11(±0,08) ribosome recycling factor 
 
ydjM  2,33  hypothetical protein  
ǂ   ǂ ǂ  ydjN 1,48  hypothetical protein 
yhdN ND  aldo/keto reductase ǂ  ǂ    
ǂ yhdO(plsC) 1,49 1,05(±0,14)  1-acyl-sn-glycerol-3-phosphate 
acyltransferase (lipid metabolism) 
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yhfE 1,63 3,65(±0,04) putative endoglucanase  
ǂ     
ǂ 
yhfF 1,40  2,18(±0,09) hypothetical protein 
yjcM 1,48  hypothetical protein  
ǂ   ǂ   ǂ   
ylpC(fapR) 1,36  1,16(±0,09) fatty acid biosynthesis transcriptional 
factor 
 
 
 
      ǂ 
 ǂ  ǂ  
 
plsX 1,66  putative glycerol-3-phosphate 
acyltransferase PlsX 
fabD 2,42  malonyl CoA-acyl carrier protein 
transacylase 
fabG 2,28  beta-ketoacyl-acyl carrier protein 
reductase 
acpA 2,29  acyl carrier protein 
yokD NR 2,65(±0,25) aminoglycosideN3'-acetyltransferase  
ǂ   ǂ    
yqgA 1,80  hypothetical protein   ǂ    ǂ 
yqxI 1,31   hypothetical protein  
ǂ    ǂ   
yqxJ 1,78  hypothetical protein 
yqxM 0,96  2,65(±0,06) lipoprotein for biofilm formation  
  ǂǂ    
  
 
sipW 2,12 1,42(±0,14) type I signal peptidase 
tasA 1,50 2,65(±0,17) major biofilm matrix component 
yuaB  3,33 2,70(±0,25) hypothetical protein  ǂ  ǂ   ǂ 
yukE 1,46 1,29(±0,06) hypothetical protein  
 
 
ǂ      
    ǂ 
 
yukD 0,85  bacteriocin 
yukC 1,75  membrane-associated enzyme 
involved in bacteriocin production 
yukB 0,46  putative cell division protein 
yukA 1,48  hypothetical protein 
yvaW(sdpA) 1,26  1,08(±0,22) sporulation delay protein-export of 
killing factor 
 
 
    ǂ 
 
yvaX (sdpB) 2,2 1,68(±0,08) Sporulation delay protein-exporter of 
killing factor SpbC 
yvaY(sdpC) 061  killing factor SdpC 
yvcA* NR 1,56(±0,01)  Lipoprotein  ǂ    ǂ  
yvcE(cwlO) 2,24 1,70(±0,05) secreted cell wall DL-endopeptidase  
   ǂ   ǂ 
yveN(epsD) 2,21 2,63(±0,05) extracellular matrix biosynthesis 
enzyme 
 
ǂ      
      
     
   
 
yveO(epsE) 2,08 1,34(±0,31) Glycosyltransferase 
yvfA(epsK) 1,49 1,10(±0,21) extracellular matrix component 
exporter 
yvfE(epsN) 0,79 1,02(±0,01) aminotransferase 
yvfF(epsO) 1,79 0,94(±0,05) pyruvyl transferase 
ywcD 1,52 2,04(±0,06) integral inner membrane protein ǂ      
ywfB(bacA)
†
 
ND  bacilysin biosynthesis protein, 
dehidratase 
 
 
 
ǂ ywfA ǂ    
   ǂ   ǂ  
 
ywfC(bacB)
 
 ND  isomerase component of bacilysin 
synthetase 
ywfD(bacC)
*
 
 
 NR  bacilysin biosynthesis 
oxidoreductase 
ywfE(bacD) ND  alanine-anticapsin ligase 
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ywfF(bacE)
* 
NR  efflux protein for bacilysin excretion, 
self-protection against bacilysin 
ywfG* NR  transaminase 
ywfH
†
 ND  carrier protein reductase of bacilysin 
biosynthesis 
yybN 1,76 2,05(±0,24) hypothetical protein  
 
 ǂ     
  ǂ  
yybM 0,87  integral inner membrane protein 
yybL 1,52 1,23(±0,12) integral inner membrane protein 
yybK 1,73  integral inner membrane protein 
yybJ 1,52  ATP-binding cassette protein 
yydF ND  biactive peptide eliciting cell 
envelope stress sensed by the LiaRS 
TCS 
 
 
ǂ      
 
 
yydG 
 
1,93 
 
1,68(±0,09) 
 
putative AdoMet radical enzyme 
yydH 0,62   membrane-embedded protease 
yydI 0,51   YydIJ: an ATP-binding cassette 
(ABC) transporter 
yydJ 0,73   
 
B. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     abh* NR -4,57(±0,28) transcriptional regulator of 
transition state genes (AbrB-like) 
 
ǂ    ǂ   
acoA -1,57 -3,07(±0,22) acetoin dehydrogenase E1 
component (TPP-dependent alpha 
subunit) 
 
 
ǂ   ǂ    
 ǂ   ǂ 
 
acoB -1,54   acetoin dehydrogenase E1 
component (TPP-dependent beta 
subunit) 
acoC -1,56   branched-chain alpha-keto acid 
dehydrogenase subunit E2 
acoL -1,36  dihydrolipoamide dehydrogenase 
aprE -2,35 -3,07(±0,91) extracellular alkaline serine 
protease (subtilisin E) 
ǂ  ǂ    
ǂ  
argC -1,63 -1,98(±0,22) N-acetyl-gamma-glutamyl-
phosphate reductase 
 
 
 
 
 
  ǂ    
    ǂ  
 
argJ -1,89  bifunctional ornithine 
acetyltransferase/N-
acetylglutamate synthase protein 
argB -2,08   acetylglutamate kinase 
argD -2,13  acetylornithine aminotransferase 
carA  -2,22   carbamoyl phosphate synthase 
small subunit 
carB  -2,15  carbamoyl phosphate synthase 
large subunit 
argF  -2,16  ornithine carbamoyltransferase 
argG -1,68   argininosuccinate synthase  
ǂ    ǂ ǂ  ǂ 
ǂ  
argH -2,04   argininosuccinate lyase 
citA -1,50 -2,20(±0,30) citrate synthase 1  
ǂ   ǂ ǂ  ǂ 
citB -1,38 -2,21(±0,21) aconitate hydratase  
ǂ     ǂ   
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glnR -1,31   -0,73(±0,10) transcriptional regulator (nitrogen 
metabolism) 
 
 ǂ     
ǂ  
glnA -1,19  glutamine synthase 
gltA -1,31 -2,04(±0) glutamate synthase (large subunit)  
ǂ   ǂ    ǂ 
  
gltB -1,45  Glutamate synthase [NADPH] 
small chain 
ispA -2,01 -1,68(±0,22) intracellular serine protease  
ǂ ǂ   ǂ   
msmR -1,48 -1,43(±0,27) transcriptional regulator (LacI 
family) 
 ǂ     
   ǂ  msmE -1,51  multiple sugar-binding lipoprotein 
pbpE ND -3,44(±1,13) penicillin-binding protein 4* 
(spore cortex) 
 
ǂ    ǂ   ǂ   racX ND  amino acid racemase 
rapI*
† -1,84(NR) 
 
  response regulator aspartate 
phosphatase 
 
   ǂ  ǂ  
phrI* NR  phosphatase RapI regulator 
sigW ND -4,31(±0,01) RNA polymerase sigma factor 
sigW 
 
trnSL-Gln2 ǂ   ǂ  
ybbM ND  hypothetical protein 
trpE -1,9 -1,26(±0,05) anthranilate synthase component I  
 
 
 
ǂ            
     
  
trpD -2,1   anthranilate 
phosphoribosyltransferase 
trpC -2,62   indole-3-glycerol-phosphate 
synthase 
trpF -2,22   N-(5'-phosphoribosyl) anthranilate 
isomerase 
trpB -2,00   tryptophan synthase subunit beta 
trpA -1,04  tryptophan synthase subunit alpha 
ybfO -1,76 -1,08(±0,06) hypothetical protein; similar to 
erythromycin esterase 
 
  ǂ ǂ   ǂ  
ybyB -1,48   hypothetical protein   
ǂ   ǂ   ǂ   
yceC -1,00  -0,88(±0,06) putative stress adaptation protein  
 
ǂ   ǂ    
    ǂ  
 
yceD -1,44   putative stress adaptation protein  
yceE -1,39   putative stress adaptation protein  
yceF -1,73 -1,38(±0,08) putative stress adaptation 
transporter  
yceH -1,43   putative stress adaptation protein  
yneN -1,41  -1,04(±0,19) putative membrane-bound protein 
with a thioredoxin-like domain  
  ǂ    ǂ 
yotH -1,80   hypothetical protein   
       
ytsC(bceA) ND -2,68(±0,32) bacitracin ABC efflux transporter 
ATP-binding protein 
 
ǂ   ǂ    
 ǂ  
ytsD(bceB) ND -3,77(±0,06) Bacitracin export permease protein 
BceB  
yuaF -1,72 -1,12(±0,09) membreane integrity integral inner 
membrane protein 
 
 ǂ     ǂ 
 ǂ 
 
yuaG -1,46  putative flotillin-like protein  
yuaI -1,62  putative acetyl-transferase 
yvqI (liaI) -1,65 -1(±0,05) putative transmembrane protein  
 
 
yvqH(liaH) -1,78  similar to phage-shock protein 
A(PspA) of E. coli 
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yvqG(liaG) -1,31   putative membrane-anchored 
hypothetical protein 
   ǂ  ǂ  
yvqF(liaF) -1,05   membrane protein 
yvqE(liaS) -1,02   LiaRS: two component regulatory 
system 
yvqC(liaR) -0,85    
Genes in an operon are grouped together 
d. Numbers indicate the log 2  transformed expression ratio‟s. 
e. Numbers indicate the log 2  transformed expression ratio‟s. (The mean of 
minimum three independent replicate experiments is given and standart 
deviation of the mean is shown in paranthesis), 
f. transcriptional organization retrieved from 
http://genolist.pasteur.fr/SubtiList/, “ǂ ” indicates the termination sites 
*    Bayes P value higher than acceptable value (>0.01) 
NR no reproducible data obtained 
ND no differential expression observed 
† Expression profiles were elucidated by lacZ-fusion analysis  
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APPENDIX B 
Table B.1 : List of primers used in this study 
abh forward 5‟ gat gaa tta ggc cgc att 3‟ 
abh reverse 5‟ ggc ttg aat ttc ttc gag 3‟ 
acoA forward 5‟ ctg gag atc agg ggc ttt 3‟ 
acoE reverse 5‟ aca gcc ttt ggc gat aca 3‟ 
aprE Forward 5‟ gcg ttc agc aac atg tct 3‟ 
aprE Reverse 5‟cac ata tgc aac gct cgg 3‟ 
aprX F 5‟ tgg act cct tgc ttc ttg 3‟ 
aprX R 5‟ tgc tga agg agt aac ctc 3‟ 
argC forward 5‟ agc gag ggt tat cct cat 3‟ 
argC reverse 5‟ cag atc acc tga cag atc 3‟ 
argG forward 5‟ gag ggc aaa gat ttg gca 3‟ 
argG reverse 5‟ acg aac ctg gtc att tcc 3‟ 
atpA reverse 5‟acc aac agg aac ctc cat 3‟ 
atpA forward 5‟gtc atc caa gtc ggt gac 3‟ 
atpE reverse  5‟gaa tgc gat aac gac  agc 
atpE forward 5‟gca gct gcg att gca att 3‟ 
atpI forward 5‟ ttg gca gtg tat gta ctg ggt-3‟ 
atpI reverse 5‟ cgg gaa ttc cat tct tct gac gag cag taa-3‟ 
bioW forward 5‟gtc aga atg agg gct tca 3‟ 
bioW reverse 5‟ cac agg caa tgg ctg aat 3‟ 
citA forward 5‟ agc ttt gaa gaa gcg gct 3‟ 
citA reverse 5‟cgg atg gaa tgt gta cgt 3‟ 
citB forward 5‟ aag gtt tcg aag ctt cct 3‟ 
citB reverse 5‟ cag tga agc cag atc tac 3‟ 
czcD forward 5‟ tct gat gca ggc cat atg ctg 3‟ 
czcD reverse 5‟ aag cat gcc ggt tgt tgc tac 3‟ 
fabHA forward 5‟ gac gag tgg att cgt aca 3‟ 
fabHA reverse 5‟ gcc gag ttg ttc ttg aat 3‟ 
fabHB forward 5‟ gaa tgg atc gtt cag cgc 3‟ 
fabHB reverse 5‟ gct ttc cca gcc gaa ata 3‟ 
ffh forward 5‟ atg atg cgt gag gtc cgt ctt-3‟ 
ffh reverse 5‟ aac ttt aat gac ctg ctg gcc-3‟ 
frr forward 5‟ tat tac gga gcg cag aca 3‟ 
frr reverse 3‟ccg tct ctc ttc tgt tag  3‟ 
ftsE forward 5‟ tat gtt gtt ggt ccg agc 3‟ 
ftsE reverse 5‟cac ttc aag ggc aaa tgc 3‟ 
glnR forward 5‟ cca gcc aga agt gaa gga 3‟ 
glnR reverse 5‟ tct cag ttc gtc atc gga 3‟ 
gltA forward 5‟ atc ggc cta tat gca cac 3‟ 
gltA reverse 5‟tcc tac ccc gta acg ttc 3‟ 
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hepS forward 5‟ gcg aag cat att tct gcg 3‟ 
hepS reverse 5‟ gag aag agt caa ttg gcg 3‟ 
ispA forward 5‟ aag gcg cca gaa atg tgg 3‟ 
ispA reverse 5‟ agc tgc aat tgt tcc ggc 3‟ 
lip forward 5‟ gtc gtt atg gtt cac ggt 3‟ 
lip reverse 5‟ cat gct gtg agc gac aat 3‟ 
mraY forward 5‟gga ccg aaa tca cat cag 3‟ 
mraY reverse 5‟gcg ctt cat gac aac ctt 3‟ 
msmR forward 5‟ ctt tct gtt gcg ggc gaa 3‟ 
msmR reverse 5‟ ccc ttt ccg aat gga aga 3‟ 
ndk forward 5‟ gtc caa cgt cag ctc att 3‟ 
ndk reverse 5‟ cag ctg tct cgt cac ttc 3‟ 
pbpE forwrd 5‟- cag ttt aac ggg acg gtt-3‟ 
pbpE reverse 5‟-ctg ata cgg aaa acc ggg-3‟ 
pksD forward 5‟ cga atc ggc aca tcc att 3‟ 
pksD reverse 5‟ cca gac tga tcc caa tac 3‟ 
pksG forward 5‟ ctt gat gtc atg gag ctg 3‟ 
pksG reverse 5‟ gtt gcg gtt gag acc taa 3‟ 
pksJ forward 5‟ ccg gct cca tta gcc gtt 3‟ 
pksJ reverse 5‟ tcc cgt act gcc tga agt 3‟ 
pksL forward 5‟ aag gct gac atg cac gca 3‟ 
pksL reverse 5‟ caa atg att ggc acc cac 3‟ 
ppsB forward 5‟ aat cta tgc gtc gac tcg 3‟ 
ppsB reverse 5‟agc atc aat cag cgt ctg 3‟ 
pyrAA forward 5‟tct tac tgc gga cag atc 3‟ 
pyrAA reverse 5‟ atc aat tcc ctg gag tcc 3‟ 
pyrB forward 5‟ttc gaa ccg agc acg aga 3‟ 
pyrB reverse 5‟ ctg gct gac aag ctc ttc 3‟ 
pyrH forward 5‟atc gct gag ctt gaa gtc gaa 3‟ 
pyrH reverse 5‟gga tgt ttg cac tct gga 3‟ 
pyrP forward 5‟gtc gga atg agt cct gct 3‟ 
pyrP reverse 5‟ caa taa gga aat cag ccc 3‟ 
pyrR forward 5‟agg att gct cac gaa atg 3‟ 
pyrR reverse 5‟ tac cgg aat atc tgc acc 3‟ 
rapI reverse 5‟-cgt gac taa gtc gta cgg aat-3‟ 
rapI BamHI reverse      5‟- cgg gga tcc ttc agc tat tcg ata agc-3‟ 
rapI HindIII forward    5‟- gcc aag ctt ttg cgg ggt gtt ttc tta-3‟ 
rnc forward 5‟-caa gaa cgg att tcg gtt cac-3‟ 
rnc reverse  5‟- cct ttc att atc ttc ata cgg-3‟ 
rplJ forward 5‟-cgc gga ctt aac gtt tct gaa-3‟ 
rplJ reverse 5‟-aag ctc agc ttg ttc aac cgc-3‟ 
sdpA BamHI forward   5‟-  gcc ggatcc ttg atg cca aca ttg ccg aga  3‟     
sdpA EcoRI reverse 5‟-cgg gaattc aat gtt ttc ttc tgt agg gct-3‟ 
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sigW forward 5‟- gcg gac atc gta gat att-3‟ 
sigW reverse 5‟-aga ata cat ggt caa gcc-3‟ 
sipW forward  5‟- tca gtt ctg tca ggt tcg atg-3‟ 
sipW reverse 5‟-aac aat tct gtg ggt gac cgc-3‟ 
tasA forward  5‟-aag ccg gga gat aag ttg aca -3‟ 
tasA reverse 5‟-ctg gct gag gaa atc ttc tgg-3‟ 
tig forward 5‟- caa gtt tca att cct gga ttc-3‟ 
tig reverse 5‟- agg gta ttc tac agg aag agg-3‟ 
trkA(czcO) forward 5‟ ata gta atc ggg gct ggt 3‟ 
trkA(czcO) reverse 5‟ tcc ttc aag atg cat tcc 3‟ 
trpE forward 5‟ gag aag ctt gac agg gag 3‟ 
trpE reverse 5‟ agg aat gcc aag ctc agg 3‟ 
tsf forward 5‟ gcg tta act gaa act gac gga 3‟ 
tsf reverse 5‟ tgc aag aag gtg gtc agc taa 3‟ 
ybfO forward 5‟ gaa cga cat gca cag cct 3‟ 
ybfO reverse 5‟ atc agg aaa gcc gga ttc 3‟ 
yceC forward 5‟ aaa ttg atg gtc ggt ctc 3‟ 
yceC reverse 5‟ cag gtt gtc gcc tgt atg 3‟ 
yceF forward 5‟ ggt ttg atc ggt tcc ctt 3‟ 
yceF reverse 5‟cac ctt gat cca cca gaa 3‟ 
yhdO forward 5‟ atc gcg tgt aca cat tcc 3‟ 
yhdO reverse 5‟ cgg cgt ttt aat act gct 3‟    
yhE reverse 5'-tcc cga ggc ggt ttc aat ttg-3‟ 
yhfE forward 5‟-gaa acg gtt cgg aac cac aag -3‟ 
yhfF forward 5‟- ctg att cag cag atc ctt gcc-3‟ 
yhfF reverse 5‟-aat tcg gtc tcc att gcc ctc-3‟ 
ylpC forward 5‟ gat gaa gaa cta gcg ggt 3‟ 
ylpC reverse 5‟ aat gga tat cgc ctg atc 3‟ 
yneN forward 5‟ gtc ggt tat acg gga tgg 3‟ 
yneN reverse 5‟ ttg cag ctt ttc cat cgc 3‟ 
yokD forward 5‟aat ggt gga gct gtt gc 3‟ 
yokD reverse 5‟ ggc tgg cat act ttc tct 3‟ 
yqxM forward 5‟ gcc gca ata tgc tta caa-3‟ 
yqxM reverse 5‟ctt aag ttt ctc acc tgt-3‟ 
ytsC forward 5‟- ggc gaa ttc gtc agt att-3‟ 
ytsC reverse 5‟-gat cga taa agg cag aag-3‟ 
ytsD forward 5‟ gtc acg ctg cag tat gat-3‟ 
ytsD reverse 5‟ tac ccc gat cgc taa tga 3‟ 
yuaB forward 5‟- gca cct aca gct tct ttc-3‟ 
yuaB reverse 5‟-aaa tcc gct tgg caa tgt-3‟ 
yuaF forward 5‟ ccg aca tta gtg ctc tca 3‟ 
yuaF reverse 5‟tcc tct gag atc atc ttc 3‟ 
yukE forward 5‟atg gca cag gag gta atg 3‟ 
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yukE reverse 5 aag gtt tga gct gct cgt 3‟ 
yvaW (sdpA) Forward (40-144)  5‟-agc aat att tca cct cag aa-3‟ 
yvaX(sdpB) forward 5‟-aga agt tta ctt ggt ttc tca-3‟ 
yvaX(sdpB) reverse 5‟-agc ggt agg gat ata gac att-3‟ 
yvcA reverse 5‟ tgt ctt agg ttc att cgc-3‟ 
yvcA forward 5‟ gaa gag gaa cca gga tat-3‟ 
yvcE(cwlO) reverse 5‟ gtt gct tgt atc aag cgc 3‟ 
yvcE(cwlO) forward 5‟ gca tcg gcg gaa aca tta 3‟ 
yveN forward   5‟- aag ctg ccg tat gtg gat gag-3‟ 
yveN reverse 5‟- gtg cgc tgt gtc cag cac ctt-3‟ 
yveO Forward 5‟-tgc gat gat gcg tca aca-3‟ 
yveO Reverse  5‟-aac cac ctg ata gtg tcg gtg-3‟ 
yvfA forward 5‟ ctc acg gct ttt ctc ttg tct 3‟ 
yvfA reverse  5‟ ata cgc att tgc ttt ctc ccg 3‟ 
yvfE forward 5‟gaa gaa cag ctg gca gaa cga 3‟ 
yvfE reverse 5‟ cat att cca cgt atc agg ctc 3‟ 
yvfF forward 5‟ cgc tgg aat cca gac aat ttc 3‟ 
yvfF reverse 5‟cgt ccg ctt gag gtt gtc ttt 3‟ 
yvfInested reverse 5' cag aag ggc ggc tga gag cgg ctg 3‟  
yvfI race reverse 5' aat atc ccg aaa gca cat 3‟  
yvfI BamHI reverse 5‟- cgg gga tcc aat atc ccg aaa gca cat  
yvfI HindIII forward 5‟- gcc aag ctt atg aaa cag gga gaa ggc 3‟  
yvqI forward 5‟ atc ggg agc ttg atg aca 3‟ 
yvqI reverse 5‟ aga agc cgg ttc agg atc 3‟ 
ywcD forward 5‟ gtt gcc gct tgg att ttg 3‟ 
ywcD reverse 5‟ ctg gcc gac aag aat gat 3‟ 
yybL forward 5‟ ttc aac cag aac cac act 3‟ 
yybL reverse 5‟ acg ctt aac cat cct cat 3‟ 
yybN forward 5‟ gta cct tat ggc tat ggt 3‟ 
yybN reverse 5‟ tcc ctg gct att tgc atg 3‟ 
yydG forward 5‟gag tta gta act gaa ttt gca 3‟ 
yydG reverse 5‟act tat agt cag tgc tat cac 3‟ 
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APPENDIX C 
Luria Bertani (LB) Agar Medium (1000 mL) 
Tryptone                                10 g/L 
Yeast Extract                           5 g/L 
NaCl2                                                     5 g/L 
Agar                                        15 g/L 
2xYT Medium (1000mL) 
Tryptone                              16 g 
Yeast Extract                      10 g 
NaCl                                     5 g 
Agar                                   15 g   
HS medium (30 mL) 
10X-S-base                             3 mL 
Glucose (50%)                    300 μL 
Yeast Extract (10%)           300 μL 
Casaminoacid (2%)            300 μL 
Arg (8%) + His (0.4%)          3 mL 
Tryptophan (0.5%)             300 μL 
Phenylalanine (0.3%)         450 μL 
Completed up to 30 mL with sterile distilled H2O and store at cold for a week. 
LS Medium (20 mL) 
10X-S-Base                             2 mL 
Glucose                                 200 μL 
Tryptophan                            200 μL 
Phenylalanine                          30 μL 
Casaminoacid                       100 μL 
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Yeast Extract                        200 μL 
Spermine (50mM)                 200 μL 
MgCl2 (1M) (filter steriled)     50 μL 
Freshly prepared and completed up to 20 mL with sterile distilled H2O. 
Perry and Abraham (PA) Medium (pH 7.4) 
KH2PO4                                               1 g/L 
KCl                                        0.2 g/L 
MgSO4.7H2O*                      0.5 g/L 
Glutamate.Na.H2O                   4 g/L 
Sucrose*                                  10 g/L  Autoclave separately 
Ferric citrate**                     0.15 g/L   Filter sterilization 
Trace elements**                      1 mL   Filter sterilization 
CoCl2.6H2O                    0.0001  g/L 
Ammonium molybdate     0.0001 g/L 
MnCl2.4H2O                     0.001  g/L 
ZnSO4.7H2O                    0.0001 g/L 
CuSO4.5H2O                 0.00001 g/L 
DSM Medium (Difco’s Sporulation Medium) 
Nutrient Broth                       8 g 
KCl (10 %  w/v)                  10 mL 
MgSO4.7H2O (1.2 %)        10 mL 
NaOH (1 M)                       0.5 mL 
Autoclaved for 30 min. and cooled down to 50 
◦
C. 
Ca(NO3)4 (1 M)                 1 mL 
MnCl2 (0.01 M)                  1 mL 
FeSO4 (1 mM)                    1 mL (resuspended before use) 
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APPENDIX D 
P1 Buffer (pH 8) 
 
Tris-base                                         6.06 gr 
EDTA.2H2O 3.72 gr 
Dissolve Tris-base and EDTA with 800 mL dH2O. Adjust pH to 8 with HCl. Adjust 
volume to 1 lt dH2O. Add 100 mg RNase A per liter of P1. 
P2 Buffer 
NaOH                                                8 gr 
SDS solution (20%)                          50 mL 
Dissolve NaOH in 950 mL dH2O.  
Add 50 mL SDS solution. 
P3 Buffer  (pH 5.5) 
Potassium acetate                              294.5 gr 
Dissolve in 500 mL dH2O.  
Adjust pH. 
TE Buffer (pH 7) 
Tris base                       10 mM 
EDTA                             1 mM 
Adjusted pH 7 with HCl. 
TAE Buffer (50X) 
Tris base (2 moles)                             242 g 
Glacial acetic acid (57.1 mL)             57.1 mL 
EDTA (100mL 0.5M)                        100 mL (0.5 M, pH 8.0) 
Add Distilled H2O up to 1L and adjust pH to 8 by HCl. 
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Low Melting Agarose Gel (1%) 
Agarose                       0.5 g 
TAE buffer (1X)          50 mL 
Add 1.5μL EtBr (final concentration: 0.5 μg/mL) before pouring the gel into tray. 
CTAB/NaCl Solution (10 % CTAB/ 0.7 M NaCl) 
4.1 g of NaCl was dissolved in 80 mL of dH2O. Then, 10 g of CTAB (hexadecyl 
trimethyl ammonium bromide) was added and dissolved with vigorously shaking 
and gentle heating up to 65 ° C. Final volume was made up to 100 mL with dH2O. 
Physiological Sodium Chloride Solution (0.85%) (1000 mL) 
NaCl2                       8.5 g 
Dissolve in 1000 mL distilled water and autoclave. 
Tris-Cl Solution (25mM, 1000 mL, pH 7.4) 
Tris (hydromethyl)aminomethane              3.03 g 
Dissolve in 1000mL distilled water and adjust pH to 7.4 with HCl (1 M) 
Z Buffer (500 mL, pH 7.0) 
Na2HPO4.7H2O  (60mM)                     5.33 g 
NaH2PO4                (40 mM)                     3.12 g 
KCl2                          (10 mM)                   0.373 g 
MgSO4.7H2O       (1 Mm)                   0.123 g 
All mixed and dissolved within 500mL distilled water and the pH was adjusted to a 
value of 7.0. 
β-mercaptoethanol final concentration: 270 μL / 100 mL (add to Z buffer on 
immediately before using) 
Lysozyme final concentration:                   2.5 mg/mL 
ONPG final concentration:                        4.0 mg/mL 
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APPPENDIX E 
Chemicals                                                                            Suppliers 
Agar Bacteriological                                                            AppliChem 
Agarose                                                                                 Prona 
Ammonium persulfate                                                          Carlo Erba 
Arginine                                                                                Merck 
CaCl2.2H2O                                                                          Merck 
Casamino acid                                                                      AppliChem 
Cloramphenicol                                                                    Sigma 
CoCl2.6H2O                                                                        Carlo Erba 
CuSO4.5H2O                                                                       Carlo Erba 
CTAB                                                                                   Sigma 
EDTA                                                                                   Sigma 
Ethanol                                                                                 Botafarma 
Ethidium bromide                                                                 Sigma 
Glucose                                                                                 Riedel deHaen 
Glycerol                                                                                 Merck 
HCl                                                                                        Carlo Erba 
Histidine                                                                                Merck 
IPTG                                                                                      Sigma 
KH2PO4                                                                                J.T.Baker 
K2HPO4                                                                                J.T.Baker 
KCl                                                                                        Carlo Erba 
Mercaptoethanol                                                                    Merck 
MgCl2.6H2O                                                                         Carlo Erba 
MgSO4.7H2O                                                                        Carlo Erba 
MnCl2.4H2O                                                                         Carlo Erba 
Na2CO3                                                                                 Riedel deHaen  
Na3citrate.2H2O                                                                    Riedel deHaen 
NaCl                                                                                       Carlo Erba 
NaOH                                                                                     Carla Erba 
2-Nitrophyl β-D-galacto pyranoside (ONPG)                        Sigma 
Nutrient Broth                                                                         Merck 
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PEG 8000                                                                                Merck 
Phenol-chloroform-isoamylalcohol                                         Fluka 
Phenylalanin                                                                            Merck 
SDS                                                                                          Merck 
Spermine                                                                                  Fluka 
Sucrose                                                                                     Merck 
Tris-base                                                                                   Merck 
Triton-X100                                                                              Sigma 
Trypton                                                                                     Acumedia 
Tryptophan                                                                               Merck 
X-Gal                                                                                        Sigma  
Yeast Extract                                                                            Acumedia 
 
Enzymes 
BamHI                                                                                              Fermentas 
HindIII                                                                                              Fermentas 
Lysozyme                                                                                         AppliChem 
Proteinase K                                                                                      Sigma 
RNAse A                                                                                           Sigma 
Taq DNA Polymerase                                                                       Fermentas 
T4 DNA Ligase                                                                                 Roche 
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APPENDIX F 
Marker                                                                                       Supplier 
Lambda DNA/EcoRI+ HindIII Marker  (Marker 3)                    MBI Fermentas 
 
 
 
ΦX174 DNA/HinfI Marker (Marker 10)                       MBI Fermentas 
 
 
MassRuler™ DNA Ladder, Low range, ready-to-use              MBI Fermentas  
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APPENDIX G 
LABORATORY EQUIPMENT 
Autoclave: Tuttnauer Systec Autoclave (2540 mL) 
Balances: Precisa 620C SCS 
      Precisa 125 A SCS 
Centrifuge: Beckman Coulter, Microfuge 18  
Centrifuge rotor: F241.5P 
Deep freezes and refrigerators: -80°C Heto Ultrafreeze 4410 
           -20°C Arçelik 209lt 
            +4°C Arçelik 
Electrophoresis equipments: E – C mini cell primo EC320 
Gel documentation system: UVI PHotoMW Version 99.05 for Windows 
Incubators: Nüve EN400 
          Nüve EN500 
Orbital shaker incubators: Sertomat S – 2 
              Thermo 430 
Pipettes: Gilson pipetteman 10 μL, 20 μL, 200 μL, 1000 μL 
      Volumate Mettler Toledo 10 μL, 20 μL, 200 μL, 1000 μL 
      Eppendorf research 2,5 μL 10 μL, 20 μL, 200 μL, 1000 μL 
pH meter: Mettler Toledo MP220 
Spectrophotometer: PerkinElmer Lambda25 UV/VIS Spectrometer 
Thermomixer: Eppendorf thermomixer comfort (1.5 mL) 
Transillumunator: Biorad UV transilluminator 2000 
Vortexing machine: Heidolph Raax top  
Waterbaths: Memmert wb-22 
Ultrafiltration tube: VIVASPIN 
Power supply: Bio-Rad 
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